| 1 | Cord Tissue | Allogeneic - Related | Chronic renal disease | Endocrinology | 2025 | Experimental Therapy | Romania | 50 |
| 2 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2025 | Experimental Therapy | Romania | 6 |
| 3 | Cord Tissue | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 6 |
| 4 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 57,2 |
| 5 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3,1 |
| 6 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3,4 |
| 7 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 2,8 |
| 8 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5,9 |
| 9 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 11,9 |
| 10 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 54,2 |
| 11 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 78,4 |
| 12 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6,8 |
| 13 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 58,2 |
| 14 | Cord Tissue | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
| 15 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
| 16 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4,1 |
| 17 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 7,9 |
| 18 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7,8 |
| 19 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 25,8 |
| 20 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6,8 |
| 21 | Cord Tissue | Allogeneic - Unrelated | Progressive bulbar palsy | Neurology | 2025 | Experimental Therapy | Poland | 62,3 |
| 22 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2025 | Experimental Therapy | Poland | 67,2 |
| 23 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7,8 |
| 24 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 61,9 |
| 25 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5,11 |
| 26 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6,8 |
| 27 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1,5 |
| 28 | Cord Tissue | Allogeneic - Unrelated | Myelitis | Neurology | 2025 | Experimental Therapy | Poland | 38,8 |
| 29 | Cord Tissue | Allogeneic - Unrelated | Anemia | Neurology | 2025 | Experimental Therapy | Poland | 3,2 |
| 30 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6,8 |
| 31 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7,1 |
| 32 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2025 | Experimental Therapy | Poland | 5,1 |
| 33 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1,2 |
| 34 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 1,1 |
| 35 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5,11 |
| 36 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 5,9 |
| 37 | Cord Blood | Autologous | Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 2 |
| 38 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 6,8 |
| 39 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Portugal | 1 year and 8 months |
| 40 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
| 41 | Cord Blood | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
| 42 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 ,5 |
| 43 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7,2 |
| 44 | Cord Blood | Allogeneic | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 10,9 |
| 45 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4,1 |
| 46 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3,1 |
| 47 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5,2 |
| 48 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 2,11 |
| 49 | Cord Blood | Autologous | Unbalanced AVSD | Cardiovascular | 2025 | Experimental Therapy | Poland | 5 months |
| 50 | Cord Blood | Allogeneic - Related | Relapsed Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Turkey | 8,5 |
| 51 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 10,1 |
| 52 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5,7 |
| 53 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Poland | 71 |
| 54 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 72 |
| 55 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 47 |
| 56 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Ukraine | 43 |
| 57 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 49 |
| 58 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 51 |
| 59 | Bone Marrow Family | Allogeneic | Philadelphia - positive Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 60 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 58 |
| 61 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | NETHERLANDS | 63 |
| 62 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
| 63 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | France | 63 |
| 64 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 68 |
| 65 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | France | 71 |
| 66 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Russia | 51 |
| 67 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 68 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 54 |
| 69 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 16 |
| 70 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 61 |
| 71 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 61 |
| 72 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 70 |
| 73 | Bone Marrow Family | Allogeneic | postET myelofibrosis | Hematology | 2025 | Standard Therapy | Netherlands | 21 |
| 74 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 68 |
| 75 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia/ Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 76 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | NETHERLANDS | 60 |
| 77 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 33 |
| 78 | Bone Marrow Family | Allogeneic | Muscular Dystrophy Association | Hematology | 2025 | Standard Therapy | United Kingdom | 75 |
| 79 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2025 | Standard Therapy | Germany | 72 |
| 80 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 77 |
| 81 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 23 |
| 82 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 83 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2025 | Standard Therapy | Spain | 15 |
| 84 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Norway | 55 |
| 85 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2025 | Standard Therapy | France | 3 |
| 86 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 7 |
| 87 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Ukraine | 36 |
| 88 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2025 | Standard Therapy | France | 10 |
| 89 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 76 |
| 90 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 39 |
| 91 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | South Africa | 6 |
| 92 | Bone Marrow | Allogeneic | Wiskott-Aldrich syndrome | Hematology | 2025 | Standard Therapy | Turkey | 6 |
| 93 | Bone Marrow | Allogeneic | Combined immnunodeficiency | Hematology | 2025 | Standard Therapy | Ukraine | 3 months |
| 94 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2025 | Standard Therapy | Poland | 3 |
| 95 | Bone Marrow | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
| 96 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 7 |
| 97 | Bone Marrow | Allogeneic | B-cell precursor Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 56 |
| 98 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 43 |
| 99 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 19 |
| 100 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 12 |
| 101 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 5 |
| 102 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 10 months |
| 103 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 6 |
| 104 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 44 |
| 105 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2025 | Standard Therapy | Poland | 25 |
| 106 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 4 |
| 107 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | USA | 21 |
| 108 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 12 |
| 109 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Hungary | 10 |
| 110 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 68 |
| 111 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2025 | Standard Therapy | Poland | 53 |
| 112 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 4 |
| 113 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | France | 4 |
| 114 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2025 | Standard Therapy | Norway | 18 |
| 115 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Spain | 24 |
| 116 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Belarus | 5 |
| 117 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Germany | 53 |
| 118 | Bone Marrow | Allogeneic | diamond-Balckfan anemia | Hematology | 2025 | Standard Therapy | Germany | 11 |
| 119 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 57 |
| 120 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 61 |
| 121 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | France | 3 |
| 122 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Belarus | 1 |
| 123 | Bone Marrow | Allogeneic | pB-Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 15 |
| 124 | Bone Marrow | Allogeneic | OHID XIAP - Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein | Hematology | 2025 | Standard Therapy | Switzerland | 2 |
| 125 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 46 |
| 126 | Bone Marrow | Allogeneic | Acquired Idiopathic Sideroblastic Anemia | Hematology | 2025 | Standard Therapy | Russian Federation | 5 |
| 127 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 10 |
| 128 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | USA | 47 |
| 129 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | CROATIA | 11 |
| 130 | Bone Marrow | Allogeneic | Juvenile myelomonocytic leukemia | Hematology | 2025 | Standard Therapy | Poland | 5 |
| 131 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Brazil | 12 |
| 132 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Australia | 8 |
| 133 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 3 |
| 134 | Bone Marrow | Allogeneic | Myelodysplatic Syndrome | Hematology | 2025 | Standard Therapy | USA | 60 |
| 135 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Russia | 36 |
| 136 | Bone Marrow | Allogeneic | Thalassemia major | Hematology | 2025 | Standard Therapy | Turkey | 10 |
| 137 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 58 |
| 138 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 2 |
| 139 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | USA | 18 |
| 140 | Bone Marrow | Allogeneic | Other Non-Malignant Disease, Specify | Hematology | 2025 | Standard Therapy | USA | 17 |
| 141 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 15 |
| 142 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 15 |
| 143 | Bone Marrow | Allogeneic | aplastic anemia | Hematology | 2025 | Standard Therapy | Belgium | 36 |
| 144 | Bone Marrow | Allogeneic | Primary Refractory | Hematology | 2025 | Standard Therapy | Ireland | 27 |
| 145 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 39 |
| 146 | Bone Marrow | Allogeneic | Sickle Cell Disease (SCD) | Hematology | 2025 | Standard Therapy | Italy | 8 |
| 147 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 68 |
| 148 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 149 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 34 |
| 150 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 61 |
| 151 | Apheresis | Allogeneic | Myelodysplastic Syndrome/Myeloproliferative neoplasm | Hematology | 2025 | Standard Therapy | NETHERLANDS | 62 |
| 152 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Austria | 68 |
| 153 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 154 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 66 |
| 155 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 77 |
| 156 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 12 |
| 157 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 158 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 67 |
| 159 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 4 |
| 160 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 73 |
| 161 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 56 |
| 162 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 50 |
| 163 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 39 |
| 164 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 43 |
| 165 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 66 |
| 166 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2025 | Standard Therapy | USA | 61 |
| 167 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Austria | 55 |
| 168 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 69 |
| 169 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Denmark | 67 |
| 170 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | United Kingdom | 75 |
| 171 | Apheresis | Allogeneic | T - cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 24 |
| 172 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Belgium | 68 |
| 173 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 42 |
| 174 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 50 |
| 175 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 62 |
| 176 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | United Kingdom | 62 |
| 177 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 69 |
| 178 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 85 |
| 179 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 54 |
| 180 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | USA | 39 |
| 181 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 45 |
| 182 | Apheresis | Autologous | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 59 |
| 183 | Apheresis | Allogeneic | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 184 | Apheresis | Allogeneic | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 185 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 73 |
| 186 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 66 |
| 187 | Apheresis | Autologous | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 69 |
| 188 | Apheresis | Autologous | Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 38 |
| 189 | Apheresis | Allogeneic | Tcell acute leukemia | Hematology | 2025 | Standard Therapy | Romania | 31 |
| 190 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 37 |
| 191 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 69 |
| 192 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 55 |
| 193 | Apheresis | Allogeneic | Fanconi's Anemia | Hematology | 2025 | Standard Therapy | Russia | 14 |
| 194 | Apheresis | Allogeneic | Peripheral T-cell Lymphoma not otherwise specified | Hematology | 2025 | Standard Therapy | Germany | 54 |
| 195 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 63 |
| 196 | Apheresis | Allogeneic | Myeloid Sarcoma | Hematology | 2025 | Standard Therapy | Poland | 48 |
| 197 | Apheresis | Allogeneic | Other Myelofibrosis/Myelosclerosis | Hematology | 2025 | Standard Therapy | USA | 72 |
| 198 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Germany | 11 |
| 199 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 37 |
| 200 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Australia | 59 |
| 201 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 35 |
| 202 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 51 |
| 203 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 59 |
| 204 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 70 |
| 205 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 70 |
| 206 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 66 |
| 207 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 63 |
| 208 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 66 |
| 209 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Italy | 61 |
| 210 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 71 |
| 211 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 45 |
| 212 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Brazil | 61 |
| 213 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Hungary | 35 |
| 214 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | NETHERLANDS | 48 |
| 215 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2025 | Standard Therapy | Ireland | 62 |
| 216 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 62 |
| 217 | Apheresis | Allogeneic | Acute Myeloid Leukemia, Myelodysplasia-Related | Hematology | 2025 | Standard Therapy | Russia | 53 |
| 218 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 56 |
| 219 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 68 |
| 220 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 221 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 222 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 53 |
| 223 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 52 |
| 224 | Apheresis | Autologous | Diffuse large B-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 63 |
| 225 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 72 |
| 226 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 227 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 74 |
| 228 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 229 | Apheresis | Allogeneic | T-cell prolymphocytic leukemia | Hematology | 2025 | Standard Therapy | Germany | 53 |
| 230 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 231 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 232 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 54 |
| 233 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 41 |
| 234 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 32 |
| 235 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 72 |
| 236 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 52 |
| 237 | Apheresis | Allogeneic | Chronic Myeloid Leukemia | Hematology | 2025 | Standard Therapy | Poland | 50 |
| 238 | Apheresis | Allogeneic | T-cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 17 |
| 239 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 66 |
| 240 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Poland | 49 |
| 241 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2025 | Standard Therapy | Poland | 5 |
| 242 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 55 |
| 243 | Apheresis | Allogeneic | Diffuse Large B-cell Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 68 |
| 244 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 64 |
| 245 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 51 |
| 246 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 58 |
| 247 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
| 248 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 61 |
| 249 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
| 250 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 19 |
| 251 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
| 252 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2025 | Standard Therapy | Poland | 47 |
| 253 | Apheresis | Allogeneic | Polycythemia Vera | Hematology | 2025 | Standard Therapy | Poland | 61 |
| 254 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 56 |
| 255 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 53 |
| 256 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 55 |
| 257 | Apheresis | Allogeneic | Myelodysplastic Syndrome, Myeloproliferative Neoplasms | Hematology | 2025 | Standard Therapy | Poland | 34 |
| 258 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 50 |
| 259 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2025 | Standard Therapy | Poland | 71 |
| 260 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | Poland | 64 |
| 261 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 54 |
| 262 | Apheresis | Autologous | Non-Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 50 |
| 263 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 50 |
| 264 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 35 |
| 265 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 54 |
| 266 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 52 |
| 267 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 268 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 55 |
| 269 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 270 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 271 | Apheresis | Allogeneic | Primary myelofibrosis | Hematology | 2025 | Standard Therapy | Germany | 71 |
| 272 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 47 |
| 273 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 274 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 275 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Portugal | 44 |
| 276 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Portugal | 59 |
| 277 | Apheresis | Autologous | Lymphoma non-Hodgkin | Hematology | 2025 | Standard Therapy | Portugal | 58 |
| 278 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 59 |
| 279 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 2 |
| 280 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 41 |
| 281 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | France | 48 |
| 282 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 64 |
| 283 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | United Kingdom | 63 |
| 284 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 64 |
| 285 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 58 |
| 286 | Apheresis | Allogeneic | Myelodysplastic Syndrome, Myeloproliferative Neoplasms | Hematology | 2025 | Standard Therapy | Poland | 68 |
| 287 | Apheresis | Allogeneic | Myelodysplastic Syndrome, Myeloproliferative Neoplasms | Hematology | 2025 | Standard Therapy | Germany | 59 |
| 288 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 56 |
| 289 | Apheresis | Allogeneic | Diffuse Large B-cell Lymphoma | Hematology | 2025 | Standard Therapy | Belarus | 53 |
| 290 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 60 |
| 291 | Apheresis | Allogeneic | Immunodeficiency – LRBA | Hematology | 2025 | Standard Therapy | Turkey | 14 |
| 292 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 20 |
| 293 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 65 |
| 294 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 54 |
| 295 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 75 |
| 296 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 58 |
| 297 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 48 |
| 298 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 37 |
| 299 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Chile | 40 |
| 300 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 72 |
| 301 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Switzerland | 65 |
| 302 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Portugal | 68 |
| 303 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Estonia | 9 |
| 304 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | USA | 63 |
| 305 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 67 |
| 306 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 45 |
| 307 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 59 |
| 308 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 69 |
| 309 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 310 | Apheresis | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2025 | Standard Therapy | Germany | 42 |
| 311 | Apheresis | Autologous | Primary central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 312 | Apheresis | Allogeneic | myelodysplastic syndrome/ Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 313 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 42 |
| 314 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 55 |
| 315 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 72 |
| 316 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 317 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 318 | Apheresis | Autologous | Follicular lymphoma | Hematology | 2025 | Standard Therapy | Germany | 67 |
| 319 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 320 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 60 |
| 321 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Portugal | 64 |
| 322 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Portugal | 63 |
| 323 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 67 |
| 324 | Apheresis | Autologous | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 60 |
| 325 | Apheresis | Autologous | Hodgkin lymphoma rezidiv | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 326 | Apheresis | Autologous | Non-Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 327 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 67 |
| 328 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 329 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 330 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 331 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 66 |
| 332 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 55 |
| 333 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 60 |
| 334 | Apheresis | Allogeneic | Fanconi's Anemia | Hematology | 2025 | Standard Therapy | Ukraine | 6 |
| 335 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 69 |
| 336 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Lithuania | 54 |
| 337 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Macedonia | 56 |
| 338 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | CROATIA | 64 |
| 339 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 75 |
| 340 | Apheresis | Allogeneic | T-cell Lymphoma | Hematology | 2025 | Standard Therapy | NETHERLANDS | 65 |
| 341 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
| 342 | Apheresis | Allogeneic | Myeloid Sarcoma | Hematology | 2025 | Standard Therapy | Brazil | 48 |
| 343 | Apheresis | Allogeneic | T-cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 17 |
| 344 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | United Kingdom | 13 |
| 345 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 69 |
| 346 | Apheresis | Allogeneic | T-cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
| 347 | Apheresis | Allogeneic | B-cell precursor Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Slovakia | 67 |
| 348 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 72 |
| 349 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 52 |
| 350 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Belgium | 64 |
| 351 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Italy | 68 |
| 352 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Canada | 56 |
| 353 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 64 |
| 354 | Apheresis | Allogeneic | Other Myelofibrosis/Myelosclerosis | Hematology | 2025 | Standard Therapy | USA | 55 |
| 355 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 64 |
| 356 | Apheresis | Allogeneic | Myelodysplastic disorder | Hematology | 2025 | Standard Therapy | France | 63 |
| 357 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 63 |
| 358 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 20 |
| 359 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 23 |
| 360 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 73 |
| 361 | Apheresis | Allogeneic | Inherited Immune System Disorder | Hematology | 2025 | Standard Therapy | France | 9 |
| 362 | Apheresis | Allogeneic | Lymphoma - DLBCL | Hematology | 2025 | Standard Therapy | United Kingdom | 55 |
| 363 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 364 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 58 |
| 365 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 73 |
| 366 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 35 |
| 367 | Apheresis | Allogeneic | Chronic myelomonocytic leukemia | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 368 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 369 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 66 |
| 370 | Apheresis | Autologous | Diffuse large B-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 42 |
| 371 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Netherlands | 65 |
| 372 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 60 |
| 373 | Apheresis | Allogeneic | Post Mielofibrosis | Hematology | 2025 | Standard Therapy | Poland | 66 |
| 374 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 74 |
| 375 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 17 |
| 376 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 72 |
| 377 | Apheresis | Allogeneic | T-cell prolymphocytic leukemia | Hematology | 2025 | Standard Therapy | New Zealand | 64 |
| 378 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 379 | Apheresis | Allogeneic | mielofibrosis | Hematology | 2025 | Standard Therapy | Finland | 68 |
| 380 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 35 |
| 381 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 34 |
| 382 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Belgium | 63 |
| 383 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 72 |
| 384 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Switzerland | 69 |
| 385 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 52 |
| 386 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 26 |
| 387 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 50 |
| 388 | Apheresis | Allogeneic | Chronic Lymphocyte Leukemia | Hematology | 2025 | Standard Therapy | Poland | 71 |
| 389 | Apheresis | Allogeneic | anaplastic large cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 3 |
| 390 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 71 |
| 391 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 29 |
| 392 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 38 |
| 393 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 28 |
| 394 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 46 |
| 395 | Apheresis | Allogeneic | Hodking lymphoma | Hematology | 2025 | Standard Therapy | Spain | 28 |
| 396 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Slovakia | 52 |
| 397 | Apheresis | Allogeneic | T-NHL Angioimmunoblastic T-cell Lymphoma | Hematology | 2025 | Standard Therapy | Germany | 56 |
| 398 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 71 |
| 399 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 23 |
| 400 | Apheresis | Allogeneic | Mielodysplastic syndrome | Hematology | 2025 | Standard Therapy | Spain | 69 |
| 401 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Brazil | 71 |
| 402 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 36 |
| 403 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 404 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 405 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 61 |
| 406 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 35 |
| 407 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 39 |
| 408 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Serbia | 58 |
| 409 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | USA | 47 |
| 410 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Netherlands | 62 |
| 411 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 69 |
| 412 | Apheresis | Allogeneic | T-cell Lymphoma | Hematology | 2025 | Standard Therapy | United Kingdom | 35 |
| 413 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 71 |
| 414 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 415 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 416 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 71 |
| 417 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 39 |
| 418 | Apheresis | Autologous | Primary central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 419 | Apheresis | Allogeneic | Myelodysplastic syndrome | Hematology | 2025 | Standard Therapy | Germany | 56 |
| 420 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 421 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 422 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 60 |
| 423 | Apheresis | Autologous | Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 32 |
| 424 | Apheresis | Allogeneic | Myelodysplastic syndrome | Hematology | 2025 | Standard Therapy | Germany | 67 |
| 425 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 56 |
| 426 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Columbia | 62 |
| 427 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 46 |
| 428 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 66 |
| 429 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 46 |
| 430 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 33 |
| 431 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 31 |
| 432 | Apheresis | Allogeneic | B-Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 433 | Apheresis | Allogeneic | B-Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 62 |
| 434 | Apheresis | Allogeneic | Hemophagocytic lymphohistiocytosis | Hematology | 2025 | Standard Therapy | Czechia | 27 |
| 435 | Apheresis | Allogeneic | Shwachman-Diamond Syndrome | Hematology | 2025 | Standard Therapy | Spain | 11 |
| 436 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 67 |
| 437 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Canada | 60 |
| 438 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | CROATIA | 43 |
| 439 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 69 |
| 440 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Austria | 61 |
| 441 | Apheresis | Allogeneic | Other Immune System | Hematology | 2025 | Standard Therapy | USA | 62 |
| 442 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 74 |
| 443 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 63 |
| 444 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 66 |
| 445 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Denmark | 50 |
| 446 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 447 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Australia | 71 |
| 448 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 76 |
| 449 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Canada | 66 |
| 450 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 74 |
| 451 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2025 | Standard Therapy | Germany | 21 |
| 452 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2025 | Standard Therapy | France | 66 |
| 453 | Apheresis | Allogeneic | Mielodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 65 |
| 454 | Apheresis | Allogeneic | T Lymphoblastic Lymphoma | Hematology | 2025 | Standard Therapy | Portugal | 25 |
| 455 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Romania | 29 |
| 456 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 37 |
| 457 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 49 |
| 458 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 32 |
| 459 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 72 |
| 460 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 43 |
| 461 | Apheresis | Allogeneic | Hodking lymphoma | Hematology | 2025 | Standard Therapy | Serbia | 32 |
| 462 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Canada | 66 |
| 463 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 71 |
| 464 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 66 |
| 465 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 68 |
| 466 | Apheresis | Allogeneic | OMDS/ Myeloproliferative Neoplasie | Hematology | 2025 | Standard Therapy | Switzerland | 46 |
| 467 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 3 |
| 468 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 75 |
| 469 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 58 |
| 470 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Greece | 63 |
| 471 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 64 |
| 472 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 65 |
| 473 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Spain | 49 |
| 474 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 30 |
| 475 | Apheresis | Allogeneic | sAcute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 66 |
| 476 | Apheresis | Allogeneic | Chronic Lymphocyte Leukemia | Hematology | 2025 | Standard Therapy | Canada | 55 |
| 477 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 64 |
| 478 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 16 |
| 479 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 73 |
| 480 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 47 |
| 481 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 64 |
| 482 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 67 |
| 483 | Apheresis | Allogeneic | Other Myelofibrosis/Myelosclerosis | Hematology | 2025 | Standard Therapy | USA | 65 |
| 484 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 58 |
| 485 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | Germany | 57 |
| 486 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | RUSSIAN FEDERATION | 22 |
| 487 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 33 |
| 488 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Slovakia | 41 |
| 489 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Greece | 54 |
| 490 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Ukraine | 46 |
| 491 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Argentina | 26 |
| 492 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 70 |
| 493 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 59 |
| 494 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 34 |
| 495 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Norway | 53 |
| 496 | Apheresis | Allogeneic | Other Immune System | Hematology | 2025 | Standard Therapy | USA | 19 |
| 497 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 6 |
| 498 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 68 |
| 499 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 72 |
| 500 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 501 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 33 |
| 502 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Italy | 63 |
| 503 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 33 |
| 504 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 61 |
| 505 | Apheresis | Allogeneic | Acute lymphocytic leukemia | Hematology | 2025 | Standard Therapy | Germany | 51 |
| 506 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 507 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 54 |
| 508 | Apheresis | Autologous | Testicular tumor | Hematology | 2025 | Standard Therapy | Germany | 42 |
| 509 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 52 |
| 510 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 49 |
| 511 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 73 |
| 512 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 513 | Apheresis | Autologous | Lymphoma Hodgkin | Hematology | 2025 | Standard Therapy | Portugal | 39 |
| 514 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Germany | 60 |
| 515 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Germany | 70 |
| 516 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Germany | 64 |
| 517 | Apheresis | Autologous | T-Cell Lymphoma | Hematology | 2025 | Standard Therapy | Germany | 60 |
| 518 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Germany | 62 |
| 519 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2025 | Standard Therapy | Germany | 60 |
| 520 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Germany | 43 |
| 521 | Apheresis | Allogeneic | Myeofibrosis | Hematology | 2025 | Standard Therapy | Poland | 37 |
| 522 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Russia | 22 |
| 523 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | NETHERLANDS | 66 |
| 524 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 57 |
| 525 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 56 |
| 526 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 78 |
| 527 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 65 |
| 528 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 53 |
| 529 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Portugal | 41 |
| 530 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 56 |
| 531 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 22 |
| 532 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 36 |
| 533 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Canada | 65 |
| 534 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 71 |
| 535 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Sweden | 73 |
| 536 | Apheresis | Allogeneic | NK LGL Leukemia | Hematology | 2025 | Standard Therapy | USA | 42 |
| 537 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 29 |
| 538 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 71 |
| 539 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 540 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Czechia | 64 |
| 541 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 10 |
| 542 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Brazil | 57 |
| 543 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 21 |
| 544 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Lithuania | 54 |
| 545 | Apheresis | Allogeneic | Richter Transformation From CLL | Hematology | 2025 | Standard Therapy | Poland | 55 |
| 546 | Apheresis | Allogeneic | Richter Transformation From CLL | Hematology | 2025 | Standard Therapy | Poland | 63 |
| 547 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 68 |
| 548 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 55 |
| 549 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 26 |
| 550 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | NETHERLANDS | 63 |
| 551 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 33 |
| 552 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | KAZAKHSTAN | 10 |
| 553 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Italy | 53 |
| 554 | Apheresis | Allogeneic | Hodking Lymphoma | Hematology | 2025 | Standard Therapy | Belgium | 62 |
| 555 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 54 |
| 556 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 66 |
| 557 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Spain | 47 |
| 558 | Apheresis | Allogeneic | T-Cell Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 25 |
| 559 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Portugal | 62 |
| 560 | Apheresis | Autologous | No Data | Hematology | 2025 | Standard Therapy | Portugal | 65 |
| 561 | Cord Tissue | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
| 562 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
| 563 | Cord Tissue | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 4 |
| 564 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
| 565 | Cord Tissue | Allogeneic - Unrelated | Degenerative and Traumatic Cartilage | Orthopedy | 2024 | Experimental Therapy | Poland | 50,3 |
| 566 | Cord Tissue | Allogeneic - Unrelated | Degenerative and Traumatic Cartilage | Orthopedy | 2024 | Experimental Therapy | Poland | 49,5 |
| 567 | Cord Tissue | Allogeneic - Unrelated | Degenerative and Traumatic Cartilage | Orthopedy | 2024 | Experimental Therapy | Poland | 58,11 |
| 568 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2024 | Experimental Therapy | Poland | 7,7 |
| 569 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2024 | Experimental Therapy | Poland | 15,7 |
| 570 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2024 | Experimental Therapy | Poland | 48,1 |
| 571 | Cord Tissue | Allogeneic - Related | Severe Pulmonary Hypertension +Mitral Regurgitation | Cardiovascular/Pulmonary | 2024 | Experimental Therapy | Romania | 2,6 |
| 572 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic lateral sclerosis | Neurology | 2024 | Experimental Therapy | Poland | 57,6 |
| 573 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2024 | Experimental Therapy | Poland | 68,2 |
| 574 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2024 | Experimental Therapy | Romania | 17 |
| 575 | Cord Tissue | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 7 |
| 576 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2024 | Experimental Therapy | Poland | 61,9 |
| 577 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2024 | Experimental Therapy | Poland | 45,4 |
| 578 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic lateral sclerosis | Neurology | 2024 | Experimental Therapy | Poland | 56,9 |
| 579 | Cord Tissue | Allogeneic - Unrelated | Graft-versus-host disease | Hematology | 2024 | Experimental Therapy | Poland | 0,10 |
| 580 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic lateral sclerosis | Neurology | 2024 | Experimental Therapy | Poland | 39,0 |
| 581 | Cord Tissue | Allogeneic - Unrelated | GvHD | Neurology | 2024 | Experimental Therapy | Poland | 9,2 |
| 582 | Cord Tissue | Allogeneic - Unrelated | Cerebral palsy | Neurology | 2024 | Experimental Therapy | Poland | 5,11 |
| 583 | Cord Tissue | Allogeneic - Unrelated | Cerebral palsy | Neurology | 2024 | Experimental Therapy | Poland | 13,10 |
| 584 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2024 | Experimental Therapy | Poland | 1,9 |
| 585 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 7,11 |
| 586 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2024 | Experimental Therapy | Poland | 1 |
| 587 | Cord Tissue | Allogeneic - Unrelated | Cerebellar-spinal ataxia | Neurology | 2024 | Experimental Therapy | Poland | 35,5 |
| 588 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2024 | Experimental Therapy | Poland | 1,9 |
| 589 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 4,5 |
| 590 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 11 |
| 591 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 10 |
| 592 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
| 593 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 4 |
| 594 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 5 |
| 595 | Cord Blood | Allogeneic | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 3,5 |
| 596 | Cord Blood | Allogeneic | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 7,7 |
| 597 | Cord Blood | Autologous | CP | Neurology | 2024 | Experimental Therapy | Hungary | 4 |
| 598 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2024 | Experimental Therapy | Poland | 3,7 |
| 599 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2024 | Experimental Therapy | Poland | 5,9 |
| 600 | Cord Blood | Autologous | Pervasive developmental disorder | Neurology | 2024 | Experimental Therapy | Poland | 4,8 |
| 601 | Cord Blood | Allogeneic - Related | fanconi aplastic anemia | Hematology | 2024 | Standard Therapy | Turkey | 12 |
| 602 | Cord Blood | Autologous | Neuroblastoma | Neurology | 2024 | Standard Therapy | Poland | 4 |
| 603 | Cord Blood | Autologous | Pervasive developmental disorder | Neurology | 2024 | Experimental Therapy | Poland | 9,9 |
| 604 | Cord Blood | Autologous | Autism | Neurology | 2024 | no data | Slovakia | 4 |
| 605 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 606 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 607 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 75 |
| 608 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 56 |
| 609 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 23 |
| 610 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 54 |
| 611 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 612 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 613 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 614 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 48 |
| 615 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 72 |
| 616 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia Richter Transformation | Hematology | 2024 | Standard Therapy | Poland | 55 |
| 617 | Bone Marrow Family | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 63 |
| 618 | Bone Marrow Family | Allogeneic | Follicular Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 48 |
| 619 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 620 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 621 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 622 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome - Refractory Cytopenia Of Childhood | Hematology | 2024 | Standard Therapy | Poland | 14 |
| 623 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome/ Myeloproliferative Neoplasms | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 624 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome-MPN | Hematology | 2024 | Standard Therapy | Poland | 71 |
| 625 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 626 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 64 |
| 627 | Bone Marrow Family | Allogeneic | Polycythemia Vera/Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 74 |
| 628 | Bone Marrow Family | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 629 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 630 | Bone Marrow Family | Allogeneic | myelodysplasia | Hematology | 2024 | Standard Therapy | United Kingdom | 57 |
| 631 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 632 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 58 |
| 633 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 60 |
| 634 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 71 |
| 635 | Bone Marrow Family | Allogeneic | High risk Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 636 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 74 |
| 637 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
| 638 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 8 |
| 639 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
| 640 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 8 |
| 641 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 52 |
| 642 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 57 |
| 643 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
| 644 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 5 |
| 645 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 54 |
| 646 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 56 |
| 647 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 3 |
| 648 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2024 | Standard Therapy | Poland | 7 |
| 649 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2024 | Standard Therapy | Poland | 7 |
| 650 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2024 | Standard Therapy | Poland | 9 |
| 651 | Bone Marrow | Allogeneic | B-Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 7 |
| 652 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2024 | Standard Therapy | Poland | 4 |
| 653 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2024 | Standard Therapy | Poland | 41 |
| 654 | Bone Marrow | Allogeneic | Chronic Lymphocytic Leukemia Richter Transformation | Hematology | 2024 | Standard Therapy | Poland | 55 |
| 655 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 656 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
| 657 | Bone Marrow | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 61 |
| 658 | Bone Marrow | Allogeneic | Genetically Determined Thrombocytopenia | Hematology | 2024 | Standard Therapy | Poland | 4 |
| 659 | Bone Marrow | Allogeneic | High Risk Acute Myeloid Leukaemia | Hematology | 2024 | Standard Therapy | Poland | 13 |
| 660 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 32 |
| 661 | Bone Marrow | Allogeneic | Inherited Metabolic Disease | Hematology | 2024 | Standard Therapy | Poland | 11 |
| 662 | Bone Marrow | Allogeneic | Mds-Rcc Relapse | Hematology | 2024 | Standard Therapy | Poland | 14 |
| 663 | Bone Marrow | Allogeneic | Mixed Cellularity Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 43 |
| 664 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 14 |
| 665 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 8 |
| 666 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 14 |
| 667 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 668 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 9 |
| 669 | Bone Marrow | Allogeneic | Osteopetrosis type B | Hematology | 2024 | Standard Therapy | Poland | 13 |
| 670 | Bone Marrow | Allogeneic | Other Leukemia | Hematology | 2024 | Standard Therapy | Poland | 9 |
| 671 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2024 | Standard Therapy | Poland | 7 |
| 672 | Bone Marrow | Allogeneic | Primary Immunodeficiency Xlp-1 | Hematology | 2024 | Standard Therapy | Poland | 18 |
| 673 | Bone Marrow | Allogeneic | Relapse T-Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
| 674 | Bone Marrow | Allogeneic | Secondary Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 4 |
| 675 | Bone Marrow | Allogeneic | Secondary Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
| 676 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 7 |
| 677 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 3 |
| 678 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
| 679 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 21 |
| 680 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 18 |
| 681 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 49 |
| 682 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 16 |
| 683 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 24 |
| 684 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 13 |
| 685 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 14 |
| 686 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 21 |
| 687 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 7 |
| 688 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2024 | Standard Therapy | Poland | 2 |
| 689 | Bone Marrow | Allogeneic | Severe Congenital Neutropenia | Hematology | 2024 | Standard Therapy | Poland | 1 |
| 690 | Bone Marrow | Allogeneic | Shwachman-Diamond Syndrome | Hematology | 2024 | Standard Therapy | Poland | 10 |
| 691 | Bone Marrow | Allogeneic | Sickle Cell Disease | Hematology | 2024 | Standard Therapy | Poland | 9 |
| 692 | Bone Marrow | Allogeneic | Biphenotypic Acute Leukemia | Hematology | 2024 | Standard Therapy | Ukraine | 10 |
| 693 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 58 |
| 694 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | United Kingdom | 12 |
| 695 | Bone Marrow | Allogeneic | hemophagocytic lymphohistiocytosis | Hematology | 2024 | Standard Therapy | Sweden | 4 months |
| 696 | Bone Marrow | Allogeneic | Severe combined immunodeficiency | Hematology | 2024 | Standard Therapy | Germany | 1 |
| 697 | Bone Marrow | Allogeneic | Beta-Thalassemia Major | Hematology | 2024 | Standard Therapy | India | 11 |
| 698 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Austria | 4 |
| 699 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Norway | 33 |
| 700 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Spain | 16 |
| 701 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Switzerland | 5 |
| 702 | Bone Marrow | Allogeneic | T- Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Ireland | 6 |
| 703 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 12 |
| 704 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2024 | Standard Therapy | USA | 4 months |
| 705 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Belgium | 50 |
| 706 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | France | 31 |
| 707 | Bone Marrow | Allogeneic | Chronic myelomonocytic leukemia | Hematology | 2024 | Standard Therapy | Italy | 64 |
| 708 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | France | 10 |
| 709 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
| 710 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | USA | 4 |
| 711 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Canada | 8 |
| 712 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 17 |
| 713 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | USA | 8 |
| 714 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | USA | 67 |
| 715 | Bone Marrow | Allogeneic | Hodgkins Lymphoma | Hematology | 2024 | Standard Therapy | United Kingdom | 36 |
| 716 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 72 |
| 717 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 9 |
| 718 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2024 | Standard Therapy | USA | 3 |
| 719 | Apheresis | Allogeneic | A- Thalassemia | Hematology | 2024 | Standard Therapy | Poland | 11 |
| 720 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 13 |
| 721 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 21 |
| 722 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 22 |
| 723 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
| 724 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 41 |
| 725 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
| 726 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
| 727 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 48 |
| 728 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 50 |
| 729 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 50 |
| 730 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 55 |
| 731 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 732 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 733 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 63 |
| 734 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
| 735 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 736 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
| 737 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 34 |
| 738 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 1 |
| 739 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
| 740 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 20 |
| 741 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 25 |
| 742 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 26 |
| 743 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 28 |
| 744 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 34 |
| 745 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 35 |
| 746 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 37 |
| 747 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
| 748 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
| 749 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 40 |
| 750 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
| 751 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 43 |
| 752 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
| 753 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
| 754 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
| 755 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 756 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 757 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 758 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 759 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 760 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 61 |
| 761 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 61 |
| 762 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 763 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 764 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
| 765 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 766 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
| 767 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 768 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 769 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 770 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 771 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 772 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 773 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 774 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 775 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 776 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 777 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 72 |
| 778 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 73 |
| 779 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 77 |
| 780 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 781 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
| 782 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 58 |
| 783 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 54 |
| 784 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 29 |
| 785 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
| 786 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 27 |
| 787 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 788 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 63 |
| 789 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 50 |
| 790 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 791 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 30 |
| 792 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 793 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 77 |
| 794 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 795 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 47 |
| 796 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 797 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 798 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
| 799 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 61 |
| 800 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
| 801 | Apheresis | Allogeneic | Acute Myelogenous Leukemia- Core-Binding Factor | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 802 | Apheresis | Allogeneic | Acute Myelogenous Leukemia, Post Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 63 |
| 803 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 36 |
| 804 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 46 |
| 805 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
| 806 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 52 |
| 807 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 808 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 809 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 810 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 71 |
| 811 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 72 |
| 812 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 813 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 32 |
| 814 | Apheresis | Autologous | Acute Myeloid Leukemia - Relapse | Hematology | 2024 | Standard Therapy | Germany | 68 |
| 815 | Apheresis | Allogeneic | Acute Myeloid Leukemia Relapse | Hematology | 2024 | Standard Therapy | Germany | 33 |
| 816 | Apheresis | Allogeneic | Amegakaryocytic/Congenital Thrombocytopenia | Hematology | 2024 | Standard Therapy | Poland | 63 |
| 817 | Apheresis | Allogeneic | Anaplastic Large Cell Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 52 |
| 818 | Apheresis | Allogeneic | Angioimmunoblastic T-Cell Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 47 |
| 819 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 19 |
| 820 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 821 | Apheresis | Allogeneic | B-Cell Progenitor Acute Lymphoblastic Leukemia High Risk | Hematology | 2024 | Standard Therapy | Poland | 4 |
| 822 | Apheresis | Allogeneic | Calr Positive Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 61 |
| 823 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 824 | Apheresis | Allogeneic | Chronic Myelogenous Leukaemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 825 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
| 826 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 35 |
| 827 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 42 |
| 828 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 49 |
| 829 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 72 |
| 830 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 71 |
| 831 | Apheresis | Allogeneic | Fanconi Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 20 |
| 832 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 48 |
| 833 | Apheresis | Allogeneic | High Risk Acute Myeloid Leukaemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
| 834 | Apheresis | Allogeneic | High Risk Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 835 | Apheresis | Allogeneic | High-Risk Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 71 |
| 836 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 27 |
| 837 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 27 |
| 838 | Apheresis | Allogeneic | Hodgkin Disease | Hematology | 2024 | Standard Therapy | Poland | 28 |
| 839 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 23 |
| 840 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome/Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 71 |
| 841 | Apheresis | Allogeneic | Infant Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
| 842 | Apheresis | Allogeneic | Kutanes T-Zell-Lymphom, Mycosis Fungoides | Hematology | 2024 | Standard Therapy | Poland | 72 |
| 843 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 51 |
| 844 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 845 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 846 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 52 |
| 847 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 848 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Poland | 43 |
| 849 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 52 |
| 850 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 54 |
| 851 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 852 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 853 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 854 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 855 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 856 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 857 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 858 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 859 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 860 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 861 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 862 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 863 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 67 |
| 864 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 68 |
| 865 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 866 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
| 867 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 71 |
| 868 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 72 |
| 869 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 870 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 871 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 872 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 873 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 874 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 875 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
| 876 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 74 |
| 877 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 878 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 879 | Apheresis | Allogeneic | Myelodysplastic | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 880 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 20 |
| 881 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 22 |
| 882 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 54 |
| 883 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 884 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 885 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 886 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 887 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 888 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 889 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 890 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 891 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 892 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 893 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 71 |
| 894 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 73 |
| 895 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 896 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 53 |
| 897 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 69 |
| 898 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 899 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 900 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 49 |
| 901 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 52 |
| 902 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 63 |
| 903 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 66 |
| 904 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 58 |
| 905 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 906 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 907 | Apheresis | Allogeneic | Myelodysplastic Syndrome + Myeloma | Hematology | 2024 | Standard Therapy | Germany | 67 |
| 908 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 40 |
| 909 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 58 |
| 910 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 911 | Apheresis | Allogeneic | Myelofibrosis Post. Polycythemia Vera | Hematology | 2024 | Standard Therapy | Poland | 66 |
| 912 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 913 | Apheresis | Allogeneic | Myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 914 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2024 | Standard Therapy | Poland | 74 |
| 915 | Apheresis | Allogeneic | Myeloproliferative Neoplasms/Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 916 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 23 |
| 917 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 50 |
| 918 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 50 |
| 919 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 67 |
| 920 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 46 |
| 921 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 922 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 923 | Apheresis | Autologous | Non-Hodgkin Lymphoma - relapse | Hematology | 2024 | Standard Therapy | Germany | 54 |
| 924 | Apheresis | Autologous | Nonseminoma | Hematology | 2024 | Standard Therapy | Germany | 38 |
| 925 | Apheresis | Allogeneic | Osteomyelitis | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 926 | Apheresis | Allogeneic | Post-Et-Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 59 |
| 927 | Apheresis | Allogeneic | Post-Pv-Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 64 |
| 928 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 929 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 52 |
| 930 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 931 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 70 |
| 932 | Apheresis | Allogeneic | Relapsed B-Cell Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
| 933 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
| 934 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
| 935 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 936 | Apheresis | Allogeneic | Severe Aplastic Anemia Progressed To Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 21 |
| 937 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 938 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 939 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 56 |
| 940 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 56 |
| 941 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 942 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 56 |
| 943 | Apheresis | Autologous | Follicular lymphoma | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 944 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 945 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 47 |
| 946 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 947 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 38 |
| 948 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 949 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
| 950 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 951 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 53 |
| 952 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 953 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 59 |
| 954 | Apheresis | Autologous | Mantle cell lymphoma | Hematology | 2024 | Standard Therapy | Germany | 45 |
| 955 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 956 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 33 |
| 957 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 958 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 59 |
| 959 | Apheresis | Allogeneic | Primary myelofibrosis | Hematology | 2024 | Standard Therapy | Germany | 55 |
| 960 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 961 | Apheresis | Allogeneic | Blastic Plasmacytoid Dendritic | Hematology | 2024 | Standard Therapy | USA | 57 |
| 962 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 32 |
| 963 | Apheresis | Allogeneic | Macrofocal multiple myeloma | Hematology | 2024 | Standard Therapy | USA | 75 |
| 964 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | United Kingdom | 62 |
| 965 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 52 |
| 966 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
| 967 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | United Kingdom | 71 |
| 968 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Romania | 35 |
| 969 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Lithuania | 47 |
| 970 | Apheresis | Allogeneic | Diffuse large B-cell lymphoma | Hematology | 2024 | Standard Therapy | Australia | 46 |
| 971 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 65 |
| 972 | Apheresis | Allogeneic | Chronic lymphatic leukemia | Hematology | 2024 | Standard Therapy | Norway | 52 |
| 973 | Apheresis | Allogeneic | Chronic myelogenous leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 974 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Hungary | 32 |
| 975 | Apheresis | Allogeneic | Malignant histiocytosis | Hematology | 2024 | Standard Therapy | Bulgaria | 41 |
| 976 | Apheresis | Allogeneic | Myelodysplastic syndrome | Hematology | 2024 | Standard Therapy | USA | 78 |
| 977 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Hungary | 20 |
| 978 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 58 |
| 979 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Portugal | 67 |
| 980 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 63 |
| 981 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Lithuania | 19 |
| 982 | Apheresis | Allogeneic | Hodgkin lymphoma | Hematology | 2024 | Standard Therapy | Russia | 34 |
| 983 | Apheresis | Allogeneic | chronic lymphocytic leukemia Richters Transformation | Hematology | 2024 | Standard Therapy | United Kingdom | 68 |
| 984 | Apheresis | Allogeneic | myelodysplasia | Hematology | 2024 | Standard Therapy | Sweden | 66 |
| 985 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 52 |
| 986 | Apheresis | Allogeneic | myelodysplasia | Hematology | 2024 | Standard Therapy | Lithuania | 70 |
| 987 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 72 |
| 988 | Apheresis | Allogeneic | plasma cell leukemia | Hematology | 2024 | Standard Therapy | USA | 59 |
| 989 | Apheresis | Allogeneic | Fibrolamellar Carcinoma | Hematology | 2024 | Standard Therapy | Czechia | 41 |
| 990 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 59 |
| 991 | Apheresis | Allogeneic | post-ET Myelofibrose | Hematology | 2024 | Standard Therapy | Austria | 61 |
| 992 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 55 |
| 993 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2024 | Standard Therapy | Poland | 67 |
| 994 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Spain | 45 |
| 995 | Apheresis | Allogeneic | Myelofibrose | Hematology | 2024 | Standard Therapy | Spain | 69 |
| 996 | Apheresis | Allogeneic | Myelofibrose | Hematology | 2024 | Standard Therapy | Poland | 60 |
| 997 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | USA | 53 |
| 998 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 35 |
| 999 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 69 |
| 1000 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Norway | 18 |
| 1001 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 51 |
| 1002 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 1003 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Hungary | 56 |
| 1004 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | USA | 19 |
| 1005 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Spain | 67 |
| 1006 | Apheresis | Allogeneic | emophagocytic lymphohistiocytosis | Hematology | 2024 | Standard Therapy | United Kingdom | 48 |
| 1007 | Apheresis | Allogeneic | Non-Hodgkin's lymphoma | Hematology | 2024 | Standard Therapy | NETHERLANDS | 61 |
| 1008 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 29 |
| 1009 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 1010 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Israel | 63 |
| 1011 | Apheresis | Allogeneic | ETP-Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 35 |
| 1012 | Apheresis | Allogeneic | Hodgkin lymphoma | Hematology | 2024 | Standard Therapy | Poland | 4 |
| 1013 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 23 |
| 1014 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2024 | Standard Therapy | USA | 27 |
| 1015 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 69 |
| 1016 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 44 |
| 1017 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 49 |
| 1018 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 20 |
| 1019 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 50 |
| 1020 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 74 |
| 1021 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Austria | 49 |
| 1022 | Apheresis | Allogeneic | Post-PV Myelofibrose | Hematology | 2024 | Standard Therapy | Germany | 59 |
| 1023 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 66 |
| 1024 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 58 |
| 1025 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 55 |
| 1026 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | France | 70 |
| 1027 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | France | 54 |
| 1028 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 68 |
| 1029 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 41 |
| 1030 | Apheresis | Allogeneic | Chronic myelogenous leukemia | Hematology | 2024 | Standard Therapy | USA | 31 |
| 1031 | Apheresis | Allogeneic | Other leukemia | Hematology | 2024 | Standard Therapy | Italy | 31 |
| 1032 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Sweden | 42 |
| 1033 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 43 |
| 1034 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 52 |
| 1035 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 1036 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 1037 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
| 1038 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 1039 | Apheresis | Allogeneic | Primary myelofibrosis | Hematology | 2024 | Standard Therapy | Germany | 55 |
| 1040 | Apheresis | Autologous | Amyloid light-chain amyloidosis | Hematology | 2024 | Standard Therapy | Germany | 55 |
| 1041 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 1042 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 1043 | Apheresis | Autologous | Epstein–Barr virus positive diffuse large B-cell lymphoma | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 1044 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 69 |
| 1045 | Apheresis | Autologous | Angioimmunoblastic T-cell lymphoma | Hematology | 2024 | Standard Therapy | Germany | 58 |
| 1046 | Apheresis | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2024 | Standard Therapy | Germany | 19 |
| 1047 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 1048 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 1049 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Canada | 16 |
| 1050 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 61 |
| 1051 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 75 |
| 1052 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | USA | 62 |
| 1053 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2024 | Standard Therapy | France | 66 |
| 1054 | Apheresis | Allogeneic | B-Cell Lymphoma | Hematology | 2024 | Standard Therapy | Canada | 70 |
| 1055 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 60 |
| 1056 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2024 | Standard Therapy | Poland | 57 |
| 1057 | Apheresis | Allogeneic | Diffuse large B-cell lymphoma | Hematology | 2024 | Standard Therapy | Poland | 17 |
| 1058 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 48 |
| 1059 | Apheresis | Allogeneic | Chronic lymphocytic leukemia | Hematology | 2024 | Standard Therapy | Germany | 63 |
| 1060 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
| 1061 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 64 |
| 1062 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 76 |
| 1063 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
| 1064 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
| 1065 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | NETHERLANDS | 25 |
| 1066 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | USA | 42 |
| 1067 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | CROATIA | 66 |
| 1068 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 70 |
| 1069 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Switzerland | 68 |
| 1070 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukaemia | Hematology | 2024 | Standard Therapy | NETHERLANDS | 62 |
| 1071 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 58 |
| 1072 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 1073 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Belarus | 54 |
| 1074 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Spain | 9 |
| 1075 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
| 1076 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 67 |
| 1077 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 54 |
| 1078 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | South Africa | 54 |
| 1079 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 60 |
| 1080 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Sweden | 60 |
| 1081 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Spain | 67 |
| 1082 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 1083 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 53 |
| 1084 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 1085 | Apheresis | Autologous | Non-Hodgkin lymphoma, rezidiv | Hematology | 2024 | Standard Therapy | Germany | 64 |
| 1086 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 57 |
| 1087 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 66 |
| 1088 | Apheresis | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2024 | Standard Therapy | Germany | 50 |
| 1089 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 57 |
| 1090 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 70 |
| 1091 | Apheresis | Allogeneic | Multiple Organ Dysfunction Syndrome | Hematology | 2024 | Standard Therapy | Germany | 42 |
| 1092 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 32 |
| 1093 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 76 |
| 1094 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Italy | 63 |
| 1095 | Apheresis | Allogeneic | Early T-cell precursor Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Australia | 43 |
| 1096 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 72 |
| 1097 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 72 |
| 1098 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 52 |
| 1099 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 73 |
| 1100 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 68 |
| 1101 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 63 |
| 1102 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Czechia | 46 |
| 1103 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 64 |
| 1104 | Apheresis | Allogeneic | Primary Immunodeficiencies | Hematology | 2024 | Standard Therapy | Russia | 7 |
| 1105 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 68 |
| 1106 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 1107 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
| 1108 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 63 |
| 1109 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Spain | 58 |
| 1110 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
| 1111 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | USA | 73 |
| 1112 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
| 1113 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 1114 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
| 1115 | Apheresis | Allogeneic | Plasmacytoma | Hematology | 2024 | Standard Therapy | Poland | 46 |
| 1116 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Portugal | 60 |
| 1117 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Portugal | 60 |
| 1118 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2023 | Experimental Therapy | Poland | 8 |
| 1119 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2023 | Experimental Therapy | Poland | 16 |
| 1120 | Cord Tissue | Allogeneic - Related | Ags (Autism + Epilepsy) | Neurology | 2023 | Experimental Therapy | Poland/Romania | 15 |
| 1121 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 8,5 |
| 1122 | Cord Tissue | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 10 |
| 1123 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 4 |
| 1124 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 1125 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3,2 |
| 1126 | Cord Tissue | Autologous | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 2 |
| 1127 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 1128 | Cord Tissue | Allogeneic - Unrelated | Disorders Of Optic Nerve | Ophthalmology | 2023 | Experimental Therapy | Poland | 39,1 |
| 1129 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2023 | Experimental Therapy | Poland | 65,1 |
| 1130 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2023 | Experimental Therapy | Poland | 50,8 |
| 1131 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2023 | Experimental Therapy | Poland | 8 months |
| 1132 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2023 | Experimental Therapy | Poland | 16,2 |
| 1133 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 20,8 |
| 1134 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 49,8 |
| 1135 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 62,7 |
| 1136 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 24,1 |
| 1137 | Cord Tissue | Allogeneic - Unrelated | Mucopolysaccharidosis Type Ii | Hematology | 2023 | Experimental Therapy | Poland | 4,7 |
| 1138 | Cord Tissue | Allogeneic - Unrelated | Non-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The Uterus | Gynecology | 2023 | Experimental Therapy | Poland | 47 |
| 1139 | Cord Tissue | Autologous | Optic Nerve Atrophy, Tetraparesis, Hydrocephalus | Neurology | 2023 | Experimental Therapy | Romania | 5,5 |
| 1140 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2023 | Experimental Therapy | Poland | 44,8 |
| 1141 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2023 | Experimental Therapy | Poland | 32,11 |
| 1142 | Cord Tissue | Allogeneic - Unrelated | Polycystic Ovary Syndrome | Gynecology | 2023 | Experimental Therapy | Poland | 39,4 |
| 1143 | Cord Tissue | Allogeneic - Related | Right Parietal Closed Schizencephaly | Neurology | 2023 | Experimental Therapy | Romania | 38 |
| 1144 | Cord Tissue | Allogeneic - Related | Rp+ Usher Syndrome | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 1145 | Cord Tissue | Allogeneic - Related | Sudden Sensorineural Hearing Loss (Ssnhl) | Neurology | 2023 | Experimental Therapy | Romania | 1 |
| 1146 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 10 |
| 1147 | Cord Blood | Allogeneic | Autism | Neurology | 2023 | Experimental Therapy | Poland | 3,3 |
| 1148 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 1149 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 1150 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 1151 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Portugal | 7 |
| 1152 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Portugal | 5 |
| 1153 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 14 |
| 1154 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 1155 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 3 |
| 1156 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3,2 |
| 1157 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 5 |
| 1158 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2023 | Standard Therapy | UK | 8 |
| 1159 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Hungary | 5 |
| 1160 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Standard Therapy | UK | 2,5 |
| 1161 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Standard Therapy | UK | 2,5 |
| 1162 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Poland | 2,1 |
| 1163 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 1164 | Cord Blood | Allogeneic - Related | Cerebral Palsy, Psychomotor Retard, Tetraparesis, Microcephaly | Neurology | 2023 | Experimental Therapy | Romania | 9 |
| 1165 | Cord Blood | Autologous | Global Developmental Delay Si Truncal Ataxia | Neurology | 2023 | Experimental Therapy | Romania | 5 |
| 1166 | Cord Blood | Allogeneic | Neuroblastoma | Hematology | 2023 | Standard Therapy | Turkey | 2,1 |
| 1167 | Cord Blood | Allogeneic - Related | Neuroblastoma | Hematology | 2023 | Standard Therapy | Turkey | 2,1 |
| 1168 | Cord Blood | Autologous | Optic Nerve Atrophy, Tetraparesis, Hydrocephalus | Neurology | 2023 | Experimental Therapy | Romania | 5,5 |
| 1169 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2023 | Experimental Therapy | Poland | 3,11 |
| 1170 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2023 | Experimental Therapy | Poland | 8,1 |
| 1171 | Cord Blood | Allogeneic - Related | Spasmodic Torticollis | Neurology | 2023 | Experimental Therapy | Romania | 41 |
| 1172 | Cord Blood | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Turkey | 17,4 |
| 1173 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2023 | Standard Therapy | Turkey | 17,4 |
| 1174 | Cord Blood | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 months |
| 1175 | Cord Blood | Autologous | Autism | Neurology | 2023 | no data | Slovakia | 2 |
| 1176 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 1177 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 1178 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 35 |
| 1179 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 1180 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1181 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1182 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 1183 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 1184 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 1185 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1186 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1187 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 39 |
| 1188 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1189 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 1190 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1191 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1192 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1193 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 1194 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1195 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1196 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1197 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1198 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1199 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1200 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1201 | Bone Marrow Family | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
| 1202 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1203 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1204 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1205 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 76 |
| 1206 | Bone Marrow Family | Allogeneic | Langerhans Cell Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1207 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1208 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1209 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1210 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1211 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1212 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Germany | 70 |
| 1213 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1214 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1215 | Bone Marrow Family | Allogeneic | Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1216 | Bone Marrow Family | Allogeneic | Secondary Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 1217 | Bone Marrow Family | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1218 | Bone Marrow Family | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1219 | Bone Marrow | Allogeneic | Acute Leukemia Of Ambiguous Lineage | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1220 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1221 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1222 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 1223 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 1224 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 1225 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1226 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 25 |
| 1227 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 1228 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1229 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 months |
| 1230 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 1231 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1232 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1233 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 1234 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 1235 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1236 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 1237 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1238 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1239 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
| 1240 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 1241 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
| 1242 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 1243 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 1244 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 1245 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 1246 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 1247 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1248 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 75 |
| 1249 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1250 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
| 1251 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 1252 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 1253 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 34 |
| 1254 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 1255 | Bone Marrow | Allogeneic | Adrenoleukodystrophy (Ald) - Siemerling-Creutzfeldt Disease | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1256 | Bone Marrow | Allogeneic | Amegakaryocytic Thrombocytopenia | Hematology | 2023 | Standard Therapy | Poland | 6 months |
| 1257 | Bone Marrow | Allogeneic | Anemia Fanconi | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 1258 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 18 |
| 1259 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 1260 | Bone Marrow | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 1261 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 1262 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1263 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1264 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 1265 | Bone Marrow | Allogeneic | Chronic Myeloid Leukemia Blast Crisis | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 1266 | Bone Marrow | Allogeneic | Clippers Syndrome | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1267 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2023 | Standard Therapy | Poland | 6 months |
| 1268 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 1269 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1270 | Bone Marrow | Allogeneic | Hodgkin’s Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 23 |
| 1271 | Bone Marrow | Allogeneic | Immunodeficiency – Xlp1 | Hematology | 2023 | Standard Therapy | Poland | 10 |
| 1272 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1273 | Bone Marrow | Allogeneic | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1274 | Bone Marrow | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 22 |
| 1275 | Bone Marrow | Allogeneic | Mitochondrial Neurogastrointestinal Encephalopathy | Hematology | 2023 | Standard Therapy | Poland | 33 |
| 1276 | Bone Marrow | Allogeneic | Mixed Lineage Acute Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1277 | Bone Marrow | Allogeneic | Monocytopenia And Mycobacterial Infection (Monomac) Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1278 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1279 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Ih (Hurler) | Hematology | 2023 | Standard Therapy | Poland | 8 months |
| 1280 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Iv | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1281 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1282 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1283 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 1284 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 1285 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 1286 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 19 |
| 1287 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 1288 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1289 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1290 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 1291 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 |
| 1292 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 months |
| 1293 | Bone Marrow | Allogeneic | Primary Combined Severe Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 14 |
| 1294 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 1295 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1296 | Bone Marrow | Allogeneic | Prolymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1297 | Bone Marrow | Allogeneic | Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1298 | Bone Marrow | Allogeneic | Secondary Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 1299 | Bone Marrow | Allogeneic | Secondary Myelofibrosis Post Polycythemia Vera | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1300 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1301 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1302 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
| 1303 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1304 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 1305 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 1306 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 1307 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 81 |
| 1308 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 29 |
| 1309 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 1310 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1311 | Bone Marrow | Allogeneic | Sickle Cell Disease | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1312 | Bone Marrow | Allogeneic | T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 1313 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 1314 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1315 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 1316 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1317 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 3 |
| 1318 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 67 |
| 1319 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1320 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1321 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 1322 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
| 1323 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1324 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1325 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1326 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
| 1327 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
| 1328 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1329 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 54 |
| 1330 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1331 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 1332 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 1333 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 40 |
| 1334 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1335 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 35 |
| 1336 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1337 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1338 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 39 |
| 1339 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1340 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1341 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1342 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 19 |
| 1343 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 1344 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1345 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 1346 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 48 |
| 1347 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 47 |
| 1348 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 64 |
| 1349 | Apheresis | Autologous | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 61 |
| 1350 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 1351 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1352 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 1353 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1354 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
| 1355 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1356 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 31 |
| 1357 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
| 1358 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1359 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1360 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 58 |
| 1361 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 1362 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
| 1363 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 1364 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1365 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1366 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1367 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1368 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1369 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 1370 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1371 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1372 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 1373 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1374 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1375 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1376 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 87 |
| 1377 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1378 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1379 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1380 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 1381 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1382 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 1383 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 33 |
| 1384 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1385 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1386 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1387 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 1388 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1389 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1390 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 1391 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1392 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1393 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1394 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1395 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
| 1396 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1397 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1398 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 82 |
| 1399 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1400 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1401 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 1402 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1403 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1404 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 1405 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1406 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1407 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 61 |
| 1408 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
| 1409 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1410 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1411 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1412 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1413 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 75 |
| 1414 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1415 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 7 |
| 1416 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
| 1417 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 1418 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1419 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1420 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 1421 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1422 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1423 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1424 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1425 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1426 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1427 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1428 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1429 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1430 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 35 |
| 1431 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 48 |
| 1432 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1433 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1434 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 1435 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
| 1436 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 74 |
| 1437 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1438 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1439 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1440 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1441 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
| 1442 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1443 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 1444 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1445 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1446 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 79 |
| 1447 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1448 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1449 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1450 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 1451 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1452 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 1453 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
| 1454 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1455 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1456 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 1457 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 1458 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1459 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1460 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1461 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1462 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1463 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1464 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 36 |
| 1465 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1466 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1467 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1468 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1469 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1470 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1471 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1472 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1473 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1474 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1475 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 1476 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 36 |
| 1477 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1478 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1479 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1480 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1481 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 22 |
| 1482 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1483 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1484 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 38 |
| 1485 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
| 1486 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
| 1487 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1488 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1489 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1490 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1491 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1492 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1493 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1494 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 1495 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1496 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1497 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1498 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 39 |
| 1499 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1500 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1501 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1502 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 1503 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1504 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1505 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1506 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1507 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1508 | Apheresis | Autologous | Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 37 |
| 1509 | Apheresis | Allogeneic | Bare Lymphocyte Syndrome Type Ii | Hematology | 2023 | Standard Therapy | Poland | 3 months |
| 1510 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1511 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1512 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 66 |
| 1513 | Apheresis | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1514 | Apheresis | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 27 |
| 1515 | Apheresis | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1516 | Apheresis | Allogeneic | Beta Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1517 | Apheresis | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1518 | Apheresis | Allogeneic | Cell Neoplasm | Hematology | 2023 | Standard Therapy | Germany | 47 |
| 1519 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1520 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 1521 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Germany | 36 |
| 1522 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1523 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 1524 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
| 1525 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 1526 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1527 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1528 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1529 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Germany | 28 |
| 1530 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1531 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1532 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1533 | Apheresis | Autologous | Composite Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 71 |
| 1534 | Apheresis | Allogeneic | Congenital Pulmonary Lymphangiectasia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1535 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 59 |
| 1536 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1537 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 70 |
| 1538 | Apheresis | Allogeneic | Ewing Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1539 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 62 |
| 1540 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1541 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2023 | Standard Therapy | Poland | 4 months |
| 1542 | Apheresis | Autologous | Hodgkin - Relapse | Hematology | 2023 | Standard Therapy | Germany | 43 |
| 1543 | Apheresis | Allogeneic | Huntington's Disease (Hd) | Hematology | 2023 | Standard Therapy | Germany | 36 |
| 1544 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 27 |
| 1545 | Apheresis | Allogeneic | Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 4 |
| 1546 | Apheresis | Allogeneic | Inherited Immune System Disorder | Hematology | 2023 | Standard Therapy | Poland | 16 |
| 1547 | Apheresis | Allogeneic | Langerhans Cell Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1548 | Apheresis | Autologous | Light-Chain Amyloidosis | Hematology | 2023 | Standard Therapy | Germany | 62 |
| 1549 | Apheresis | Allogeneic | Macrofocal Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 94 |
| 1550 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 54 |
| 1551 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 64 |
| 1552 | Apheresis | Allogeneic | Mast Cell Sarcoma, Systemic Mastocytosis Nr | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 1553 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1554 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2023 | Standard Therapy | Germany | 43 |
| 1555 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2023 | Standard Therapy | Germany | 57 |
| 1556 | Apheresis | Allogeneic | Mucopolysaccharidosis /Myelodysplastic Syndrome Overlap | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1557 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 47 |
| 1558 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 53 |
| 1559 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 65 |
| 1560 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 1561 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1562 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1563 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 72 |
| 1564 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 61 |
| 1565 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 68 |
| 1566 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 54 |
| 1567 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 67 |
| 1568 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 69 |
| 1569 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 61 |
| 1570 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1571 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1572 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 61 |
| 1573 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 64 |
| 1574 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 69 |
| 1575 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 58 |
| 1576 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 56 |
| 1577 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 66 |
| 1578 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1579 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1580 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 53 |
| 1581 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 66 |
| 1582 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
| 1583 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
| 1584 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 64 |
| 1585 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1586 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 68 |
| 1587 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 1588 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 42 |
| 1589 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 62 |
| 1590 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 50 |
| 1591 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
| 1592 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 56 |
| 1593 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 64 |
| 1594 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
| 1595 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1596 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1597 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1598 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1599 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1600 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1601 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 1602 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1603 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1604 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1605 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1606 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 29 |
| 1607 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1608 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1609 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 40 |
| 1610 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1611 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1612 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 1613 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1614 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1615 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1616 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1617 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1618 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1619 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1620 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1621 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1622 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 44 |
| 1623 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1624 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 48 |
| 1625 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 45 |
| 1626 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1627 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1628 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1629 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 1630 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1631 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1632 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 1633 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 74 |
| 1634 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1635 | Apheresis | Allogeneic | Myelodysplastic Syndrome Lb High Risk | Hematology | 2023 | Standard Therapy | Poland | 58 |
| 1636 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Multilineage Dysplasia | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1637 | Apheresis | Allogeneic | Myelodysplastic Syndrome/Acute Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 1638 | Apheresis | Allogeneic | Myelodysplastic Syndrome-Eb1 | Hematology | 2023 | Standard Therapy | Poland | 48 |
| 1639 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 73 |
| 1640 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 76 |
| 1641 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1642 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 1643 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1644 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1645 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1646 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1647 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1648 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1649 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1650 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1651 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1652 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1653 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1654 | Apheresis | Autologous | No Data | Hematology | 2023 | Standard Therapy | Germany | 69 |
| 1655 | Apheresis | Autologous | No Data | Hematology | 2023 | Standard Therapy | Germany | 53 |
| 1656 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 1657 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 23 |
| 1658 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 39 |
| 1659 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1660 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 52 |
| 1661 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1662 | Apheresis | Autologous | No Data | Hematology | 2023 | Standard Therapy | Germany | 60 |
| 1663 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1664 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 44 |
| 1665 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 72 |
| 1666 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
| 1667 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 33 |
| 1668 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 1669 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1670 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 19 |
| 1671 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 54 |
| 1672 | Apheresis | Autologous | Nonseminoma, Relapse | Hematology | 2023 | Standard Therapy | Germany | 48 |
| 1673 | Apheresis | Allogeneic | Orofacial Myofunctional Disorders (Omds), Primary Myelofibrosis (Pmf) | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 1674 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1675 | Apheresis | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 71 |
| 1676 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 1677 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 1678 | Apheresis | Allogeneic | Other Non-Malignant Disease | Hematology | 2023 | Standard Therapy | Poland | 70 |
| 1679 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2023 | Standard Therapy | Poland | 36 |
| 1680 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 1681 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2023 | Standard Therapy | Germany | 70 |
| 1682 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2023 | Standard Therapy | Germany | 56 |
| 1683 | Apheresis | Autologous | Plasmacytoma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1684 | Apheresis | Allogeneic | Post Therapeutic Myelodysplastic Syndrome /Acute Myelogenous Leukemia After Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 1685 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 38 |
| 1686 | Apheresis | Allogeneic | Pra B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
| 1687 | Apheresis | Allogeneic | Pre-B-Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 1688 | Apheresis | Allogeneic | Pre-B-Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 1689 | Apheresis | Allogeneic | Pre-B-Acute Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1690 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 63 |
| 1691 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 73 |
| 1692 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Germany | 70 |
| 1693 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1694 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1695 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 31 |
| 1696 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1697 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Germany | 46 |
| 1698 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
| 1699 | Apheresis | Allogeneic | Relapsed B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
| 1700 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 1701 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
| 1702 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 36 |
| 1703 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 1704 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 9 |
| 1705 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 1706 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
| 1707 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 1 |
| 1708 | Apheresis | Allogeneic | Systemic Mastocytosis | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 1709 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
| 1710 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
| 1711 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
| 1712 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1713 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 18 |
| 1714 | Apheresis | Allogeneic | T-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 65 |
| 1715 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1716 | Apheresis | Allogeneic | Treatment-Related Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 1717 | Apheresis | Allogeneic | Treatment-Related Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
| 1718 | Apheresis | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 2 |
| 1719 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 15 |
| 1720 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 6 |
| 1721 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 12 |
| 1722 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 7 |
| 1723 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 2 |
| 1724 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia | Hematology | 2022 | Experimental Therapy | Poland | 4,6 |
| 1725 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia | Hematology | 2022 | Experimental Therapy | Poland | 5,4 |
| 1726 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 42,8 |
| 1727 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 60,5 |
| 1728 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 69,7 |
| 1729 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 70,5 |
| 1730 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 54,2 |
| 1731 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 76,1 |
| 1732 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,3 |
| 1733 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 9,1 |
| 1734 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 3,9 |
| 1735 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,3 |
| 1736 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,8 |
| 1737 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 1738 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 12,8 |
| 1739 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,1 |
| 1740 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 5,3 |
| 1741 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 4,8 |
| 1742 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 1743 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Romania | 14 |
| 1744 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 4,9 |
| 1745 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 2,6 |
| 1746 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,9 |
| 1747 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,6 |
| 1748 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 5,5 |
| 1749 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,4 |
| 1750 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,11 |
| 1751 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 3,5 |
| 1752 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland/Romania | 6,7 |
| 1753 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,8 |
| 1754 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,8 |
| 1755 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland/Romania | 8 |
| 1756 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 13,7 |
| 1757 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland/Romania | 10,2 |
| 1758 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,4 |
| 1759 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,2 |
| 1760 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 12,4 |
| 1761 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 10,4 |
| 1762 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,11 |
| 1763 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 5,3 |
| 1764 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
| 1765 | Cord Tissue | Allogeneic - Unrelated | Bone Marrow Transplant Rejection | Hematology | 2022 | Experimental Therapy | Poland | 2,5 |
| 1766 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 8 |
| 1767 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
| 1768 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 12,3 |
| 1769 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,5 |
| 1770 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,6 |
| 1771 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,4 |
| 1772 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
| 1773 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 5,11 |
| 1774 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,4 |
| 1775 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,1 |
| 1776 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Romania | 3 |
| 1777 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,9 |
| 1778 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,8 |
| 1779 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 1,5 |
| 1780 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,4 |
| 1781 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,3 |
| 1782 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 11,8 |
| 1783 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 5 |
| 1784 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 1785 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
| 1786 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 1,8 |
| 1787 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2022 | Experimental Therapy | Poland | 21,2 |
| 1788 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 51,4 |
| 1789 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 8,3 |
| 1790 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2022 | Experimental Therapy | Poland | 18,4 |
| 1791 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2022 | Experimental Therapy | Poland | 6,5 |
| 1792 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Global Developmental Delay; Hypoxic Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 3,6 |
| 1793 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 2,1 |
| 1794 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2022 | Experimental Therapy | Poland | 10,2 |
| 1795 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 56,3 |
| 1796 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 38,7 |
| 1797 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 49,1 |
| 1798 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 1,1 |
| 1799 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 2,11 |
| 1800 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 16,1 |
| 1801 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,7 |
| 1802 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 11,7 |
| 1803 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4,2 |
| 1804 | Cord Tissue | Allogeneic - Related | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Romania | 3 |
| 1805 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,1 |
| 1806 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
| 1807 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4,7 |
| 1808 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
| 1809 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 47,1 |
| 1810 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 22,11 |
| 1811 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 49,1 |
| 1812 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 54,6 |
| 1813 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2022 | Experimental Therapy | Poland | 62,9 |
| 1814 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
| 1815 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 1,4 |
| 1816 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 25,7 |
| 1817 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 14,1 |
| 1818 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 26,1 |
| 1819 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2022 | Experimental Therapy | Poland | 37,11 |
| 1820 | Cord Tissue | Allogeneic - Unrelated | Premature Ovarian Failure; Status After Oncological Treatment Of Breast Cancer | Gynecology | 2022 | Experimental Therapy | Poland | 45,2 |
| 1821 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2022 | Experimental Therapy | Poland | 41,3 |
| 1822 | Cord Tissue | Allogeneic - Unrelated | Sequelae Of Spinal Cord Injury; Condition After A Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 23,9 |
| 1823 | Cord Tissue | Allogeneic - Unrelated | Spasmic Paralysis Of The Limbs | Neurology | 2022 | Experimental Therapy | Poland | 33,9 |
| 1824 | Cord Tissue | Allogeneic - Unrelated | Spastic Limb Paralysis | Neurology | 2022 | Experimental Therapy | Poland | 30,11 |
| 1825 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 12,11 |
| 1826 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 20 |
| 1827 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 39,11 |
| 1828 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2022 | Experimental Therapy | Poland | 35,6 |
| 1829 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
| 1830 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1831 | Cord Blood | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 2,5 |
| 1832 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 1833 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Hungary | 13 |
| 1834 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 8,8 |
| 1835 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Romania | 5 |
| 1836 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | UK | 11 |
| 1837 | Cord Blood | Allogeneic - Related | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Turkey | 19 |
| 1838 | Cord Blood | Autologous | Hydrocephalus | Neurology | 2022 | Experimental Therapy | Romania | 6 |
| 1839 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2022 | Standard Therapy | Turkey | 7,7 |
| 1840 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2022 | Standard Therapy | Turkey | 19,2 |
| 1841 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1842 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1843 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1844 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1845 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1846 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 79 |
| 1847 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
| 1848 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 1849 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 1850 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 1851 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 1852 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1853 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 1854 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
| 1855 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 1856 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 1857 | Bone Marrow Family | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 1858 | Bone Marrow Family | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 1859 | Bone Marrow Family | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1860 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 1861 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia, Type 2 | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1862 | Bone Marrow Family | Allogeneic | Leukocyte Adhesion Deficiency | Hematology | 2022 | Standard Therapy | Poland | 33 |
| 1863 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 1864 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 1865 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 1866 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 1867 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 1868 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 1869 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 1870 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1871 | Bone Marrow Family | Allogeneic | Myelofibrosis Post Essential Thrombocythemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1872 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1873 | Bone Marrow Family | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 1874 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1875 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 1876 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1877 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1878 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1879 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 1880 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1881 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1882 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 38 |
| 1883 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1884 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1885 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1886 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 1887 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 1888 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 1889 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1890 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 20 |
| 1891 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1892 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1893 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1894 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1895 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1896 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1897 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1898 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1899 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1900 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 44 |
| 1901 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1902 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 75 |
| 1903 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 1904 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1905 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
| 1906 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
| 1907 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 1908 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 1909 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 1910 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1911 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1912 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 1913 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1914 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 1915 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 1916 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1917 | Bone Marrow | Allogeneic | Adenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) | Hematology | 2022 | Standard Therapy | Poland | 3 months |
| 1918 | Bone Marrow | Allogeneic | Amyloidosis | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1919 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
| 1920 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1921 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1922 | Bone Marrow | Allogeneic | Bone Marrow Failure Syndrome | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1923 | Bone Marrow | Allogeneic | Chediak-Higashi-Syndrome | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1924 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1925 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 1926 | Bone Marrow | Allogeneic | Common Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung Disease | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1927 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1928 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 1929 | Bone Marrow | Allogeneic | Dock8 Deficiency | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1930 | Bone Marrow | Allogeneic | Early Isolated All Bm Relapse | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1931 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 1932 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 1933 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1934 | Bone Marrow | Allogeneic | Griscelli Syndrome Type 2 | Hematology | 2022 | Standard Therapy | Poland | 2 months |
| 1935 | Bone Marrow | Allogeneic | Hemophagocytic Lymphocytosis | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1936 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 1937 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 1938 | Bone Marrow | Allogeneic | Infant Acute Lymphoblastic Leukemia With Kmt2a Gene Rearrangement | Hematology | 2022 | Standard Therapy | Poland | 7 months |
| 1939 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1940 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1941 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1942 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1943 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 1944 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1945 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 1946 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1947 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 51 |
| 1948 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 1949 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1950 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 1951 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 1952 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 1953 | Bone Marrow | Allogeneic | Nhl (Non-Hodgkin's Lymphoma) | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1954 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1955 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1956 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1957 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1958 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 1959 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1960 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 1961 | Bone Marrow | Allogeneic | Other Immune System Disorders | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1962 | Bone Marrow | Allogeneic | Other Non-Malignant Disease | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 1963 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 1964 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria With Marrow Failure | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1965 | Bone Marrow | Allogeneic | Philadelphia-Positive Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1966 | Bone Marrow | Allogeneic | Pre-B Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 32 |
| 1967 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1968 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 9 months |
| 1969 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 1970 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1971 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1972 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 1973 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1974 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1975 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1976 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1977 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1978 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
| 1979 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1980 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1981 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
| 1982 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1983 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 1984 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 1985 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 1986 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1987 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 months |
| 1988 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 2 months |
| 1989 | Bone Marrow | Allogeneic | Shwachman-Diamond Syndrome – Sds | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 1990 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1991 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1992 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1993 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1994 | Bone Marrow | Allogeneic | X-Linked Congenital Dyskeratosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 1995 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 22 |
| 1996 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1997 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 1998 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 1999 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 2000 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2001 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2002 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2003 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 24 |
| 2004 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
| 2005 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 24 |
| 2006 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 47 |
| 2007 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 2008 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 2009 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 2010 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2011 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 2012 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 2013 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2014 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
| 2015 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2016 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2017 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2018 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2019 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2020 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 75 |
| 2021 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2022 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 2023 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2024 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2025 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2026 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 29 |
| 2027 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 36 |
| 2028 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 57 |
| 2029 | Apheresis | Allogeneic | Acute Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2030 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2031 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
| 2032 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2033 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2034 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 2035 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2036 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 74 |
| 2037 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
| 2038 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
| 2039 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2040 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 78 |
| 2041 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 42 |
| 2042 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
| 2043 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 51 |
| 2044 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2045 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 2046 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2047 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2048 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2049 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
| 2050 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2051 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 38 |
| 2052 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2053 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2054 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2055 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2056 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2057 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2058 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2059 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2060 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2061 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2062 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 44 |
| 2063 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2064 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2065 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2066 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2067 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 2068 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2069 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2070 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 31 |
| 2071 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 2072 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2073 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 74 |
| 2074 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
| 2075 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2076 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2077 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2078 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 2079 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
| 2080 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2081 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2082 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 77 |
| 2083 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 34 |
| 2084 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2085 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2086 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2087 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 76 |
| 2088 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
| 2089 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2090 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 2091 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2092 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2093 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2094 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
| 2095 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 2096 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
| 2097 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
| 2098 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2099 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2100 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2101 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2102 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
| 2103 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2104 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
| 2105 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
| 2106 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2107 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
| 2108 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 2109 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2110 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2111 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2112 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2113 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2114 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2115 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
| 2116 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2117 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2118 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 70 |
| 2119 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
| 2120 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2121 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 28 |
| 2122 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 88 |
| 2123 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2124 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2125 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2126 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2127 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2128 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2129 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2130 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2131 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2132 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2133 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2134 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
| 2135 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
| 2136 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2137 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 26 |
| 2138 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 20 |
| 2139 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 74 |
| 2140 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2141 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2142 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2143 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2144 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2145 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2146 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2147 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
| 2148 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
| 2149 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2150 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
| 2151 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2152 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 47 |
| 2153 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 34 |
| 2154 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2155 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2156 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2157 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2158 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 2159 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2160 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2161 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
| 2162 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
| 2163 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2164 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 21 |
| 2165 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 58 |
| 2166 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 45 |
| 2167 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 63 |
| 2168 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 54 |
| 2169 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 48 |
| 2170 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 61 |
| 2171 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 27 |
| 2172 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 61 |
| 2173 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 66 |
| 2174 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2022 | Standard Therapy | Germany | 47 |
| 2175 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Germany | 55 |
| 2176 | Apheresis | Allogeneic | Acute Promyelocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2177 | Apheresis | Allogeneic | Acute Promyelocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
| 2178 | Apheresis | Allogeneic | Alk-Positive Anaplastic T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2179 | Apheresis | Autologous | Anaplastic Large Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 22 |
| 2180 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 22 |
| 2181 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2182 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 2183 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Germany | 67 |
| 2184 | Apheresis | Allogeneic | Atypical Chronic Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2185 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2186 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2187 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 54 |
| 2188 | Apheresis | Allogeneic | Beta Thalassemia Major | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2189 | Apheresis | Allogeneic | C-All Rez (Acute Lymphoblastic Leukemia) | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2190 | Apheresis | Allogeneic | C-All Rez (Acute Lymphoblastic Leukemia) | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 2191 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2192 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2193 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 2194 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2195 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2196 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 58 |
| 2197 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia Richter Transformation 7/22 | Hematology | 2022 | Standard Therapy | Poland | 44 |
| 2198 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2199 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2200 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2201 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2202 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2203 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2204 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 70 |
| 2205 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2206 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2207 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2208 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2209 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2210 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2211 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2212 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2213 | Apheresis | Allogeneic | Combined Immunodeficiency Syndrome With Hyper-Igm | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2214 | Apheresis | Allogeneic | Congenital Dyserythropoietic Anemia | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2215 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 68 |
| 2216 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
| 2217 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 69 |
| 2218 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 50 |
| 2219 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 56 |
| 2220 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
| 2221 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 47 |
| 2222 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2022 | Standard Therapy | Germany | 66 |
| 2223 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 66 |
| 2224 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2022 | Standard Therapy | Germany | 39 |
| 2225 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2022 | Standard Therapy | Germany | 33 |
| 2226 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 2227 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 21 |
| 2228 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 26 |
| 2229 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 31 |
| 2230 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 2231 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 2232 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 67 |
| 2233 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2022 | Standard Therapy | Germany | 69 |
| 2234 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2022 | Standard Therapy | Germany | 48 |
| 2235 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 26 |
| 2236 | Apheresis | Allogeneic | Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2237 | Apheresis | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 2238 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 64 |
| 2239 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 61 |
| 2240 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 2241 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 44 |
| 2242 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 53 |
| 2243 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 49 |
| 2244 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 64 |
| 2245 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2246 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2022 | Standard Therapy | Germany | 36 |
| 2247 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2022 | Standard Therapy | Germany | 62 |
| 2248 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2022 | Standard Therapy | Germany | 63 |
| 2249 | Apheresis | Allogeneic | Mucopolysaccharidosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2250 | Apheresis | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2251 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 58 |
| 2252 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 53 |
| 2253 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 57 |
| 2254 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 64 |
| 2255 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 50 |
| 2256 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 67 |
| 2257 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 55 |
| 2258 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 73 |
| 2259 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 63 |
| 2260 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 65 |
| 2261 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 58 |
| 2262 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 37 |
| 2263 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 47 |
| 2264 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 68 |
| 2265 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 53 |
| 2266 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 60 |
| 2267 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 60 |
| 2268 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 47 |
| 2269 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 59 |
| 2270 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 64 |
| 2271 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 59 |
| 2272 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 2273 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 73 |
| 2274 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 68 |
| 2275 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 63 |
| 2276 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 66 |
| 2277 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 50 |
| 2278 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 69 |
| 2279 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 57 |
| 2280 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 55 |
| 2281 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 61 |
| 2282 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 64 |
| 2283 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 71 |
| 2284 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 61 |
| 2285 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 62 |
| 2286 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 60 |
| 2287 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 33 |
| 2288 | Apheresis | Allogeneic | Multiple Myeloma - Relapse | Hematology | 2022 | Standard Therapy | Germany | 43 |
| 2289 | Apheresis | Autologous | Multiple Myeloma Angioimmunoblastic T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 62 |
| 2290 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2291 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2292 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2293 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 76 |
| 2294 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 45 |
| 2295 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2296 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2297 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 70 |
| 2298 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 45 |
| 2299 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2300 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 21 |
| 2301 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2302 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2303 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2304 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2305 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2306 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2307 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2308 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2309 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 33 |
| 2310 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2311 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2312 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2313 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2314 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2315 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2316 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2317 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2318 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2319 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2320 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2321 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2322 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 79 |
| 2323 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2324 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 44 |
| 2325 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 2326 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2327 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2328 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2329 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2330 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2331 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2332 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 70 |
| 2333 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2334 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 88 |
| 2335 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2336 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 52 |
| 2337 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2338 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2339 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 36 |
| 2340 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2341 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2342 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Germany | 61 |
| 2343 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb2 | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2344 | Apheresis | Allogeneic | Myelodysplastic Syndrome Rc | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2345 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Blasts 1 | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2346 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Blasts 2 | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2347 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Fibrosis | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2348 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2349 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2350 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 2351 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2352 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2353 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2354 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2355 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2356 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2357 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2358 | Apheresis | Allogeneic | Myelofibrosis Post Essential Thrombocythemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2359 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2360 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2361 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2362 | Apheresis | Autologous | Myeloma | Hematology | 2022 | Standard Therapy | Germany | 54 |
| 2363 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2022 | Standard Therapy | Poland | 31 |
| 2364 | Apheresis | Allogeneic | Myeloproliferative Neoplasms With Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 59 |
| 2365 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 50 |
| 2366 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2367 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2368 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2369 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 21 |
| 2370 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 38 |
| 2371 | Apheresis | Autologous | Nodular Lymphocyte Predominant Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 31 |
| 2372 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2373 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2374 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 2375 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2376 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 28 |
| 2377 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2378 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2379 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 2380 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2381 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2382 | Apheresis | Allogeneic | Other Immune System | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2383 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2022 | Standard Therapy | Poland | 72 |
| 2384 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 32 |
| 2385 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2386 | Apheresis | Allogeneic | Plasma Cell Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2387 | Apheresis | Allogeneic | Post-Essential Thrombocythemia-Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2388 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis (Post-Pv Mf) | Hematology | 2022 | Standard Therapy | Poland | 48 |
| 2389 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
| 2390 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
| 2391 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 58 |
| 2392 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 39 |
| 2393 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 67 |
| 2394 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 37 |
| 2395 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 69 |
| 2396 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2397 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2398 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 70 |
| 2399 | Apheresis | Allogeneic | Primary Refractory T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2400 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 2401 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 51 |
| 2402 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 2403 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
| 2404 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 months |
| 2405 | Apheresis | Allogeneic | Sezary Syndrome | Hematology | 2022 | Standard Therapy | Poland | 59 |
| 2406 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2407 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 37 |
| 2408 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 30 |
| 2409 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
| 2410 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 2411 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 51 |
| 2412 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
| 2413 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 60 |
| 2414 | Apheresis | Autologous | Testicular Cancer | Hematology | 2022 | Standard Therapy | Germany | 48 |
| 2415 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2416 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 60,11 |
| 2417 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 41,9 |
| 2418 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 30,1 |
| 2419 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 53 |
| 2420 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2021 | Experimental Therapy | Poland | 7 |
| 2421 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 7,8 |
| 2422 | Cord Tissue | Allogeneic - Unrelated | Acute Myeloid Leukemia - Transplantation Failure | Hematology | 2021 | Experimental Therapy | Poland | 13,5 |
| 2423 | Cord Tissue | Allogeneic - Unrelated | Ags (Autism + Epilepsy) | Neurology | 2021 | Experimental Therapy | Poland | 13,3 |
| 2424 | Cord Tissue | Allogeneic - Unrelated | Ags (Autism + Epilepsy) | Neurology | 2021 | Experimental Therapy | Romania | 13 |
| 2425 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 74,4 |
| 2426 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 64,11 |
| 2427 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 70,11 |
| 2428 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 59,2 |
| 2429 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 47,9 |
| 2430 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2431 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2432 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 66,8 |
| 2433 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 28,4 |
| 2434 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2435 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2436 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2437 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2438 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2439 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2440 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2441 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2442 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2443 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2444 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 54,11 |
| 2445 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2446 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2447 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2448 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2449 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 55,2 |
| 2450 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2451 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 70,5 |
| 2452 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 54,2 |
| 2453 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 58,11 |
| 2454 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2455 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2456 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
| 2457 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 62,4 |
| 2458 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 74,6 |
| 2459 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4 |
| 2460 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9,2 |
| 2461 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 10 |
| 2462 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,6 |
| 2463 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 15,5 |
| 2464 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | no data |
| 2465 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7,11 |
| 2466 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 6,9 |
| 2467 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,9 |
| 2468 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 12,5 |
| 2469 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 12,1 |
| 2470 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7,5 |
| 2471 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 8,7 |
| 2472 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 11,1 |
| 2473 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5,3 |
| 2474 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,5 |
| 2475 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 8,11 |
| 2476 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 6,4 |
| 2477 | Cord Tissue | Allogeneic - Unrelated | Bone Marrow Transplant Rejection; Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 6,8 |
| 2478 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2021 | Experimental Therapy | Poland | 59 |
| 2479 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,1 |
| 2480 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,1 |
| 2481 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5 |
| 2482 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 17 |
| 2483 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6,6 |
| 2484 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6,1 |
| 2485 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,9 |
| 2486 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11 |
| 2487 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,11 |
| 2488 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 12 |
| 2489 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,9 |
| 2490 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,9 |
| 2491 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,9 |
| 2492 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,7 |
| 2493 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 2494 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,11 |
| 2495 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11,4 |
| 2496 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,3 |
| 2497 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 2498 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2,11 |
| 2499 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11,6 |
| 2500 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,1 |
| 2501 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2 |
| 2502 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,4 |
| 2503 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 months |
| 2504 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2,1 |
| 2505 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 23,3 |
| 2506 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 22,9 |
| 2507 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,11 |
| 2508 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,5 |
| 2509 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 8 |
| 2510 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Romania | 11 months |
| 2511 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 12,2 |
| 2512 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Devic Syndrome | Neurology | 2021 | Experimental Therapy | Poland | 32,5 |
| 2513 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 2,6 |
| 2514 | Cord Tissue | Allogeneic - Unrelated | Condition After Cerebral Infarction | Neurology | 2021 | Experimental Therapy | Poland | 42,7 |
| 2515 | Cord Tissue | Allogeneic - Unrelated | Condition After Knee Injury | Orthopedy | 2021 | Experimental Therapy | Poland | 54,5 |
| 2516 | Cord Tissue | Allogeneic - Unrelated | Condition After Knee Injury | Orthopedy | 2021 | Experimental Therapy | Poland | 40,4 |
| 2517 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 69,4 |
| 2518 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 55,2 |
| 2519 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 50,2 |
| 2520 | Cord Tissue | Allogeneic - Unrelated | Degenerative Disease Of The Spine | Orthopedy | 2021 | Experimental Therapy | Poland | 51,2 |
| 2521 | Cord Tissue | Allogeneic - Unrelated | Degenerative Disease Of The Spine | Orthopedy | 2021 | Experimental Therapy | Poland | 56,2 |
| 2522 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2021 | Experimental Therapy | Poland | 6,5 |
| 2523 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2021 | Experimental Therapy | Poland | 27,2 |
| 2524 | Cord Tissue | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Hematology | 2021 | Experimental Therapy | Turkey | 25 |
| 2525 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2021 | Experimental Therapy | Poland | 35,2 |
| 2526 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 2,4 |
| 2527 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 6,5 |
| 2528 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2529 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2530 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2531 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2532 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | 21,11 |
| 2533 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2534 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2535 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2536 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2537 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2538 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2539 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2540 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2541 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2542 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2543 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2544 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2545 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2546 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2547 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2548 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2549 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 6,7 |
| 2550 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 9,8 |
| 2551 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 9,7 |
| 2552 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 2,11 |
| 2553 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 5,11 |
| 2554 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy; Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 2,8 |
| 2555 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 5,7 |
| 2556 | Cord Tissue | Allogeneic - Related | Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 2 |
| 2557 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay; Encephalopathy | Neurology | 2021 | Experimental Therapy | Poland | 2,9 |
| 2558 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay; Encephalopathy | Neurology | 2021 | Experimental Therapy | Poland | 7,8 |
| 2559 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 59,11 |
| 2560 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 48,6 |
| 2561 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 53,6 |
| 2562 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 40 |
| 2563 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 62,11 |
| 2564 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 63 |
| 2565 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 72,5 |
| 2566 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 58,1 |
| 2567 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 46,3 |
| 2568 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 50,2 |
| 2569 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 51,2 |
| 2570 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 52,5 |
| 2571 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 4,7 |
| 2572 | Cord Tissue | Allogeneic - Unrelated | Hemiparesis | Neurology | 2021 | Experimental Therapy | Poland | 37,3 |
| 2573 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2021 | Experimental Therapy | Poland | 30,5 |
| 2574 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2021 | Experimental Therapy | Poland | 7 months |
| 2575 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2021 | Experimental Therapy | Poland | 44,8 |
| 2576 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5,7 |
| 2577 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 10,1 |
| 2578 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5,5 |
| 2579 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 4 |
| 2580 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 2 |
| 2581 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 9,5 |
| 2582 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 4,5 |
| 2583 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5 |
| 2584 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5,6 |
| 2585 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 1,1 |
| 2586 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2021 | Experimental Therapy | Poland | 1,6 |
| 2587 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2021 | Experimental Therapy | Poland | 50,7 |
| 2588 | Cord Tissue | Allogeneic - Unrelated | Nervous System Degeneration | Neurology | 2021 | Experimental Therapy | Poland | 56,9 |
| 2589 | Cord Tissue | Allogeneic - Unrelated | Non-Hodkin Lymphoma; Chronic Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 14,8 |
| 2590 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 13,7 |
| 2591 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 26,4 |
| 2592 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 45,1 |
| 2593 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 27,3 |
| 2594 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 22,2 |
| 2595 | Cord Tissue | Allogeneic - Unrelated | Osteoarthritis | Orthopedy | 2021 | Experimental Therapy | Poland | 57,2 |
| 2596 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2021 | Experimental Therapy | Poland | 29,7 |
| 2597 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases | Orthopedy | 2021 | Experimental Therapy | Poland | 68,4 |
| 2598 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases | Orthopedy | 2021 | Experimental Therapy | Poland | 52,7 |
| 2599 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2021 | Experimental Therapy | Poland | 24,11 |
| 2600 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 24 |
| 2601 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 2602 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 30,8 |
| 2603 | Cord Tissue | Allogeneic - Unrelated | Thermal Injury | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2604 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2605 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2606 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2607 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2608 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2609 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2610 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2611 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2612 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2613 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2614 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2615 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2616 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
| 2617 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2618 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2619 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2620 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
| 2621 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5,8 |
| 2622 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9,7 |
| 2623 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7 |
| 2624 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
| 2625 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 3,9 |
| 2626 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 5,2 |
| 2627 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 2628 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Germany | 8 |
| 2629 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 9 |
| 2630 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
| 2631 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 6 |
| 2632 | Cord Blood | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 |
| 2633 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6 |
| 2634 | Cord Blood | Allogeneic - Related | Diamond Blackfan Anemia | Hematology | 2021 | Standard Therapy | Turkey | 3,12 |
| 2635 | Cord Blood | Autologous | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Germany | 7 |
| 2636 | Cord Blood | Allogeneic - Related | Immune Failure-Cd40 L Deficiency | Hematology | 2021 | Standard Therapy | Turkey | 12,4 |
| 2637 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 5,6 |
| 2638 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16,6 |
| 2639 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 7,3 |
| 2640 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
| 2641 | Cord Blood | Autologous | Autism | Neurology | 2021 | no data | Slovakia | 4 |
| 2642 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2643 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 33 |
| 2644 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2645 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2646 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2647 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2648 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 2649 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 2650 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 2651 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2652 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2653 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 2654 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2655 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2656 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 2657 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2658 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2659 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
| 2660 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2661 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 36 |
| 2662 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 39 |
| 2663 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 71 |
| 2664 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2665 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2666 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2667 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 2668 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 2669 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 2670 | Bone Marrow Family | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 2671 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2672 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 2673 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 2674 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2675 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 2676 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2677 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 2678 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 2679 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 2680 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2681 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2682 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2683 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 2684 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2685 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2686 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2687 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2688 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2689 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 2690 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 2691 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 15 |
| 2692 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2693 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2021 | Standard Therapy | Poland | 8 |
| 2694 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2695 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 2696 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
| 2697 | Bone Marrow | Allogeneic | Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2698 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 16 |
| 2699 | Bone Marrow | Allogeneic | Bcr-Abl Pos. All | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 2700 | Bone Marrow | Allogeneic | Beta Thalassemia Major | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 2701 | Bone Marrow | Allogeneic | Cartilage Hair Hypoplasia | Hematology | 2021 | Standard Therapy | Poland | 7 |
| 2702 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2703 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2704 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2705 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 44 |
| 2706 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2707 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2708 | Bone Marrow | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2709 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2710 | Bone Marrow | Allogeneic | Combined Immunodeficiency Syndrome With Hyper-Igm | Hematology | 2021 | Standard Therapy | Poland | 5 |
| 2711 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 2712 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 2713 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 2714 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2715 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2716 | Bone Marrow | Allogeneic | Ipex- Other Immune | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 2717 | Bone Marrow | Allogeneic | Leukemia Lymphoblastic Acuta | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 2718 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2719 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 10 |
| 2720 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 2721 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 30 |
| 2722 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 2723 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2724 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2725 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 2726 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2727 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 2728 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2729 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2021 | Standard Therapy | Poland | 7 |
| 2730 | Bone Marrow | Allogeneic | Other Leukemia Specify | Hematology | 2021 | Standard Therapy | Poland | 35 |
| 2731 | Bone Marrow | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 72 |
| 2732 | Bone Marrow | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 7 |
| 2733 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 2734 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2735 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
| 2736 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 5 |
| 2737 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
| 2738 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
| 2739 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2740 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2741 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 2742 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2021 | Standard Therapy | Poland | 9 months |
| 2743 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 2744 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 2745 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 2746 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 2747 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 2748 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
| 2749 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 27 |
| 2750 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 2751 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 2752 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2753 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2754 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 10 |
| 2755 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 2756 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 5 |
| 2757 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 2758 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2759 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
| 2760 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2761 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
| 2762 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 2763 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2764 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 2765 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2766 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2767 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 2768 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 2769 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
| 2770 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 2771 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 29 |
| 2772 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 2773 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 2774 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 2775 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 2776 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 2777 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
| 2778 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2779 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 2780 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 2781 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 2782 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2783 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 2784 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2785 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2786 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 2787 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2788 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 2789 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2790 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
| 2791 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 2792 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2793 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2794 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
| 2795 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 2796 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2797 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 2798 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2799 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2800 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2801 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2802 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 37 |
| 2803 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 21 |
| 2804 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 2805 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 2806 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 43 |
| 2807 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 2808 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2809 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 2810 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2811 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2812 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 2813 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2814 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 2815 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2816 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2817 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2818 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 2819 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2820 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2821 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2822 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2823 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 2824 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2825 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 2826 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 2827 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 2828 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2829 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2830 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 2831 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 2832 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 2833 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 2834 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2835 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2836 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 2837 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 2838 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 71 |
| 2839 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2840 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 29 |
| 2841 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2842 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 30 |
| 2843 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2844 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2845 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2846 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 2847 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2848 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 30 |
| 2849 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2850 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 44 |
| 2851 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2852 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2853 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2854 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 2855 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2856 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
| 2857 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2858 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 2859 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 37 |
| 2860 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 2861 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2862 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2863 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
| 2864 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2865 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 2866 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2867 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
| 2868 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 39 |
| 2869 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2870 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2871 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 2872 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2873 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2874 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2875 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 2876 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2877 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2878 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2879 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 57 |
| 2880 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 2881 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
| 2882 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2883 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2884 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2885 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 2886 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2887 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 2888 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 2889 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
| 2890 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 2891 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 25 |
| 2892 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2893 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 2894 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 2895 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 2896 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2897 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 2898 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 35 |
| 2899 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2900 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 2901 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
| 2902 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 80 |
| 2903 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2904 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 2905 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2906 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 2907 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2908 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 10 |
| 2909 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 2910 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 57 |
| 2911 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 2912 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2913 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 2914 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 2915 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
| 2916 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
| 2917 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 39 |
| 2918 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 2919 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2920 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 22 |
| 2921 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 2922 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
| 2923 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 2924 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 2925 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
| 2926 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 32 |
| 2927 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 2928 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 72 |
| 2929 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 55 |
| 2930 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 2931 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 2932 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 46 |
| 2933 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 2934 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 2935 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 71 |
| 2936 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 53 |
| 2937 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 2938 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 50 |
| 2939 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 32 |
| 2940 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 71 |
| 2941 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 2942 | Apheresis | Autologous | Amyloidosis | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 2943 | Apheresis | Allogeneic | Anaplastic Large Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 56 |
| 2944 | Apheresis | Autologous | Angioimmunoblastic T-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 2945 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 2946 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 7 |
| 2947 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 2948 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 2949 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 36 |
| 2950 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 59 |
| 2951 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 33 |
| 2952 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 2953 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 49 |
| 2954 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 2955 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 11 |
| 2956 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2957 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 2958 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2959 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 2960 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 2961 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 37 |
| 2962 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2963 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 2964 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
| 2965 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 2966 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 2967 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 18 |
| 2968 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 2969 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 2970 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 2971 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2972 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
| 2973 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2974 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 71 |
| 2975 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2021 | Standard Therapy | Germany | 67 |
| 2976 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 2977 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 2978 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 68 |
| 2979 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 2980 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 2981 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 2982 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2021 | Standard Therapy | Germany | 71 |
| 2983 | Apheresis | Allogeneic | Farber Disease | Hematology | 2021 | Standard Therapy | Poland | 9 |
| 2984 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 2985 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 55 |
| 2986 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 64 |
| 2987 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 50 |
| 2988 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2021 | Standard Therapy | Germany | 28 |
| 2989 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 2990 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 2991 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 2992 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 27 |
| 2993 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 2994 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 26 |
| 2995 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 2996 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 21 |
| 2997 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 37 |
| 2998 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 30 |
| 2999 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 47 |
| 3000 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 36 |
| 3001 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 30 |
| 3002 | Apheresis | Allogeneic | Hurler Syndrome | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3003 | Apheresis | Allogeneic | Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 12 |
| 3004 | Apheresis | Allogeneic | Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 3005 | Apheresis | Allogeneic | Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3006 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3007 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 3008 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3009 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 3010 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 3011 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 56 |
| 3012 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 3013 | Apheresis | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 3014 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2021 | Standard Therapy | Germany | 36 |
| 3015 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2021 | Standard Therapy | Germany | 50 |
| 3016 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2021 | Standard Therapy | Germany | 21 |
| 3017 | Apheresis | Allogeneic | Mucopolysaccharidosis | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 3018 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Poland | 44 |
| 3019 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 3020 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 70 |
| 3021 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 71 |
| 3022 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 53 |
| 3023 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 51 |
| 3024 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 3025 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 3026 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 3027 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 3028 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3029 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 50 |
| 3030 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 3031 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 50 |
| 3032 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 47 |
| 3033 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 43 |
| 3034 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3035 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 56 |
| 3036 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 3037 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 51 |
| 3038 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 3039 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 3040 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 68 |
| 3041 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 70 |
| 3042 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 70 |
| 3043 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 38 |
| 3044 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 3045 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 3046 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 71 |
| 3047 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 52 |
| 3048 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 63 |
| 3049 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 3050 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 68 |
| 3051 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 3052 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 58 |
| 3053 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 3054 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 60 |
| 3055 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 58 |
| 3056 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 67 |
| 3057 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 3058 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 42 |
| 3059 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 3060 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 67 |
| 3061 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
| 3062 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 68 |
| 3063 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3064 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 3065 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 60 |
| 3066 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 3067 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 3068 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3069 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3070 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3071 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 3072 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3073 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 57 |
| 3074 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 3075 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3076 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 29 |
| 3077 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3078 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3079 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3080 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 3081 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 3082 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 3083 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 3084 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3085 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3086 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 3087 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3088 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 3089 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3090 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 75 |
| 3091 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 72 |
| 3092 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3093 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 3094 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3095 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 3096 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 72 |
| 3097 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3098 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3099 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 3100 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 3101 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 3102 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3103 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 3104 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3105 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 26 |
| 3106 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 3107 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 3108 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 3109 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3110 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3111 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Germany | 48 |
| 3112 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Germany | 58 |
| 3113 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Germany | 59 |
| 3114 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3115 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 3116 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3117 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3118 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3119 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 3120 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 75 |
| 3121 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3122 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 3123 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 3124 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 75 |
| 3125 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3126 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 3127 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 3128 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 3129 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3130 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2021 | Standard Therapy | Germany | 51 |
| 3131 | Apheresis | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3132 | Apheresis | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 57 |
| 3133 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 30 |
| 3134 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 3135 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3136 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 56 |
| 3137 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3138 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 3139 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 3140 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 3141 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3142 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3143 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 3144 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 61 |
| 3145 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 49 |
| 3146 | Apheresis | Allogeneic | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 3147 | Apheresis | Allogeneic | Osteomyelitis | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 3148 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 3149 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 43 |
| 3150 | Apheresis | Autologous | Osteosclerotic Myeloma | Hematology | 2021 | Standard Therapy | Germany | 54 |
| 3151 | Apheresis | Allogeneic | Other Myelodysplastic Syndromes | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3152 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3153 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 3154 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 72 |
| 3155 | Apheresis | Allogeneic | Other Plasma Cell Disorder | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 3156 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 3157 | Apheresis | Allogeneic | Philadelphia-Positive Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 3158 | Apheresis | Allogeneic | Polycythemia Vera | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 3159 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 71 |
| 3160 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3161 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 62 |
| 3162 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 53 |
| 3163 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 44 |
| 3164 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 54 |
| 3165 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 3166 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 65 |
| 3167 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 60 |
| 3168 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 3169 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 63 |
| 3170 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 3171 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3172 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 3173 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 3174 | Apheresis | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 3175 | Apheresis | Allogeneic | Secondary Acute Lymphoblastic Leukemia From Chronic Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3176 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 70 |
| 3177 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 64 |
| 3178 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 39 |
| 3179 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 60 |
| 3180 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 35 |
| 3181 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 3182 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 3183 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 3184 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3185 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 3186 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 26 |
| 3187 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 37 |
| 3188 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 54 |
| 3189 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3190 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
| 3191 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 29 |
| 3192 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 3193 | Apheresis | Autologous | Testicular Cancer | Hematology | 2021 | Standard Therapy | Germany | 33 |
| 3194 | Apheresis | Allogeneic | Β - Thalassemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 3195 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 51,1 |
| 3196 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 44,4 |
| 3197 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 35,8 |
| 3198 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2021 | Experimental Therapy | Poland | 40.9 |
| 3199 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2021 | Experimental Therapy | Poland | 27,5 |
| 3200 | Placenta blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,6 |
| 3201 | Cord Tissue | Allogeneic - Unrelated | Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 84,5 |
| 3202 | Cord Tissue | Allogeneic - Unrelated | Acquired Epileptic Aphasia | Neurology | 2020 | Experimental Therapy | Poland | 4,11 |
| 3203 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 8,11 |
| 3204 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 8 |
| 3205 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 2,4 |
| 3206 | Cord Tissue | Allogeneic - Unrelated | Acute Respiratory Distress Syndrome; Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 53 |
| 3207 | Cord Tissue | Allogeneic - Unrelated | Acute Respiratory Distress Syndrome; Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 66,11 |
| 3208 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 8,1 |
| 3209 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2020 | Experimental Therapy | Poland | 36,6 |
| 3210 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 53,2 |
| 3211 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 54,4 |
| 3212 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 48,1 |
| 3213 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 64,11 |
| 3214 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 62,9 |
| 3215 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 69,1 |
| 3216 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 52,11 |
| 3217 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 58 |
| 3218 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 59,7 |
| 3219 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 52,7 |
| 3220 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 62,5 |
| 3221 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 59,6 |
| 3222 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 59,1 |
| 3223 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 58,1 |
| 3224 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 4,3 |
| 3225 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
| 3226 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 8,7 |
| 3227 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,6 |
| 3228 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 9,11 |
| 3229 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 4,9 |
| 3230 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 6,1 |
| 3231 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2020 | Experimental Therapy | Poland | 8 |
| 3232 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
| 3233 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
| 3234 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 5,1 |
| 3235 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 9,4 |
| 3236 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2020 | Experimental Therapy | Romania | 13 |
| 3237 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2020 | Experimental Therapy | Poland | 10 |
| 3238 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 6,5 |
| 3239 | Cord Tissue | Allogeneic - Unrelated | Bone Marrow Transplant Rejection | Hematology | 2020 | Experimental Therapy | Poland | 14,2 |
| 3240 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 57,11 |
| 3241 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 17,2 |
| 3242 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
| 3243 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,7 |
| 3244 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 5 |
| 3245 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,7 |
| 3246 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 8,7 |
| 3247 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 15,6 |
| 3248 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6 |
| 3249 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 3,1 |
| 3250 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,7 |
| 3251 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 13 |
| 3252 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,9 |
| 3253 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,1 |
| 3254 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 8,3 |
| 3255 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 7,11 |
| 3256 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 4,4 |
| 3257 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 4 |
| 3258 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,11 |
| 3259 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 4,11 |
| 3260 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 18,2 |
| 3261 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 5,8 |
| 3262 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 10,9 |
| 3263 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 5,9 |
| 3264 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 9,8 |
| 3265 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 1,7 |
| 3266 | Cord Tissue | Allogeneic - Unrelated | Chondromalacia | Orthopedy | 2020 | Experimental Therapy | Poland | 61,7 |
| 3267 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 4,7 |
| 3268 | Cord Tissue | Allogeneic - Unrelated | Condition After Knee Injury | Orthopedy | 2020 | Experimental Therapy | Poland | 42,1 |
| 3269 | Cord Tissue | Allogeneic - Unrelated | Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 74,5 |
| 3270 | Cord Tissue | Allogeneic - Unrelated | Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 76,2 |
| 3271 | Cord Tissue | Allogeneic - Unrelated | Covid-19; Severe Pneumonia; Acute Respiratory Failure | Pulmonology | 2020 | Experimental Therapy | Poland | 59,5 |
| 3272 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 46,4 |
| 3273 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2020 | Experimental Therapy | Poland | 5,8 |
| 3274 | Cord Tissue | Allogeneic - Related | Developmental Delay | Neurology | 2020 | Experimental Therapy | Romania | 13 |
| 3275 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2020 | Experimental Therapy | Poland | 6 |
| 3276 | Cord Tissue | Allogeneic - Unrelated | Disorder Of Brain, Unspecified; Adrenoleukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 11,9 |
| 3277 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2020 | Experimental Therapy | Poland | 26,6 |
| 3278 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 35,6 |
| 3279 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 44 |
| 3280 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 35,3 |
| 3281 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 29,3 |
| 3282 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 30,9 |
| 3283 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 5,3 |
| 3284 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 17,11 |
| 3285 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 21,5 |
| 3286 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 10,9 |
| 3287 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 2,1 |
| 3288 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 15,8 |
| 3289 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Encephalopathy; Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
| 3290 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2020 | Experimental Therapy | Poland | 40,5 |
| 3291 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
| 3292 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,8 |
| 3293 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 62,8 |
| 3294 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 62,11 |
| 3295 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,1 |
| 3296 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 73,6 |
| 3297 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,8 |
| 3298 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,3 |
| 3299 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 64,8 |
| 3300 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 57,5 |
| 3301 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 53,9 |
| 3302 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,9 |
| 3303 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,7 |
| 3304 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 49,9 |
| 3305 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 58 |
| 3306 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,4 |
| 3307 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,2 |
| 3308 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 50,8 |
| 3309 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Portugal | 18 |
| 3310 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease; Transplantation Failure | Hematology | 2020 | Experimental Therapy | Poland | 2,9 |
| 3311 | Cord Tissue | Allogeneic - Unrelated | Guillain-Barré Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 43,5 |
| 3312 | Cord Tissue | Allogeneic - Unrelated | Head Injury | Neurology | 2020 | Experimental Therapy | Poland | 16,3 |
| 3313 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
| 3314 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2020 | Experimental Therapy | Poland | 5,4 |
| 3315 | Cord Tissue | Allogeneic - Unrelated | Hypoxic Encephalopathy; Drug-Resistant Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 20,9 |
| 3316 | Cord Tissue | Allogeneic - Unrelated | Limb Ulceration | Dermatology | 2020 | Experimental Therapy | Poland | 82,7 |
| 3317 | Cord Tissue | Allogeneic - Unrelated | Macular Degeneration | Ophthalmology | 2020 | Experimental Therapy | Poland | 20,8 |
| 3318 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2020 | Experimental Therapy | Poland | 56,4 |
| 3319 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2020 | Experimental Therapy | Poland | 8,11 |
| 3320 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele; Arnold-Chiari Malformation | Neurology | 2020 | Experimental Therapy | Poland | 2,5 |
| 3321 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele; Hydrocephalus | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
| 3322 | Cord Tissue | Allogeneic - Unrelated | Myoclonic Epilepsy With Ragged Red Fibers | Neurology | 2020 | Experimental Therapy | Poland | 23,4 |
| 3323 | Cord Tissue | Allogeneic - Unrelated | No Bone Adhesion | Orthopedy | 2020 | Experimental Therapy | Poland | 69,5 |
| 3324 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 16,3 |
| 3325 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 66,3 |
| 3326 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 23,11 |
| 3327 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 27,1 |
| 3328 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 31,9 |
| 3329 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 58,3 |
| 3330 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 41,2 |
| 3331 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2020 | Experimental Therapy | Poland | 41,2 |
| 3332 | Cord Tissue | Allogeneic - Unrelated | Osteoarthritis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,5 |
| 3333 | Cord Tissue | Allogeneic - Unrelated | Other Specific Cartilage Diseases | Orthopedy | 2020 | Experimental Therapy | Poland | 39,4 |
| 3334 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2020 | Experimental Therapy | Poland | 4,1 |
| 3335 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System - Global Development Delay And Microcephaly | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
| 3336 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect | Neurology | 2020 | Experimental Therapy | Poland | 2,6 |
| 3337 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect | Neurology | 2020 | Experimental Therapy | Poland | 5,2 |
| 3338 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Cornelia De Lange Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 4,4 |
| 3339 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic Encephalopathy | Neurology | 2020 | Experimental Therapy | Poland | 4,3 |
| 3340 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Lissencephaly | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
| 3341 | Cord Tissue | Allogeneic - Unrelated | Other Sphingolipidoses; Krabbe's Leukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 4 |
| 3342 | Cord Tissue | Allogeneic - Unrelated | Other Spinal Muscular Atrophy And Related Syndromes; Bulbar Palsy | Neurology | 2020 | Experimental Therapy | Poland | no data |
| 3343 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2020 | Experimental Therapy | Poland | 43,11 |
| 3344 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2020 | Experimental Therapy | Poland | 33,7 |
| 3345 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2020 | Experimental Therapy | Poland | 61,5 |
| 3346 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2020 | Experimental Therapy | Poland | 59,6 |
| 3347 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2020 | Experimental Therapy | Poland | 11 months |
| 3348 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2020 | Experimental Therapy | Poland | 1,3 |
| 3349 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2020 | Experimental Therapy | Poland | 33,2 |
| 3350 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2020 | Experimental Therapy | Poland | 37,11 |
| 3351 | Cord Tissue | Allogeneic - Unrelated | State After Encephalitis | Neurology | 2020 | Experimental Therapy | Poland | 3,8 |
| 3352 | Cord Tissue | Allogeneic - Unrelated | Tendon Injury | Orthopedy | 2020 | Experimental Therapy | Poland | 29 |
| 3353 | Cord Tissue | Allogeneic - Unrelated | Transplantation Failure; Coexisting Viral Infections | Hematology | 2020 | Experimental Therapy | Poland | 13,1 |
| 3354 | Cord Tissue | Allogeneic | no data | no data | 2020 | no data | Slovakia | 63 |
| 3355 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Poland | no data |
| 3356 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Germany | 9 |
| 3357 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Germany | 5 |
| 3358 | Cord Blood | Autologous | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | UK | 5 |
| 3359 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,2 |
| 3360 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,9 |
| 3361 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,4 |
| 3362 | Cord Blood | Allogeneic - Related | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | no data |
| 3363 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 3,4 |
| 3364 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 3,4 |
| 3365 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 4,4 |
| 3366 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 4,4 |
| 3367 | Cord Blood | Allogeneic | no data | no data | 2020 | no data | Slovakia | 63 |
| 3368 | Cord Blood | Autologous | Drowning - Persistent Vegetative State, Decortication | Neurology | 2020 | no data | Czechia | 2 |
| 3369 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2020 | Standard Therapy | Germany | 57 |
| 3370 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 3371 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 48 |
| 3372 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3373 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
| 3374 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3375 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 38 |
| 3376 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3377 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 76 |
| 3378 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2020 | Standard Therapy | Germany | 61 |
| 3379 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3380 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3381 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 35 |
| 3382 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 71 |
| 3383 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 31 |
| 3384 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3385 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3386 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3387 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3388 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3389 | Bone Marrow Family | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 24 |
| 3390 | Bone Marrow (Apheresismily donor) | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 3391 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 3392 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3393 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3394 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3395 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 4 |
| 3396 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 15 |
| 3397 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
| 3398 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 3 |
| 3399 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3400 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 47 |
| 3401 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3402 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 16 |
| 3403 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 3404 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
| 3405 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 10 |
| 3406 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 27 |
| 3407 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 23 |
| 3408 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2020 | Standard Therapy | Poland | 6 |
| 3409 | Bone Marrow | Allogeneic | Congenital Neutropenia | Hematology | 2020 | Standard Therapy | Poland | 2 |
| 3410 | Bone Marrow | Allogeneic | Familial Hemophagocytic Lymphohistiocytosis Type 2 | Hematology | 2020 | Standard Therapy | Poland | 8 |
| 3411 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 11 |
| 3412 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 6 |
| 3413 | Bone Marrow | Allogeneic | Immune Deficiency; Neutropenia | Hematology | 2020 | Standard Therapy | Poland | 4 |
| 3414 | Bone Marrow | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2020 | Standard Therapy | Poland | 6 |
| 3415 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2020 | Standard Therapy | Poland | 2 |
| 3416 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Ii | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3417 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3418 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3419 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 3 |
| 3420 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 28 |
| 3421 | Bone Marrow | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3422 | Bone Marrow | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 10 |
| 3423 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3424 | Bone Marrow | Allogeneic | Primary Immunodeficiency With Severe Mds Associated | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 3425 | Bone Marrow | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3426 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
| 3427 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 3428 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 27 |
| 3429 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 3430 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 10 |
| 3431 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
| 3432 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 11 |
| 3433 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
| 3434 | Bone Marrow | Allogeneic | X-Linked Chronic Granulomatous Disease | Hematology | 2020 | Standard Therapy | Poland | 5 |
| 3435 | Bone Marrow | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 13 |
| 3436 | Bone Marrow | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 17 |
| 3437 | Bone Marrow | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 6 |
| 3438 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 71 |
| 3439 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3440 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
| 3441 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 41 |
| 3442 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 3443 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3444 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 60 |
| 3445 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
| 3446 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 23 |
| 3447 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 40 |
| 3448 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 51 |
| 3449 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 71 |
| 3450 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
| 3451 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3452 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 50 |
| 3453 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 18 |
| 3454 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 3455 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
| 3456 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 13 |
| 3457 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
| 3458 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3459 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
| 3460 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 36 |
| 3461 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3462 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 3463 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3464 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 36 |
| 3465 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 25 |
| 3466 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3467 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 52 |
| 3468 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 48 |
| 3469 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3470 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3471 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
| 3472 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3473 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3474 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3475 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3476 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 37 |
| 3477 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3478 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3479 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 46 |
| 3480 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 3481 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3482 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 73 |
| 3483 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 27 |
| 3484 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 29 |
| 3485 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3486 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3487 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 3488 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3489 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3490 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3491 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3492 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 60 |
| 3493 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 32 |
| 3494 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3495 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3496 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 40 |
| 3497 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3498 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 3499 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 38 |
| 3500 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 49 |
| 3501 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 3502 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3503 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3504 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3505 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 73 |
| 3506 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3507 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3508 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3509 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3510 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 3511 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3512 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 60 |
| 3513 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 3514 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3515 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 3516 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
| 3517 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3518 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 3519 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3520 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 3521 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3522 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 30 |
| 3523 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
| 3524 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3525 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3526 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 35 |
| 3527 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
| 3528 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 3529 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3530 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 49 |
| 3531 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3532 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3533 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 39 |
| 3534 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 45 |
| 3535 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3536 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3537 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3538 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3539 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3540 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 3541 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 3542 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 15 |
| 3543 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3544 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3545 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3546 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
| 3547 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 51 |
| 3548 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 3549 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 39 |
| 3550 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 42 |
| 3551 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3552 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 3553 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 3554 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3555 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3556 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3557 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 37 |
| 3558 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
| 3559 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 64 |
| 3560 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 45 |
| 3561 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 67 |
| 3562 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 67 |
| 3563 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 61 |
| 3564 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 36 |
| 3565 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 34 |
| 3566 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 48 |
| 3567 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 60 |
| 3568 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 48 |
| 3569 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 35 |
| 3570 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 42 |
| 3571 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 3572 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 20 |
| 3573 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 58 |
| 3574 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 44 |
| 3575 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 30 |
| 3576 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3577 | Apheresis | Allogeneic | Acute Undifferentiated Leukemia | Hematology | 2020 | Standard Therapy | Poland | 31 |
| 3578 | Apheresis | Autologous | Amyloid Light-Chain Amyloidosis | Hematology | 2020 | Standard Therapy | Germany | 62 |
| 3579 | Apheresis | Autologous | Amyloidosis | Hematology | 2020 | Standard Therapy | Germany | 58 |
| 3580 | Apheresis | Allogeneic | Anaplastic Large Cell Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 8 |
| 3581 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
| 3582 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 29 |
| 3583 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 58 |
| 3584 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3585 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 70 |
| 3586 | Apheresis | Autologous | B-Cell Lymphoma - Second Primary Central Nervous System Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 70 |
| 3587 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 57 |
| 3588 | Apheresis | Autologous | Bone Tumor | Hematology | 2020 | Standard Therapy | Germany | 28 |
| 3589 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 49 |
| 3590 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 74 |
| 3591 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3592 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3593 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3594 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 3595 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 47 |
| 3596 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 73 |
| 3597 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3598 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 3599 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3600 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3601 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3602 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 31 |
| 3603 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3604 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3605 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 51 |
| 3606 | Apheresis | Allogeneic | Dyskeratosis Congenita | Hematology | 2020 | Standard Therapy | Poland | 19 |
| 3607 | Apheresis | Allogeneic | Erdheim-Chester Disease | Hematology | 2020 | Standard Therapy | Poland | 4 |
| 3608 | Apheresis | Autologous | Ewing Sarcoma | Hematology | 2020 | Standard Therapy | Germany | 30 |
| 3609 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3610 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 29 |
| 3611 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2020 | Standard Therapy | Germany | 30 |
| 3612 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 48 |
| 3613 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 22 |
| 3614 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3615 | Apheresis | Allogeneic | Lymphoblastic Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 24 |
| 3616 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 3617 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 3618 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 48 |
| 3619 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 53 |
| 3620 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 3621 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3622 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 58 |
| 3623 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 49 |
| 3624 | Apheresis | Allogeneic | Mast Cell Leukemia | Hematology | 2020 | Standard Therapy | Germany | 55 |
| 3625 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3626 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2020 | Standard Therapy | Germany | 53 |
| 3627 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2020 | Standard Therapy | Germany | 18 |
| 3628 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 3629 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3630 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 3631 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3632 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 70 |
| 3633 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 41 |
| 3634 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 3635 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 61 |
| 3636 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
| 3637 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 67 |
| 3638 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 52 |
| 3639 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 69 |
| 3640 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 64 |
| 3641 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 46 |
| 3642 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
| 3643 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 60 |
| 3644 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3645 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 51 |
| 3646 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
| 3647 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 63 |
| 3648 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3649 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
| 3650 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3651 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3652 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3653 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 42 |
| 3654 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 3655 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3656 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3657 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 67 |
| 3658 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3659 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 60 |
| 3660 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3661 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 63 |
| 3662 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3663 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 63 |
| 3664 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 62 |
| 3665 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 49 |
| 3666 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 45 |
| 3667 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
| 3668 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 45 |
| 3669 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3670 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 40 |
| 3671 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 53 |
| 3672 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 3673 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 44 |
| 3674 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3675 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 48 |
| 3676 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3677 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3678 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
| 3679 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 3680 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3681 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3682 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 60 |
| 3683 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3684 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 3685 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3686 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3687 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 51 |
| 3688 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 3689 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3690 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3691 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 73 |
| 3692 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3693 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 37 |
| 3694 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
| 3695 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3696 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 74 |
| 3697 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3698 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 22 |
| 3699 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3700 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3701 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3702 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3703 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 60 |
| 3704 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 3705 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3706 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 3707 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 47 |
| 3708 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 3709 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 3710 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3711 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3712 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 3713 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3714 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 3715 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3716 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Germany | 73 |
| 3717 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3718 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 3719 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 3720 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3721 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3722 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 3723 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3724 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3725 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 3726 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2020 | Standard Therapy | Poland | 40 |
| 3727 | Apheresis | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 71 |
| 3728 | Apheresis | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3729 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 3730 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3731 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3732 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 3733 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3734 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 3735 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 3736 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 3737 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 3738 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 34 |
| 3739 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 42 |
| 3740 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 62 |
| 3741 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 3742 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 67 |
| 3743 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 3744 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3745 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 3746 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 3747 | Apheresis | Allogeneic | Perforin Deficiency | Hematology | 2020 | Standard Therapy | Poland | 2 |
| 3748 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 3749 | Apheresis | Autologous | Primary Cerebral Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3750 | Apheresis | Autologous | Primary Cerebral Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 3751 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 3752 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3753 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 51 |
| 3754 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 3755 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 3756 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 3757 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Germany | 58 |
| 3758 | Apheresis | Allogeneic | Purine Nucleoside Phosphorylase Deficiency | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 3759 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 3760 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 76 |
| 3761 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 3762 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 3763 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 3764 | Apheresis | Autologous | Secondary B-Cell Non-Hodgkin-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 73 |
| 3765 | Apheresis | Autologous | Secondary Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 3766 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
| 3767 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 3768 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 3769 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2020 | Standard Therapy | Poland | 2 |
| 3770 | Apheresis | Allogeneic | Sezary Syndrome | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 3771 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 3772 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 57 |
| 3773 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 29 |
| 3774 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 64 |
| 3775 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 63 |
| 3776 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 29 |
| 3777 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 51 |
| 3778 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 60 |
| 3779 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 3780 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 74 |
| 3781 | Apheresis | Allogeneic | Β - Thalassemia | Hematology | 2020 | Standard Therapy | Poland | 6 |
| 3782 | Apheresis | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 17 |
| 3783 | Adipose Tissue | Autologous | Alopecia | Dermatology | 2020 | Experimental Therapy | Poland | 68,5 |
| 3784 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2020 | Experimental Therapy | Poland | 45,9 |
| 3785 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 52,8 |
| 3786 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,4 |
| 3787 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 41,1 |
| 3788 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 34,8 |
| 3789 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 48,1 |
| 3790 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 57,11 |
| 3791 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 59,8 |
| 3792 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 35,1 |
| 3793 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,8 |
| 3794 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,5 |
| 3795 | Adipose Tissue | Autologous | Gonarthrosis; Shoulder Osteoarthritis | Orthopedy | 2020 | Experimental Therapy | Poland | 42,5 |
| 3796 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2020 | Experimental Therapy | Poland | 53,6 |
| 3797 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2020 | Experimental Therapy | Poland | 49,2 |
| 3798 | Adipose Tissue | Autologous | Omarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 70,1 |
| 3799 | Adipose Tissue | Autologous | Other Acquired Deformities Of The Ankle And Foot | Orthopedy | 2020 | Experimental Therapy | Poland | 41,6 |
| 3800 | Adipose Tissue | Autologous | Scar | Dermatology | 2020 | Clinical Trial | Poland | no data |
| 3801 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2020 | Experimental Therapy | Poland | 61,1 |
| 3802 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
| 3803 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 1,9 |
| 3804 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 6,1 |
| 3805 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 2,2 |
| 3806 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 10,1 |
| 3807 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 18,2 |
| 3808 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 10,2 |
| 3809 | Cord Tissue | Allogeneic - Unrelated | Agenesis Of Corpus Callosum; Atrophy Of The Optic Nerves | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
| 3810 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2019 | Experimental Therapy | Poland | 47,11 |
| 3811 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2019 | Experimental Therapy | Poland | 57,9 |
| 3812 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2019 | Experimental Therapy | Poland | 43,3 |
| 3813 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 54,9 |
| 3814 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 58,7 |
| 3815 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65,5 |
| 3816 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 60,11 |
| 3817 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 38,2 |
| 3818 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 61,9 |
| 3819 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 70,11 |
| 3820 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 73,1 |
| 3821 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 58,1 |
| 3822 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65,1 |
| 3823 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 39,8 |
| 3824 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 46,1 |
| 3825 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,1 |
| 3826 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 61 |
| 3827 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 66,2 |
| 3828 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 44,1 |
| 3829 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65,1 |
| 3830 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65 |
| 3831 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 41,5 |
| 3832 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,8 |
| 3833 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 32,2 |
| 3834 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 56,1 |
| 3835 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 61,5 |
| 3836 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 49,7 |
| 3837 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 67,11 |
| 3838 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,3 |
| 3839 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | no data |
| 3840 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 57,7 |
| 3841 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 62,4 |
| 3842 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 67,8 |
| 3843 | Cord Tissue | Allogeneic - Unrelated | Angelman Syndrome; Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 13,5 |
| 3844 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita; Myopathy | Neurology | 2019 | Experimental Therapy | Poland | 3,11 |
| 3845 | Cord Tissue | Allogeneic - Unrelated | Arthrosis Of The Knee Joint - Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 51,4 |
| 3846 | Cord Tissue | Allogeneic - Unrelated | Asperger Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 10,8 |
| 3847 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2019 | Experimental Therapy | Poland | 38,7 |
| 3848 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,6 |
| 3849 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 2,6 |
| 3850 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 11,6 |
| 3851 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
| 3852 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,9 |
| 3853 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,2 |
| 3854 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,8 |
| 3855 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,2 |
| 3856 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 9 |
| 3857 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 11,1 |
| 3858 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4,8 |
| 3859 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 13,4 |
| 3860 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
| 3861 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 2,7 |
| 3862 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
| 3863 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,2 |
| 3864 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,9 |
| 3865 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4 |
| 3866 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,3 |
| 3867 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,5 |
| 3868 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
| 3869 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7 |
| 3870 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4,2 |
| 3871 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
| 3872 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4,6 |
| 3873 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
| 3874 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 9,5 |
| 3875 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,11 |
| 3876 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
| 3877 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
| 3878 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | no data |
| 3879 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,2 |
| 3880 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,6 |
| 3881 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
| 3882 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,7 |
| 3883 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,7 |
| 3884 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 9,11 |
| 3885 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 12,4 |
| 3886 | Cord Tissue | Allogeneic - Unrelated | Autism; Diabetes Mellitus Type 1 | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
| 3887 | Cord Tissue | Allogeneic - Unrelated | Autism; Microcephaly | Neurology | 2019 | Experimental Therapy | Poland | 7,8 |
| 3888 | Cord Tissue | Allogeneic - Unrelated | Best Disease | Ophthalmology | 2019 | Experimental Therapy | Poland | 56,4 |
| 3889 | Cord Tissue | Allogeneic - Unrelated | Birth Asphyxia | Neurology | 2019 | Experimental Therapy | Poland | 5,4 |
| 3890 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 50,1 |
| 3891 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 37,7 |
| 3892 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome; Multiple System Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 57,2 |
| 3893 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6 |
| 3894 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,11 |
| 3895 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 11 months |
| 3896 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,5 |
| 3897 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,4 |
| 3898 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 11,1 |
| 3899 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,2 |
| 3900 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,3 |
| 3901 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,5 |
| 3902 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,6 |
| 3903 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,1 |
| 3904 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4 |
| 3905 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
| 3906 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,3 |
| 3907 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,9 |
| 3908 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2 |
| 3909 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 1,6 |
| 3910 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 15,5 |
| 3911 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,7 |
| 3912 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,9 |
| 3913 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,11 |
| 3914 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,1 |
| 3915 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,6 |
| 3916 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,6 |
| 3917 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 1,1 |
| 3918 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
| 3919 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 22,8 |
| 3920 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 28,2 |
| 3921 | Cord Tissue | Allogeneic - Unrelated & Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland/Romania | 7,5 |
| 3922 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,7 |
| 3923 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 10 |
| 3924 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,8 |
| 3925 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
| 3926 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 10,8 |
| 3927 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,1 |
| 3928 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
| 3929 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 14,9 |
| 3930 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,9 |
| 3931 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 52,7 |
| 3932 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
| 3933 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,9 |
| 3934 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,11 |
| 3935 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 16,1 |
| 3936 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,1 |
| 3937 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,7 |
| 3938 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
| 3939 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
| 3940 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
| 3941 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 11,6 |
| 3942 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
| 3943 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,5 |
| 3944 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Dandy-Walker Malformation | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
| 3945 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 18,9 |
| 3946 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
| 3947 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
| 3948 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,5 |
| 3949 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
| 3950 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 10,1 |
| 3951 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 7,11 |
| 3952 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
| 3953 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 8,5 |
| 3954 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 6,3 |
| 3955 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,6 |
| 3956 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 15,7 |
| 3957 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 6 |
| 3958 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 1,11 |
| 3959 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy; Microcephalia | Neurology | 2019 | Experimental Therapy | Poland | 9,3 |
| 3960 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Hydrocephalus | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
| 3961 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Hydrocephalus | Neurology | 2019 | Experimental Therapy | Poland | 4,2 |
| 3962 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Hydrocephalus; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
| 3963 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Wolf-Hirschhorn Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 10,1 |
| 3964 | Cord Tissue | Allogeneic - Unrelated | Chondrocalcinosis; Moderate Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 79,1 |
| 3965 | Cord Tissue | Allogeneic - Unrelated | Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 60,9 |
| 3966 | Cord Tissue | Allogeneic - Unrelated | Choroideremia | Ophthalmology | 2019 | Experimental Therapy | Poland | 24,5 |
| 3967 | Cord Tissue | Allogeneic - Unrelated | Choroideremia | Ophthalmology | 2019 | Experimental Therapy | Poland | 30,1 |
| 3968 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 10,5 |
| 3969 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Aplastic Anemia | Hematology | 2019 | Experimental Therapy | Poland | 9 |
| 3970 | Cord Tissue | Allogeneic - Unrelated | Condition After Bilateral Optic Nerve Inflammation | Ophthalmology | 2019 | Experimental Therapy | Poland | 46,11 |
| 3971 | Cord Tissue | Allogeneic - Unrelated | Condition After Sympathetic Inflammation Of The Left Eye | Ophthalmology | 2019 | Experimental Therapy | Poland | 23,1 |
| 3972 | Cord Tissue | Allogeneic - Related | Coxarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 57 |
| 3973 | Cord Tissue | Allogeneic - Unrelated | Dandy-Walker Malformation; Trisomy 9 | Neurology | 2019 | Experimental Therapy | Poland | 10,8 |
| 3974 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2019 | Experimental Therapy | Poland | 44,7 |
| 3975 | Cord Tissue | Allogeneic - Unrelated | Degenerative Disease Of The Spine | Orthopedy | 2019 | Experimental Therapy | Poland | 86,11 |
| 3976 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Chiari Malformation | Neurology | 2019 | Experimental Therapy | Poland | 4,6 |
| 3977 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Congenital Cytomegalovirus | Neurology | 2019 | Experimental Therapy | Poland | 8,3 |
| 3978 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 2,1 |
| 3979 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3980 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3981 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3982 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3983 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3984 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3985 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3986 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3987 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3988 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
| 3989 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Experimental Therapy | Poland | 2,11 |
| 3990 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Experimental Therapy | Poland | 37,5 |
| 3991 | Cord Tissue | Allogeneic - Unrelated | Dravet's Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 19,7 |
| 3992 | Cord Tissue | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2019 | Experimental Therapy | Poland | 15 |
| 3993 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 7,8 |
| 3994 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 7,7 |
| 3995 | Cord Tissue | Allogeneic - Related | Encephalopathy; Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6 |
| 3996 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 17,1 |
| 3997 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3,6 |
| 3998 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy; Delayed Psychomotor Development | Neurology | 2019 | Experimental Therapy | Poland | 13,1 |
| 3999 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy; Delayed Psychomotor Development | Neurology | 2019 | Experimental Therapy | Poland | 2,5 |
| 4000 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 4,4 |
| 4001 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 5,8 |
| 4002 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 7,4 |
| 4003 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 7,4 |
| 4004 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2019 | Experimental Therapy | Poland | 51,1 |
| 4005 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
| 4006 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 13,9 |
| 4007 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 9,4 |
| 4008 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 3,2 |
| 4009 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
| 4010 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 16,2 |
| 4011 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 2,11 |
| 4012 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 39,1 |
| 4013 | Cord Tissue | Allogeneic - Unrelated | Fragile X Syndrome; Pervasive Developmental Disorder | Neurology | 2019 | Experimental Therapy | Poland | 4 |
| 4014 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 59,6 |
| 4015 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2019 | Experimental Therapy | Poland | 2,1 |
| 4016 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
| 4017 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 70,8 |
| 4018 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 78,7 |
| 4019 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 84,1 |
| 4020 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 48,7 |
| 4021 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 34,2 |
| 4022 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 63,7 |
| 4023 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 64,8 |
| 4024 | Cord Tissue | Allogeneic - Unrelated | Hyperacute Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Congenital Neutropenia | Hematology | 2019 | Experimental Therapy | Poland | 8 months |
| 4025 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
| 4026 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2019 | Experimental Therapy | Poland | 2,5 |
| 4027 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2019 | Experimental Therapy | Poland | 4,8 |
| 4028 | Cord Tissue | Allogeneic - Unrelated | Ischemic Stroke | Neurology | 2019 | Experimental Therapy | Poland | 40,7 |
| 4029 | Cord Tissue | Allogeneic - Unrelated | Ischemic Stroke | Neurology | 2019 | Experimental Therapy | Poland | no data |
| 4030 | Cord Tissue | Allogeneic - Unrelated | Krabbe Disease | Neurology | 2019 | Experimental Therapy | Poland | 3,3 |
| 4031 | Cord Tissue | Allogeneic - Unrelated | Macular Degeneration | Ophthalmology | 2019 | Experimental Therapy | Poland | 15,2 |
| 4032 | Cord Tissue | Allogeneic - Unrelated | Microcephalia; Cerebellar Syndrome; Delayed Psychomotor Development | Neurology | 2019 | Experimental Therapy | Poland | 7,7 |
| 4033 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 54,1 |
| 4034 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 71,11 |
| 4035 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 46,1 |
| 4036 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 17,3 |
| 4037 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 13,1 |
| 4038 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
| 4039 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 19,11 |
| 4040 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 2,1 |
| 4041 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 1,11 |
| 4042 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 4,11 |
| 4043 | Cord Tissue | Allogeneic - Unrelated | Non-Adhesion Left Tibia Shank Fracture; Neurofibromatosis T. I | Orthopedy | 2019 | Experimental Therapy | Poland | 18,4 |
| 4044 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 43,9 |
| 4045 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 68,4 |
| 4046 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 72,5 |
| 4047 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 33,3 |
| 4048 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 26 |
| 4049 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 23,9 |
| 4050 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 35,1 |
| 4051 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 38,3 |
| 4052 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 24,5 |
| 4053 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 12,1 |
| 4054 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 9,8 |
| 4055 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 41,3 |
| 4056 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 34,7 |
| 4057 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 59,4 |
| 4058 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 53,2 |
| 4059 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 12,3 |
| 4060 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2019 | Experimental Therapy | Poland | 26,8 |
| 4061 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2019 | Experimental Therapy | Poland | 71,3 |
| 4062 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2019 | Experimental Therapy | Poland | 49,8 |
| 4063 | Cord Tissue | Allogeneic - Unrelated | Other Disorders Of The Central Nervous System; Genetic Defect; Suspected Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
| 4064 | Cord Tissue | Allogeneic - Unrelated | Other Disorders Of The Central Nervous System; Genetic Defect; Suspected Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
| 4065 | Cord Tissue | Allogeneic - Unrelated | Other Disorders Of The Optic Disc | Neurology | 2019 | Experimental Therapy | Poland | 3 |
| 4066 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 1,7 |
| 4067 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 4,1 |
| 4068 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 11 months |
| 4069 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 3,1 |
| 4070 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 3,6 |
| 4071 | Cord Tissue | Allogeneic - Unrelated | Other Vascular And Retinal Disorders | Ophthalmology | 2019 | Experimental Therapy | Poland | 34,2 |
| 4072 | Cord Tissue | Allogeneic - Unrelated | Parkinson Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 51,2 |
| 4073 | Cord Tissue | Allogeneic - Unrelated | Paroxysmal Dystonia | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
| 4074 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2019 | Experimental Therapy | Poland | 60,8 |
| 4075 | Cord Tissue | Allogeneic - Unrelated | Progressive Supranuclear Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 62,4 |
| 4076 | Cord Tissue | Allogeneic - Unrelated | Propionic Aciduria | Neurology | 2019 | Experimental Therapy | Poland | 10,7 |
| 4077 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 19,1 |
| 4078 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 35 |
| 4079 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 21,6 |
| 4080 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 67,2 |
| 4081 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 63,4 |
| 4082 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 69 |
| 4083 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 62,7 |
| 4084 | Cord Tissue | Allogeneic - Related | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 61 |
| 4085 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 61,6 |
| 4086 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 59,7 |
| 4087 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 22,9 |
| 4088 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 64 |
| 4089 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 54,6 |
| 4090 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,5 |
| 4091 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
| 4092 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 10 months |
| 4093 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 10 months |
| 4094 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
| 4095 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
| 4096 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2019 | Experimental Therapy | Poland | 33 |
| 4097 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | no data |
| 4098 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2019 | Experimental Therapy | Poland | 27,5 |
| 4099 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2019 | Experimental Therapy | Poland | 26,9 |
| 4100 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | 38,6 |
| 4101 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | 27,8 |
| 4102 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | 41,1 |
| 4103 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 11 |
| 4104 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 40 |
| 4105 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 26,1 |
| 4106 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 54,11 |
| 4107 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 37 |
| 4108 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2019 | Experimental Therapy | Poland | 30,5 |
| 4109 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2019 | Experimental Therapy | Poland | 40 |
| 4110 | Cord Tissue | Allogeneic - Unrelated | Status After Meningitis And Encephalitis; Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 4 |
| 4111 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Turkey | 2 |
| 4112 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 6 |
| 4113 | Cord Blood | Autologous | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,6 |
| 4114 | Cord Blood | Autologous | Autism | Neurology | 2019 | Experimental Therapy | Poland | 10,5 |
| 4115 | Cord Blood | Autologous | Autism | Neurology | 2019 | Experimental Therapy | Germany | 4 |
| 4116 | Cord Blood | Autologous | Brain Damage | Neurology | 2019 | Experimental Therapy | Germany | 11 months |
| 4117 | Cord Blood | Autologous | Brain Damage | Neurology | 2019 | Experimental Therapy | Germany | 1,5 |
| 4118 | Cord Blood | Allogeneic - Related | Brain Damage | Neurology | 2019 | Experimental Therapy | Germany | 7 |
| 4119 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | UK | 3 |
| 4120 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,5 |
| 4121 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 8,8 |
| 4122 | Cord Blood | Allogeneic - Related | Fanconi Anemia | Hematology | 2019 | Standard Therapy | Turkey | 12,4 |
| 4123 | Cord Blood | Autologous | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Portugal | 4 |
| 4124 | Cord Blood | Allogeneic - Related | Severe Chronic Neutropenia | Hematology | 2019 | Standard Therapy | Germany | 6 |
| 4125 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2019 | Standard Therapy | Turkey | 5,5 |
| 4126 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2019 | Standard Therapy | Turkey | 5,11 |
| 4127 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 5,1 |
| 4128 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 3,5 |
| 4129 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 12 |
| 4130 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 16 |
| 4131 | Bone Marrow Family | Allogeneic | Activated Pi3k Delta Syndrome (Apds) | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4132 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4133 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 4134 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 73 |
| 4135 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4136 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4137 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 4138 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4139 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4140 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4141 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
| 4142 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
| 4143 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4144 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4145 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
| 4146 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4147 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4148 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4149 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4150 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4151 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4152 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2019 | Standard Therapy | Germany | 61 |
| 4153 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2019 | Standard Therapy | Germany | 22 |
| 4154 | Bone Marrow Family | Allogeneic | Glanzmann Thrombasthenia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4155 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4156 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 78 |
| 4157 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4158 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4159 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 4160 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 4161 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4162 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4163 | Bone Marrow Family | Allogeneic | Refractory Anemia With Blast Excess Relapse | Hematology | 2019 | Standard Therapy | Germany | 53 |
| 4164 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 4165 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 4166 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4167 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 21 |
| 4168 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
| 4169 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4170 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
| 4171 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4172 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4173 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
| 4174 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4175 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 4176 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 4177 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4178 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4179 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 4180 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 4181 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
| 4182 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4183 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4184 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4185 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4186 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4187 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 4188 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 4189 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 4190 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4191 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4192 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4193 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 4194 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4195 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 4196 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
| 4197 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4198 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 4199 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 30 |
| 4200 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4201 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 32 |
| 4202 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4203 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 4204 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4205 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4206 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 4207 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4208 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2019 | Standard Therapy | Poland | 3 |
| 4209 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
| 4210 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 4211 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 4212 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 4213 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 30 |
| 4214 | Bone Marrow | Allogeneic | C-Hhyp Cartilage-Hair Hypoplasia | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4215 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 7 |
| 4216 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 9 |
| 4217 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 35 |
| 4218 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4219 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4220 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2019 | Standard Therapy | Poland | 6 |
| 4221 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4222 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4223 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4224 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4225 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 4226 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 4227 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 4228 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4229 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 4230 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4231 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 4232 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4233 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 4234 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4235 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4236 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 6 |
| 4237 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 4238 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4239 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4240 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4241 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4242 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 4243 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4244 | Bone Marrow | Allogeneic | Ohis - Other Histiocytic Disorders | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4245 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 1 |
| 4246 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 5 months |
| 4247 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4248 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4249 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 22 |
| 4250 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4251 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
| 4252 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4253 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
| 4254 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 4255 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 22 |
| 4256 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4257 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4258 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4259 | Bone Marrow | Allogeneic | Shwachman Diamond Anemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4260 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 4261 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 5 |
| 4262 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 10 |
| 4263 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 4264 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 4265 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 4266 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 4267 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4268 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4269 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4270 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
| 4271 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4272 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
| 4273 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 4274 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 4275 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 7 |
| 4276 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4277 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 4278 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 4279 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4280 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 28 |
| 4281 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 4282 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 4283 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4284 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 4285 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 32 |
| 4286 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 44 |
| 4287 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4288 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4289 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 39 |
| 4290 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 4291 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4292 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4293 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
| 4294 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 4295 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
| 4296 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 4297 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 4298 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
| 4299 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4300 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4301 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4302 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 4303 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4304 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4305 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4306 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4307 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4308 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
| 4309 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4310 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 4311 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4312 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
| 4313 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 4314 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4315 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4316 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4317 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4318 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 4319 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4320 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4321 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4322 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4323 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4324 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4325 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4326 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 4327 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
| 4328 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
| 4329 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 4330 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4331 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4332 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4333 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 4334 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 4335 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4336 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 4337 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4338 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4339 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4340 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4341 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 4342 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
| 4343 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4344 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 4345 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4346 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4347 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4348 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4349 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4350 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4351 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4352 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4353 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 40 |
| 4354 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 4355 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4356 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 44 |
| 4357 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4358 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
| 4359 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 4360 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
| 4361 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4362 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4363 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4364 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 4365 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4366 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4367 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4368 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4369 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4370 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4371 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4372 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4373 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4374 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
| 4375 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4376 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4377 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4378 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4379 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
| 4380 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 39 |
| 4381 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 4382 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 71 |
| 4383 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 4384 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
| 4385 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4386 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4387 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4388 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 31 |
| 4389 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
| 4390 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4391 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
| 4392 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4393 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 4394 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 4395 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 4396 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 31 |
| 4397 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 47 |
| 4398 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4399 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 46 |
| 4400 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 40 |
| 4401 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 60 |
| 4402 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4403 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4404 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4405 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 26 |
| 4406 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 4407 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 38 |
| 4408 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 4409 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2019 | Standard Therapy | Germany | 51 |
| 4410 | Apheresis | Autologous | Amyloidosis | Hematology | 2019 | Standard Therapy | Germany | 60 |
| 4411 | Apheresis | Allogeneic | Aplasia | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 4412 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 4413 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
| 4414 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 46 |
| 4415 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 21 |
| 4416 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 28 |
| 4417 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4418 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4419 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 2 |
| 4420 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 4421 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 3 |
| 4422 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4423 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4424 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4425 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4426 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
| 4427 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4428 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
| 4429 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 34 |
| 4430 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
| 4431 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 4432 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4433 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 4434 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 31 |
| 4435 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 4436 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 4437 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
| 4438 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4439 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 73 |
| 4440 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4441 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4442 | Apheresis | Autologous | Embryonal Cell Carcinoma Of The Testicle | Hematology | 2019 | Standard Therapy | Germany | 29 |
| 4443 | Apheresis | Allogeneic | Extracranial Malignant Germ Cell Tumors | Hematology | 2019 | Standard Therapy | Poland | 53 |
| 4444 | Apheresis | Allogeneic | Glanzmann Thrombasthenia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4445 | Apheresis | Allogeneic | High-Risk Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4446 | Apheresis | Allogeneic | Histiocytosis X | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4447 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4448 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4449 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 28 |
| 4450 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 44 |
| 4451 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4452 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 32 |
| 4453 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 34 |
| 4454 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4455 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4456 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4457 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4458 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4459 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4460 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4461 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4462 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 54 |
| 4463 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4464 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4465 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4466 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 71 |
| 4467 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4468 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4469 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4470 | Apheresis | Autologous | Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy | Hematology | 2019 | Standard Therapy | Germany | 36 |
| 4471 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4472 | Apheresis | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 1 |
| 4473 | Apheresis | Allogeneic | Mucopolysaccharidosis Type Ii | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 4474 | Apheresis | Allogeneic | Mucopolysaccharidosis Type Ii | Metabolic | 2019 | Standard Therapy | Poland | 2 |
| 4475 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Poland | 52 |
| 4476 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4477 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4478 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 4479 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 4480 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 69 |
| 4481 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 4482 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4483 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 4484 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 4485 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 54 |
| 4486 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 51 |
| 4487 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 4488 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 4489 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 61 |
| 4490 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4491 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4492 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4493 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 39 |
| 4494 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
| 4495 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4496 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4497 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 40 |
| 4498 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 4499 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 53 |
| 4500 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4501 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
| 4502 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4503 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 4504 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4505 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 35 |
| 4506 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
| 4507 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 4508 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 41 |
| 4509 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 60 |
| 4510 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4511 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4512 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4513 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4514 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4515 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 4516 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4517 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 67 |
| 4518 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4519 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
| 4520 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4521 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4522 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
| 4523 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 4524 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4525 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 72 |
| 4526 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4527 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4528 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4529 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4530 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 14 |
| 4531 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4532 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4533 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
| 4534 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4535 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 4536 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4537 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4538 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4539 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 40 |
| 4540 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4541 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 72 |
| 4542 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 50 |
| 4543 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4544 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4545 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4546 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4547 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4548 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4549 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 4550 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4551 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4552 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 64 |
| 4553 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4554 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4555 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4556 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4557 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4558 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4559 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4560 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4561 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 4 |
| 4562 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 56 |
| 4563 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4564 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4565 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4566 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4567 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4568 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 44 |
| 4569 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4570 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 33 |
| 4571 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4572 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4573 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 49 |
| 4574 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4575 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 71 |
| 4576 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 25 |
| 4577 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4578 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 4579 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4580 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 49 |
| 4581 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4582 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4583 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 67 |
| 4584 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4585 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2019 | Standard Therapy | Poland | 21 |
| 4586 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2019 | Standard Therapy | Poland | 16 |
| 4587 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4588 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 4589 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4590 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 47 |
| 4591 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 33 |
| 4592 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4593 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 4594 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 66 |
| 4595 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 69 |
| 4596 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4597 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4598 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4599 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4600 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 62 |
| 4601 | Apheresis | Autologous | Myeloma; Amyloidosis | Hematology | 2019 | Standard Therapy | Germany | 47 |
| 4602 | Apheresis | Autologous | Natural Killer / T-Cell-Non-Hodgkin-Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 32 |
| 4603 | Apheresis | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 43 |
| 4604 | Apheresis | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4605 | Apheresis | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4606 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 68 |
| 4607 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 28 |
| 4608 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
| 4609 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 67 |
| 4610 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 51 |
| 4611 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4612 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 42 |
| 4613 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4614 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 4615 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4616 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4617 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2019 | Standard Therapy | Germany | 69 |
| 4618 | Apheresis | Allogeneic | Osteomyelofibrosis - Other | Hematology | 2019 | Standard Therapy | Poland | 63 |
| 4619 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 70 |
| 4620 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 61 |
| 4621 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 50 |
| 4622 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2019 | Standard Therapy | Poland | 24 |
| 4623 | Apheresis | Allogeneic | Plasma Cell Leukemia | Hematology | 2019 | Standard Therapy | Poland | 35 |
| 4624 | Apheresis | Allogeneic | Polycythemia Vera-Myelofibrosis | Hematology | 2019 | Standard Therapy | Germany | 58 |
| 4625 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2019 | Standard Therapy | Germany | 70 |
| 4626 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 65 |
| 4627 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4628 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 69 |
| 4629 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4630 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 4631 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 57 |
| 4632 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
| 4633 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 67 |
| 4634 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 78 |
| 4635 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 21 |
| 4636 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 19 |
| 4637 | Apheresis | Allogeneic | Primary Mediastinal | Hematology | 2019 | Standard Therapy | Poland | 33 |
| 4638 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 46 |
| 4639 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 45 |
| 4640 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2019 | Standard Therapy | Germany | 55 |
| 4641 | Apheresis | Allogeneic | Relapsed Peripheral T Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
| 4642 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
| 4643 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 64 |
| 4644 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 60 |
| 4645 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Myeloproliferative Neoplasms | Hematology | 2019 | Standard Therapy | Germany | 56 |
| 4646 | Apheresis | Autologous | Secondary Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
| 4647 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
| 4648 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
| 4649 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
| 4650 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4651 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 44 |
| 4652 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 55 |
| 4653 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
| 4654 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 67 |
| 4655 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 45 |
| 4656 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 72 |
| 4657 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 61 |
| 4658 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 61 |
| 4659 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2019 | Standard Therapy | Germany | 29 |
| 4660 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 20 |
| 4661 | Apheresis | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2019 | Standard Therapy | Poland | 1 |
| 4662 | Apheresis | Allogeneic | Β - Thalassemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
| 4663 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 48,8 |
| 4664 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 38,6 |
| 4665 | Adipose Tissue | Autologous | Coxarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 34 |
| 4666 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4667 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4668 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4669 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4670 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4671 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4672 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4673 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4674 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4675 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4676 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4677 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4678 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4679 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4680 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4681 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4682 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4683 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4684 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4685 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4686 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4687 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4688 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4689 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 44,11 |
| 4690 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 65,3 |
| 4691 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 68,6 |
| 4692 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 36,1 |
| 4693 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 54,3 |
| 4694 | Adipose Tissue | Autologous | Mild Arthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 21,2 |
| 4695 | Adipose Tissue | Autologous | Mild Arthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 68,5 |
| 4696 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 52,8 |
| 4697 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 44,8 |
| 4698 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 52,5 |
| 4699 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 54,5 |
| 4700 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 55,11 |
| 4701 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4702 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4703 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4704 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4705 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4706 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4707 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4708 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4709 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4710 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4711 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4712 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4713 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4714 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4715 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4716 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4717 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4718 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4719 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4720 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4721 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4722 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4723 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
| 4724 | Adipose Tissue | Autologous | Shoulder Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 47,1 |
| 4725 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2019 | Experimental Therapy | Poland | 45,3 |
| 4726 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2018 | Experimental Therapy | Poland | 7 |
| 4727 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2018 | Experimental Therapy | Poland | no data |
| 4728 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2018 | Experimental Therapy | Poland | 4,7 |
| 4729 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2018 | Experimental Therapy | Poland | 46,7 |
| 4730 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2018 | Experimental Therapy | Poland | 20,6 |
| 4731 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2018 | Experimental Therapy | Poland | 82,11 |
| 4732 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 61,11 |
| 4733 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 67,1 |
| 4734 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 41,8 |
| 4735 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 52,3 |
| 4736 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 66,3 |
| 4737 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 46,2 |
| 4738 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 65,2 |
| 4739 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 47,3 |
| 4740 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 52,11 |
| 4741 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 40 |
| 4742 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 54,2 |
| 4743 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 67,11 |
| 4744 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 41,9 |
| 4745 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 80,3 |
| 4746 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 65,7 |
| 4747 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 65,2 |
| 4748 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 60,2 |
| 4749 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 67,9 |
| 4750 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 49,2 |
| 4751 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 64,5 |
| 4752 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 63,7 |
| 4753 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 62,1 |
| 4754 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 55,6 |
| 4755 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 38,8 |
| 4756 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 69,5 |
| 4757 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 37,11 |
| 4758 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 56,8 |
| 4759 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 71,1 |
| 4760 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 64,3 |
| 4761 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 68,5 |
| 4762 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 78,2 |
| 4763 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 70,9 |
| 4764 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 62,4 |
| 4765 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 61,8 |
| 4766 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 41,7 |
| 4767 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 38,1 |
| 4768 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 62,7 |
| 4769 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 44,3 |
| 4770 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 55,11 |
| 4771 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita; Epilepsia | Neurology | 2018 | Experimental Therapy | Poland | 6,3 |
| 4772 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2018 | Experimental Therapy | Poland | 18,11 |
| 4773 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,5 |
| 4774 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9 |
| 4775 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
| 4776 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,1 |
| 4777 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9,5 |
| 4778 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,11 |
| 4779 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,3 |
| 4780 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,1 |
| 4781 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 11,11 |
| 4782 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,7 |
| 4783 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,5 |
| 4784 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5 |
| 4785 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
| 4786 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,3 |
| 4787 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,4 |
| 4788 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,9 |
| 4789 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,1 |
| 4790 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 11,4 |
| 4791 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,11 |
| 4792 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,1 |
| 4793 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6 |
| 4794 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9,2 |
| 4795 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9,6 |
| 4796 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,5 |
| 4797 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,11 |
| 4798 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5 |
| 4799 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,9 |
| 4800 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,7 |
| 4801 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 15 |
| 4802 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,3 |
| 4803 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
| 4804 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2018 | Experimental Therapy | Poland | 4 |
| 4805 | Cord Tissue | Allogeneic - Unrelated | Autism - Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 6 |
| 4806 | Cord Tissue | Allogeneic - Related | Autism; Congenital Cytomegalovirus | Neurology | 2018 | Experimental Therapy | Poland | 6 |
| 4807 | Cord Tissue | Allogeneic - Unrelated | Bilateral Edema Of The Optic Nerves | Ophthalmology | 2018 | Experimental Therapy | Poland | 12,4 |
| 4808 | Cord Tissue | Allogeneic - Unrelated | Brain Disorder, Unspecified | Neurology | 2018 | Experimental Therapy | Poland | 10,1 |
| 4809 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2018 | Experimental Therapy | Poland | 56 |
| 4810 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome; Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 3,7 |
| 4811 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 16,7 |
| 4812 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,8 |
| 4813 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,11 |
| 4814 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,11 |
| 4815 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 9,4 |
| 4816 | Cord Tissue | Allogeneic - Unrelated & Related | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 13,1 |
| 4817 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
| 4818 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
| 4819 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
| 4820 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,11 |
| 4821 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,6 |
| 4822 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 11,6 |
| 4823 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
| 4824 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,2 |
| 4825 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
| 4826 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,3 |
| 4827 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,6 |
| 4828 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,2 |
| 4829 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 16,5 |
| 4830 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
| 4831 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,6 |
| 4832 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,9 |
| 4833 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
| 4834 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
| 4835 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,3 |
| 4836 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,11 |
| 4837 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,1 |
| 4838 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,8 |
| 4839 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,1 |
| 4840 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,4 |
| 4841 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 8,5 |
| 4842 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 12,4 |
| 4843 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,7 |
| 4844 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 10 months |
| 4845 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 8,9 |
| 4846 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,2 |
| 4847 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 15,7 |
| 4848 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,2 |
| 4849 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 13,5 |
| 4850 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
| 4851 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,4 |
| 4852 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,6 |
| 4853 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
| 4854 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,2 |
| 4855 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,9 |
| 4856 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
| 4857 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,9 |
| 4858 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,5 |
| 4859 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,1 |
| 4860 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,3 |
| 4861 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,11 |
| 4862 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 13,2 |
| 4863 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,3 |
| 4864 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,2 |
| 4865 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 16 |
| 4866 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,4 |
| 4867 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 12,2 |
| 4868 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
| 4869 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 10 |
| 4870 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2 |
| 4871 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,2 |
| 4872 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,6 |
| 4873 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 9,5 |
| 4874 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 1,11 |
| 4875 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,7 |
| 4876 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 9,2 |
| 4877 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
| 4878 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 10,9 |
| 4879 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 7,4 |
| 4880 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,6 |
| 4881 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
| 4882 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2 |
| 4883 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
| 4884 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
| 4885 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 10,11 |
| 4886 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2,3 |
| 4887 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy; Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 8,11 |
| 4888 | Cord Tissue | Allogeneic - Unrelated | Congenital Myasthenia | Neurology | 2018 | Experimental Therapy | Poland | 6,4 |
| 4889 | Cord Tissue | Allogeneic - Unrelated | Congenital Myasthenia | Neurology | 2018 | Experimental Therapy | Poland | 3,3 |
| 4890 | Cord Tissue | Allogeneic - Unrelated | Damage To The Intercondylar Fissure Of The Right Knee | Orthopedy | 2018 | Experimental Therapy | Poland | 40 |
| 4891 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 34 |
| 4892 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 57 |
| 4893 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 6,2 |
| 4894 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 5,4 |
| 4895 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 4,8 |
| 4896 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 7,11 |
| 4897 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 4,7 |
| 4898 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 4,2 |
| 4899 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Atrophy Of The Optic Nerves | Neurology | 2018 | Experimental Therapy | Poland | 2 |
| 4900 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
| 4901 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 14 |
| 4902 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 7,11 |
| 4903 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 5,2 |
| 4904 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4905 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4906 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4907 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4908 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4909 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4910 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4911 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4912 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
| 4913 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2018 | Experimental Therapy | Poland | 8,8 |
| 4914 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 54,8 |
| 4915 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 11,4 |
| 4916 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 24,5 |
| 4917 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 22,1 |
| 4918 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 21,2 |
| 4919 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 20,9 |
| 4920 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 13,3 |
| 4921 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 7,6 |
| 4922 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 4 |
| 4923 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
| 4924 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Agenesis Of Corpus Callosum | Neurology | 2018 | Experimental Therapy | Poland | 2 |
| 4925 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 27,6 |
| 4926 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 31,5 |
| 4927 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 22,4 |
| 4928 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2018 | Experimental Therapy | Poland | 2,5 |
| 4929 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2018 | Experimental Therapy | Poland | 9,11 |
| 4930 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2018 | Experimental Therapy | Poland | 7,3 |
| 4931 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia; Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,4 |
| 4932 | Cord Tissue | Allogeneic - Unrelated | Genetic Syndrome - Deletion Of Part Of Chromosome 3 | Neurology | 2018 | Experimental Therapy | Poland | 8,1 |
| 4933 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 44,11 |
| 4934 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 46,1 |
| 4935 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 28,11 |
| 4936 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 66 |
| 4937 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 48 |
| 4938 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 43 |
| 4939 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 48 |
| 4940 | Cord Tissue | Allogeneic - Unrelated | Holoprosencephaly | Neurology | 2018 | Experimental Therapy | Poland | 12,2 |
| 4941 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development, Unspecified | Neurology | 2018 | Experimental Therapy | Poland | 10,2 |
| 4942 | Cord Tissue | Allogeneic - Unrelated | Leber's Hereditary Optic Neuropathy | Ophthalmology | 2018 | Experimental Therapy | Poland | 18,11 |
| 4943 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2018 | Experimental Therapy | Poland | 5,2 |
| 4944 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2018 | Experimental Therapy | Poland | 7,5 |
| 4945 | Cord Tissue | Allogeneic - Unrelated | Microcephalia | Neurology | 2018 | Experimental Therapy | Poland | 12,1 |
| 4946 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2018 | Experimental Therapy | Poland | 47,8 |
| 4947 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2018 | Experimental Therapy | Poland | 61,8 |
| 4948 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 28,1 |
| 4949 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 21,7 |
| 4950 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 22,6 |
| 4951 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 29,9 |
| 4952 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 21,8 |
| 4953 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 66,2 |
| 4954 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2018 | Experimental Therapy | Poland | 1 |
| 4955 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele; Hydrocephalus | Neurology | 2018 | Experimental Therapy | Poland | 2,9 |
| 4956 | Cord Tissue | Allogeneic - Unrelated | Myopathy | Neurology | 2018 | Experimental Therapy | Poland | 57,3 |
| 4957 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 27,4 |
| 4958 | Cord Tissue | Allogeneic - Unrelated | Neuropathy | Neurology | 2018 | Experimental Therapy | Poland | 47,6 |
| 4959 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 68,5 |
| 4960 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 31,11 |
| 4961 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 55,4 |
| 4962 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 36,6 |
| 4963 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,11 |
| 4964 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 27,2 |
| 4965 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 59,3 |
| 4966 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 50,8 |
| 4967 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,6 |
| 4968 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 55,8 |
| 4969 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 62,5 |
| 4970 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 35 |
| 4971 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 57,8 |
| 4972 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 75,5 |
| 4973 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 54,4 |
| 4974 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 80,5 |
| 4975 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 40,9 |
| 4976 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 70,11 |
| 4977 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 47,1 |
| 4978 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,2 |
| 4979 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 67,1 |
| 4980 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,7 |
| 4981 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 55,8 |
| 4982 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 27,5 |
| 4983 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,7 |
| 4984 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 23,7 |
| 4985 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 50,1 |
| 4986 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 70,5 |
| 4987 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 66,7 |
| 4988 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 22 |
| 4989 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 69,8 |
| 4990 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 78 |
| 4991 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 30 |
| 4992 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 73,8 |
| 4993 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 30,7 |
| 4994 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 49,7 |
| 4995 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,9 |
| 4996 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 46,5 |
| 4997 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 53,7 |
| 4998 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 56,7 |
| 4999 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 54,9 |
| 5000 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 42,4 |
| 5001 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 44,6 |
| 5002 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 60,3 |
| 5003 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 42,2 |
| 5004 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 52 |
| 5005 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2018 | Experimental Therapy | Poland | 15,8 |
| 5006 | Cord Tissue | Allogeneic - Unrelated | Other Reduction Deformities Of Brain; Schizencephaly | Neurology | 2018 | Experimental Therapy | Poland | 5,7 |
| 5007 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 1,11 |
| 5008 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 1,9 |
| 5009 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 16,1 |
| 5010 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 5 |
| 5011 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 6 |
| 5012 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 11 months |
| 5013 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
| 5014 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 1,2 |
| 5015 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
| 5016 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System - Syndrome Pierre-Robin | Neurology | 2018 | Experimental Therapy | Poland | 2,7 |
| 5017 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System- Pitt Hopkins Syndrome | Neurology | 2018 | Experimental Therapy | Poland | 10,1 |
| 5018 | Cord Tissue | Allogeneic - Unrelated | Paralysis | Neurology | 2018 | Experimental Therapy | Poland | 14,11 |
| 5019 | Cord Tissue | Allogeneic - Unrelated | Phelan-Mcdermid Syndrome | Neurology | 2018 | Experimental Therapy | Poland | 17,1 |
| 5020 | Cord Tissue | Allogeneic - Unrelated | Progressive Supranuclear Atrophy | Neurology | 2018 | Experimental Therapy | Poland | 62 |
| 5021 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 25,5 |
| 5022 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 36,3 |
| 5023 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 48,11 |
| 5024 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 44,3 |
| 5025 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 52,8 |
| 5026 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 32,3 |
| 5027 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 46,7 |
| 5028 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 47,8 |
| 5029 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 51,9 |
| 5030 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,1 |
| 5031 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 30,4 |
| 5032 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,2 |
| 5033 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 28,6 |
| 5034 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 83,5 |
| 5035 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 57,5 |
| 5036 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 45,11 |
| 5037 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 28,6 |
| 5038 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 61,3 |
| 5039 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 20,8 |
| 5040 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 76,1 |
| 5041 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 35,1 |
| 5042 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 31,2 |
| 5043 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,4 |
| 5044 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 66,2 |
| 5045 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 75,7 |
| 5046 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 62 |
| 5047 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 44 |
| 5048 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 48,1 |
| 5049 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 47,11 |
| 5050 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 44,2 |
| 5051 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 42,6 |
| 5052 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,9 |
| 5053 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 85,1 |
| 5054 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 61,9 |
| 5055 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,3 |
| 5056 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 51,6 |
| 5057 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 40,11 |
| 5058 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 50,4 |
| 5059 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 49,2 |
| 5060 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 33,5 |
| 5061 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 54,7 |
| 5062 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 36,7 |
| 5063 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 59,1 |
| 5064 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 66,8 |
| 5065 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 39,5 |
| 5066 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 44,2 |
| 5067 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 39,1 |
| 5068 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 47,3 |
| 5069 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 58,2 |
| 5070 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 42 |
| 5071 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Neurology | 2018 | Experimental Therapy | Poland | 12 |
| 5072 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2,6 |
| 5073 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
| 5074 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 4,11 |
| 5075 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 4,4 |
| 5076 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1 |
| 5077 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2 |
| 5078 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,5 |
| 5079 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,1 |
| 5080 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,4 |
| 5081 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2,8 |
| 5082 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2,6 |
| 5083 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 3,2 |
| 5084 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,6 |
| 5085 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 33,11 |
| 5086 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 30,9 |
| 5087 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 25,9 |
| 5088 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 25,9 |
| 5089 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 34,3 |
| 5090 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 18,5 |
| 5091 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 26,6 |
| 5092 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 18,2 |
| 5093 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 38 |
| 5094 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 64,1 |
| 5095 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,1 |
| 5096 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 22,4 |
| 5097 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 34 |
| 5098 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 39,2 |
| 5099 | Cord Tissue | Allogeneic - Unrelated | State After Encephalitis; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 44,11 |
| 5100 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 70,1 |
| 5101 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 53,4 |
| 5102 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 67,3 |
| 5103 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 42,3 |
| 5104 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 60,9 |
| 5105 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2018 | Experimental Therapy | Poland | 32,2 |
| 5106 | Cord Tissue | Allogeneic - Unrelated | Visual Pathway Dysfunction | Ophthalmology | 2018 | Experimental Therapy | Poland | 48,9 |
| 5107 | Cord Tissue | Allogeneic - Unrelated | Wolf-Hirschhorn Syndrome | Neurology | 2018 | Experimental Therapy | Poland | 1,8 |
| 5108 | Cord Blood | Allogeneic - Related | Alpha-Mannosidosis | Neurology | 2018 | Experimental Therapy | Germany | 8 |
| 5109 | Cord Blood | Autologous | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 3,5 |
| 5110 | Cord Blood | Autologous | Autism | Neurology | 2018 | Experimental Therapy | Portugal | 6 |
| 5111 | Cord Blood | Autologous | Autism | Neurology | 2018 | Experimental Therapy | Portugal | 8 |
| 5112 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
| 5113 | Cord Blood | Autologous | Autism | Neurology | 2018 | Experimental Therapy | UK | 5,4 |
| 5114 | Cord Blood | Autologous | Brain Damage | Neurology | 2018 | Experimental Therapy | Germany | 3 |
| 5115 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,7 |
| 5116 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | UK | 3,4 |
| 5117 | Cord Blood | Allogeneic | Immunodeficiency | Hematology | 2018 | Standard Therapy | Germany | 3 months |
| 5118 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2018 | Standard Therapy | Turkey | 10,1 |
| 5119 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2018 | Standard Therapy | Turkey | 6 |
| 5120 | Cord Blood | Allogeneic | Sphingolipidosis | Neurology | 2018 | Experimental Therapy | Germany | 4 |
| 5121 | Cord Blood | Autologous | Stroke | Neurology | 2018 | Experimental Therapy | Germany | 8 months |
| 5122 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 8,6 |
| 5123 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 4,3 |
| 5124 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 3,1 |
| 5125 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 5 |
| 5126 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 10,9 |
| 5127 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 3 |
| 5128 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Germany | 5 |
| 5129 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5130 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5131 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5132 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
| 5133 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 27 |
| 5134 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5135 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 28 |
| 5136 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
| 5137 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5138 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5139 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5140 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5141 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
| 5142 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
| 5143 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5144 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 5145 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
| 5146 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 5147 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5148 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 34 |
| 5149 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia In First Complete Remission | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5150 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5151 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5152 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 23 |
| 5153 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5154 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5155 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5156 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5157 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5158 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5159 | Bone Marrow Family | Allogeneic | Relapsed Peripheral T Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 44 |
| 5160 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 9 |
| 5161 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5162 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 9 months |
| 5163 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 12 |
| 5164 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5165 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 11 |
| 5166 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
| 5167 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5168 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 |
| 5169 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5170 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
| 5171 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 5172 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5173 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 12 |
| 5174 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 5175 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
| 5176 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2018 | Standard Therapy | Poland | 14 |
| 5177 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5178 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5179 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5180 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 36 |
| 5181 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
| 5182 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 1 |
| 5183 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5184 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5185 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5186 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
| 5187 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
| 5188 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 17 |
| 5189 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
| 5190 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5191 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5192 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5193 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
| 5194 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
| 5195 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 22 |
| 5196 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5197 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
| 5198 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
| 5199 | Bone Marrow | Allogeneic | Bilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5200 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 1 |
| 5201 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5202 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5203 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5204 | Bone Marrow | Allogeneic | Congenital Hypoplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5205 | Bone Marrow | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 68 |
| 5206 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5207 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5208 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 31 |
| 5209 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5210 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 11 |
| 5211 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
| 5212 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 12 |
| 5213 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5214 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5215 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
| 5216 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
| 5217 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 31 |
| 5218 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 37 |
| 5219 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 16 |
| 5220 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 48 |
| 5221 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 5222 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 1 |
| 5223 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 1 |
| 5224 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5225 | Bone Marrow | Allogeneic | Other Non-Malignant Disease | Hematology | 2018 | Standard Therapy | Poland | 29 |
| 5226 | Bone Marrow | Allogeneic | Primary Myelofibrosis Grade Iii | Hematology | 2018 | Standard Therapy | Germany | 73 |
| 5227 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 19 |
| 5228 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
| 5229 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 27 |
| 5230 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
| 5231 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5232 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
| 5233 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 5234 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 5235 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5236 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 1 |
| 5237 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 7 months |
| 5238 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 21 |
| 5239 | Bone Marrow | Allogeneic | T-Cell Leukemia/Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 10 |
| 5240 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 14 |
| 5241 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 12 |
| 5242 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 29 |
| 5243 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5244 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5245 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
| 5246 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5247 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
| 5248 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5249 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
| 5250 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 47 |
| 5251 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5252 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5253 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5254 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5255 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5256 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
| 5257 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 27 |
| 5258 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 1 |
| 5259 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5260 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
| 5261 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
| 5262 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 21 |
| 5263 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
| 5264 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5265 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 months |
| 5266 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
| 5267 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5268 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 36 |
| 5269 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5270 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
| 5271 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 44 |
| 5272 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5273 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
| 5274 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 30 |
| 5275 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 5276 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
| 5277 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
| 5278 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5279 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 9 |
| 5280 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5281 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 47 |
| 5282 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
| 5283 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 5284 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 43 |
| 5285 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 5286 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 59 |
| 5287 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 24 |
| 5288 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 26 |
| 5289 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 35 |
| 5290 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5291 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
| 5292 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5293 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5294 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5295 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 5296 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
| 5297 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5298 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5299 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5300 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 30 |
| 5301 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5302 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5303 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5304 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 51 |
| 5305 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5306 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5307 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5308 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5309 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5310 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 76 |
| 5311 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 5312 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5313 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5314 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5315 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5316 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 68 |
| 5317 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 37 |
| 5318 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5319 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5320 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
| 5321 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5322 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 73 |
| 5323 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5324 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 5325 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5326 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5327 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 35 |
| 5328 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5329 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
| 5330 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
| 5331 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
| 5332 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5333 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5334 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
| 5335 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5336 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5337 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
| 5338 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
| 5339 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5340 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5341 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5342 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 31 |
| 5343 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5344 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5345 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 5346 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5347 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
| 5348 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5349 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 69 |
| 5350 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5351 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 28 |
| 5352 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 5353 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5354 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
| 5355 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5356 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 47 |
| 5357 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 29 |
| 5358 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 37 |
| 5359 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5360 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 5361 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5362 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5363 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 31 |
| 5364 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5365 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5366 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5367 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
| 5368 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5369 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 68 |
| 5370 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5371 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5372 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5373 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5374 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
| 5375 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 75 |
| 5376 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 43 |
| 5377 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
| 5378 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 37 |
| 5379 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
| 5380 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5381 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
| 5382 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5383 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5384 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5385 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
| 5386 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
| 5387 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5388 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5389 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5390 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 5391 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 20 |
| 5392 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 47 |
| 5393 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 5394 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 31 |
| 5395 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
| 5396 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 5397 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 59 |
| 5398 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5399 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5400 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 5401 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 5402 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5403 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 5404 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5405 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 19 |
| 5406 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
| 5407 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5408 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5409 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myeloproliferative Syndrome | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5410 | Apheresis | Autologous | Amyloidosis | Hematology | 2018 | Standard Therapy | Germany | 72 |
| 5411 | Apheresis | Autologous | Amyloidosis | Hematology | 2018 | Standard Therapy | Germany | 75 |
| 5412 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 5413 | Apheresis | Autologous | Apoplexy | Hematology | 2018 | Standard Therapy | Germany | 3 |
| 5414 | Apheresis | Allogeneic | Atypical Chronic Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5415 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
| 5416 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5417 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 5418 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 5419 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 5420 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5421 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5422 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 5423 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 43 |
| 5424 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5425 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 32 |
| 5426 | Apheresis | Allogeneic | Blastic Nk Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5427 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 15 |
| 5428 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5429 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5430 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 5431 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5432 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
| 5433 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
| 5434 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
| 5435 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Germany | 44 |
| 5436 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 5437 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
| 5438 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5439 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5440 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5441 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 51 |
| 5442 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5443 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5444 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5445 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5446 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5447 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 71 |
| 5448 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2018 | Standard Therapy | Germany | 71 |
| 5449 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 9 |
| 5450 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 44 |
| 5451 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5452 | Apheresis | Allogeneic | Follicular Lymphoma (Non-Hodgkin Lymphoma) | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5453 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2018 | Standard Therapy | Germany | 23 |
| 5454 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2018 | Standard Therapy | Germany | 31 |
| 5455 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 5456 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 27 |
| 5457 | Apheresis | Allogeneic | Hypoplastic Mds-Eb2 With Incipient Saml | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5458 | Apheresis | Autologous | Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5459 | Apheresis | Allogeneic | Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 5460 | Apheresis | Allogeneic | Lymphomatoid Granulomatosis | Hematology | 2018 | Standard Therapy | Germany | 36 |
| 5461 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5462 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 5463 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 44 |
| 5464 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5465 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5466 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2018 | Standard Therapy | Germany | 31 |
| 5467 | Apheresis | Allogeneic | Morbus Hodgkin-Relapse | Hematology | 2018 | Standard Therapy | Germany | 35 |
| 5468 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5469 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 5470 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 5471 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5472 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 57 |
| 5473 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 53 |
| 5474 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 57 |
| 5475 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5476 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 47 |
| 5477 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 5478 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5479 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5480 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5481 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5482 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 5483 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 5484 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 51 |
| 5485 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 5486 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 5487 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5488 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5489 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5490 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5491 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 5492 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 5493 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 55 |
| 5494 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 5495 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 5496 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5497 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 5498 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 55 |
| 5499 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5500 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 5501 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 5502 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 5503 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 5504 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 73 |
| 5505 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 42 |
| 5506 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 5507 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5508 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5509 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5510 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5511 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 51 |
| 5512 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 5513 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 50 |
| 5514 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5515 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 50 |
| 5516 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 5517 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 56 |
| 5518 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 74 |
| 5519 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5520 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 72 |
| 5521 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5522 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5523 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5524 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 68 |
| 5525 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5526 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5527 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 22 |
| 5528 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5529 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 77 |
| 5530 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5531 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5532 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 68 |
| 5533 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 39 |
| 5534 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5535 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5536 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5537 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5538 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 27 |
| 5539 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5540 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 39 |
| 5541 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 5542 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 32 |
| 5543 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5544 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5545 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5546 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5547 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5548 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5549 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 48 |
| 5550 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5551 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5552 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5553 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5554 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
| 5555 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5556 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 69 |
| 5557 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 5558 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 8 |
| 5559 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5560 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5561 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5562 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 5563 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5564 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 57 |
| 5565 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 27 |
| 5566 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5567 | Apheresis | Allogeneic | Myelodysplastic Syndrome Refractory Anemia With Blast Proliferation Ii | Hematology | 2018 | Standard Therapy | Germany | 57 |
| 5568 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 5569 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Acute Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 74 |
| 5570 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Myeloproliferative Neoplasms | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5571 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 5572 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5573 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5574 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5575 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5576 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 68 |
| 5577 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 72 |
| 5578 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 53 |
| 5579 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 5580 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5581 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 55 |
| 5582 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 5583 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2018 | Standard Therapy | Poland | 61 |
| 5584 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 69 |
| 5585 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5586 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 5587 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 22 |
| 5588 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 5589 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 19 |
| 5590 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5591 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 22 |
| 5592 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5593 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 5594 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 23 |
| 5595 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 69 |
| 5596 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5597 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 17 |
| 5598 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 31 |
| 5599 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 66 |
| 5600 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 17 |
| 5601 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5602 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 11 |
| 5603 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5604 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 30 |
| 5605 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 5606 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 72 |
| 5607 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 5608 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 5609 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 5610 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 48 |
| 5611 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 5612 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5613 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2018 | Standard Therapy | Germany | 51 |
| 5614 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 5615 | Apheresis | Allogeneic | Other Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 5616 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5617 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 5618 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 5619 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 5620 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 5621 | Apheresis | Allogeneic | Post-Essential Thrombocythemia-Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 53 |
| 5622 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5623 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 5624 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 5625 | Apheresis | Autologous | Primary Central Nervous System Lymphoma Relapse | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 5626 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 5627 | Apheresis | Allogeneic | Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
| 5628 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 5629 | Apheresis | Autologous | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 36 |
| 5630 | Apheresis | Allogeneic | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 50 |
| 5631 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 5632 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
| 5633 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Primary Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 56 |
| 5634 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
| 5635 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 74 |
| 5636 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
| 5637 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 5638 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 5639 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
| 5640 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 5641 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 |
| 5642 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
| 5643 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 5644 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
| 5645 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5646 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 5647 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 23 |
| 5648 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 5 |
| 5649 | Apheresis | Allogeneic | Therapy-Related Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 5650 | Adipose Tissue | Autologous | Condition After Injury Of The Left Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 33 |
| 5651 | Adipose Tissue | Autologous | Coxarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 53 |
| 5652 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5653 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5654 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5655 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5656 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5657 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5658 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5659 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5660 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 69 |
| 5661 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 42 |
| 5662 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5663 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5664 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5665 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5666 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5667 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5668 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5669 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5670 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5671 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5672 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 5673 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 44,2 |
| 5674 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 25,8 |
| 5675 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 38,5 |
| 5676 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 26,1 |
| 5677 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 37,11 |
| 5678 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 62,5 |
| 5679 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 35,4 |
| 5680 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 31,3 |
| 5681 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 13 |
| 5682 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 11,1 |
| 5683 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 2,4 |
| 5684 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 8,1 |
| 5685 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 7,6 |
| 5686 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2017 | Experimental Therapy | Poland | 33,4 |
| 5687 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 67,11 |
| 5688 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 37,9 |
| 5689 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 71,7 |
| 5690 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | no data |
| 5691 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 47,6 |
| 5692 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
| 5693 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 48,11 |
| 5694 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46,3 |
| 5695 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 45,9 |
| 5696 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 75,9 |
| 5697 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,3 |
| 5698 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,8 |
| 5699 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 64,9 |
| 5700 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
| 5701 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 40,11 |
| 5702 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 69,1 |
| 5703 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 52 |
| 5704 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 35,1 |
| 5705 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 77,2 |
| 5706 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 35,6 |
| 5707 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 33,5 |
| 5708 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,6 |
| 5709 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46 |
| 5710 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 54,1 |
| 5711 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 63,2 |
| 5712 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 43,8 |
| 5713 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 64,7 |
| 5714 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,6 |
| 5715 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 70,11 |
| 5716 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 65,1 |
| 5717 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,3 |
| 5718 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 68,1 |
| 5719 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,3 |
| 5720 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 49,1 |
| 5721 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 60,1 |
| 5722 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
| 5723 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 58,7 |
| 5724 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 63 |
| 5725 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 62,9 |
| 5726 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 57,9 |
| 5727 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,11 |
| 5728 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46,5 |
| 5729 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 53,9 |
| 5730 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 55,2 |
| 5731 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 54,6 |
| 5732 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 78,6 |
| 5733 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 44 |
| 5734 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 78,7 |
| 5735 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 60,1 |
| 5736 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 28,7 |
| 5737 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 78,5 |
| 5738 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 54,2 |
| 5739 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 45,3 |
| 5740 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 48,2 |
| 5741 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 71,8 |
| 5742 | Cord Tissue | Allogeneic - Unrelated | Anterior Ischemic Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 67,7 |
| 5743 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita | Neurology | 2017 | Experimental Therapy | Poland | 1,7 |
| 5744 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita | Neurology | 2017 | Experimental Therapy | Poland | 3,5 |
| 5745 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2017 | Experimental Therapy | Poland | 23,9 |
| 5746 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2017 | Experimental Therapy | Poland | 35,5 |
| 5747 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
| 5748 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 13,4 |
| 5749 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 11,11 |
| 5750 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 9,1 |
| 5751 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
| 5752 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
| 5753 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 10,2 |
| 5754 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,8 |
| 5755 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,8 |
| 5756 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7 |
| 5757 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,8 |
| 5758 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 10,8 |
| 5759 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 13,1 |
| 5760 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
| 5761 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,8 |
| 5762 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 12,2 |
| 5763 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 5,1 |
| 5764 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,5 |
| 5765 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,8 |
| 5766 | Cord Tissue | Allogeneic - Unrelated | Autism; Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
| 5767 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2017 | Experimental Therapy | Poland | 61 |
| 5768 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2017 | Experimental Therapy | Poland | 46 |
| 5769 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 33 |
| 5770 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 11,5 |
| 5771 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 60,5 |
| 5772 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 52,6 |
| 5773 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 60,11 |
| 5774 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 46,5 |
| 5775 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 18,7 |
| 5776 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 15,4 |
| 5777 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
| 5778 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 31,9 |
| 5779 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,7 |
| 5780 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 12 |
| 5781 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,9 |
| 5782 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,3 |
| 5783 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,1 |
| 5784 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 13,6 |
| 5785 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,2 |
| 5786 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,7 |
| 5787 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,4 |
| 5788 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 15,1 |
| 5789 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 18,4 |
| 5790 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 7,9 |
| 5791 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,5 |
| 5792 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,7 |
| 5793 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,5 |
| 5794 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,1 |
| 5795 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,4 |
| 5796 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,3 |
| 5797 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,7 |
| 5798 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,2 |
| 5799 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,7 |
| 5800 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
| 5801 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 15,3 |
| 5802 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 13,6 |
| 5803 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,4 |
| 5804 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,3 |
| 5805 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,3 |
| 5806 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,2 |
| 5807 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3 |
| 5808 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,9 |
| 5809 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 7,8 |
| 5810 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
| 5811 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 10 |
| 5812 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,6 |
| 5813 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,11 |
| 5814 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,2 |
| 5815 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 24,8 |
| 5816 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,1 |
| 5817 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,6 |
| 5818 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
| 5819 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 10,9 |
| 5820 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 17 |
| 5821 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,6 |
| 5822 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,9 |
| 5823 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
| 5824 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,6 |
| 5825 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
| 5826 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,6 |
| 5827 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,5 |
| 5828 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
| 5829 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 5,8 |
| 5830 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 3,6 |
| 5831 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 2,1 |
| 5832 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Neonatal Cerebral Leukomalacia | Neurology | 2017 | Experimental Therapy | Poland | 1,9 |
| 5833 | Cord Tissue | Allogeneic - Unrelated | Chronic Myelogenous Leukemia | Hematology | 2017 | Experimental Therapy | Poland | 5,11 |
| 5834 | Cord Tissue | Allogeneic - Unrelated | Condition After Encephalitis | Neurology | 2017 | Experimental Therapy | Poland | 19,7 |
| 5835 | Cord Tissue | Allogeneic - Unrelated | Condition After Myelitis | Neurology | 2017 | Experimental Therapy | Poland | 34,11 |
| 5836 | Cord Tissue | Allogeneic - Unrelated | Congenital Fiber-Type Disproportion Myopathy | Neurology | 2017 | Experimental Therapy | Poland | 1,1 |
| 5837 | Cord Tissue | Allogeneic - Unrelated | Congenital Malformations Of The Nervous System, Unspecified | Neurology | 2017 | Experimental Therapy | Poland | 8,2 |
| 5838 | Cord Tissue | Allogeneic - Unrelated | Cranium Bifidum | Neurology | 2017 | Experimental Therapy | Poland | 5,2 |
| 5839 | Cord Tissue | Allogeneic - Unrelated | Cri Du Chat Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 8,6 |
| 5840 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 3,5 |
| 5841 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
| 5842 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 5 |
| 5843 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 7,9 |
| 5844 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 8,3 |
| 5845 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 11,8 |
| 5846 | Cord Tissue | Allogeneic - Unrelated | Devic’s Disease | Neurology | 2017 | Experimental Therapy | Poland | 45,2 |
| 5847 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 28,6 |
| 5848 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 28,11 |
| 5849 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 23,9 |
| 5850 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 9,1 |
| 5851 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 14,5 |
| 5852 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 21,1 |
| 5853 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 5 |
| 5854 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 5,5 |
| 5855 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 1,6 |
| 5856 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,4 |
| 5857 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,5 |
| 5858 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 3,1 |
| 5859 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 16,4 |
| 5860 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 9,11 |
| 5861 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 12,11 |
| 5862 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 15,9 |
| 5863 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Autism | Neurology | 2017 | Experimental Therapy | Poland | 6 |
| 5864 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 22,1 |
| 5865 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 31,6 |
| 5866 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 32,3 |
| 5867 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 33,4 |
| 5868 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 42,1 |
| 5869 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 22,4 |
| 5870 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2017 | Experimental Therapy | Poland | 4,7 |
| 5871 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
| 5872 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2017 | Experimental Therapy | Poland | 58 |
| 5873 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2017 | Experimental Therapy | Poland | 65,6 |
| 5874 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2017 | Experimental Therapy | Poland | 66 |
| 5875 | Cord Tissue | Allogeneic - Unrelated | Hydrocephalus; Neonatal Cerebral Leukomalacia | Neurology | 2017 | Experimental Therapy | Poland | 2,3 |
| 5876 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2017 | Experimental Therapy | Poland | 1,9 |
| 5877 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2017 | Experimental Therapy | Poland | 1,1 |
| 5878 | Cord Tissue | Allogeneic - Unrelated | Ischemia Within The Optic Nerve | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,11 |
| 5879 | Cord Tissue | Allogeneic - Unrelated | Krabbe Disease | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
| 5880 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2017 | Experimental Therapy | Poland | 7,1 |
| 5881 | Cord Tissue | Allogeneic - Unrelated | Moyamoya Disease | Neurology | 2017 | Experimental Therapy | Poland | 17,7 |
| 5882 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 26,11 |
| 5883 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 34,1 |
| 5884 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 6,7 |
| 5885 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 12,1 |
| 5886 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 10,8 |
| 5887 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 8 |
| 5888 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 29,8 |
| 5889 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 7,4 |
| 5890 | Cord Tissue | Allogeneic - Unrelated | Myopathy Of Congenital Fiber Type Disproportion; Damage To The Central Nervous System | Neurology | 2017 | Experimental Therapy | Poland | 2,2 |
| 5891 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 37,7 |
| 5892 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 41,11 |
| 5893 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 3,2 |
| 5894 | Cord Tissue | Allogeneic - Unrelated | No Bone Adhesion | Orthopedy | 2017 | Experimental Therapy | Poland | 14,1 |
| 5895 | Cord Tissue | Allogeneic - Unrelated | No Bone Adhesion | Orthopedy | 2017 | Experimental Therapy | Poland | 17,11 |
| 5896 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 39 |
| 5897 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 30,9 |
| 5898 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,7 |
| 5899 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 66,11 |
| 5900 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,5 |
| 5901 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 39,7 |
| 5902 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 76,1 |
| 5903 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 77,5 |
| 5904 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 30,6 |
| 5905 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 85,7 |
| 5906 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 52,8 |
| 5907 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,1 |
| 5908 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 59 |
| 5909 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 66,1 |
| 5910 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 56,4 |
| 5911 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 30,11 |
| 5912 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 74,5 |
| 5913 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 7,11 |
| 5914 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2017 | Experimental Therapy | Poland | 2,1 |
| 5915 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2017 | Experimental Therapy | Poland | 2,4 |
| 5916 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 58,1 |
| 5917 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 49 |
| 5918 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 56,8 |
| 5919 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 65,2 |
| 5920 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 43,4 |
| 5921 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 42,11 |
| 5922 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 41 |
| 5923 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 52,1 |
| 5924 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 61,5 |
| 5925 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 48,1 |
| 5926 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,1 |
| 5927 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 52,11 |
| 5928 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 36,11 |
| 5929 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 63,11 |
| 5930 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,9 |
| 5931 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 45,5 |
| 5932 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 49,1 |
| 5933 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 26,9 |
| 5934 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 65,4 |
| 5935 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 43,11 |
| 5936 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 22,1 |
| 5937 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 61,3 |
| 5938 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 61,7 |
| 5939 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 65,1 |
| 5940 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 43,1 |
| 5941 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 36,9 |
| 5942 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 48,8 |
| 5943 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 52,9 |
| 5944 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 47,2 |
| 5945 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 46,9 |
| 5946 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 38 |
| 5947 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 25,2 |
| 5948 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 53,1 |
| 5949 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 47,6 |
| 5950 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 32,9 |
| 5951 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 69,2 |
| 5952 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 64,3 |
| 5953 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Neurology | 2017 | Experimental Therapy | Poland | 29,4 |
| 5954 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
| 5955 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 1,11 |
| 5956 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 6,4 |
| 5957 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
| 5958 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 1,1 |
| 5959 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 4,1 |
| 5960 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 3,6 |
| 5961 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 3,4 |
| 5962 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 2,11 |
| 5963 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 5,8 |
| 5964 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 6,1 |
| 5965 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
| 5966 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 2,3 |
| 5967 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 18,5 |
| 5968 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 5,1 |
| 5969 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 11,1 |
| 5970 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 10,3 |
| 5971 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 9 months |
| 5972 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 34,11 |
| 5973 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 34,1 |
| 5974 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 24,9 |
| 5975 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 39 |
| 5976 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 6,4 |
| 5977 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | no data |
| 5978 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | no data |
| 5979 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 27,3 |
| 5980 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 33,8 |
| 5981 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 3,4 |
| 5982 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 38,4 |
| 5983 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 14,4 |
| 5984 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 57,1 |
| 5985 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury; Tetraparesis | Orthopedy | 2017 | Experimental Therapy | Poland | 42,9 |
| 5986 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 10,6 |
| 5987 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 41,4 |
| 5988 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 12,11 |
| 5989 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 8,5 |
| 5990 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 24,9 |
| 5991 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 44,1 |
| 5992 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 24,6 |
| 5993 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 35,9 |
| 5994 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 24,6 |
| 5995 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,4 |
| 5996 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,6 |
| 5997 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 30 |
| 5998 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 23,7 |
| 5999 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 27,11 |
| 6000 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 45,4 |
| 6001 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 48,1 |
| 6002 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,8 |
| 6003 | Cord Tissue | Allogeneic - Unrelated | Syndrome Ifap | Hematology | 2017 | Experimental Therapy | Poland | 3,5 |
| 6004 | Cord Tissue | Allogeneic - Unrelated | Syringomyelia | Neurology | 2017 | Experimental Therapy | Poland | 42,6 |
| 6005 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2017 | Experimental Therapy | Poland | 27,11 |
| 6006 | Cord Tissue | Allogeneic - Unrelated | Transverse Myelitis | Neurology | 2017 | Experimental Therapy | Poland | 8,3 |
| 6007 | Cord Tissue | Allogeneic - Unrelated | Traumatic Brain Injury | Neurology | 2017 | Experimental Therapy | Poland | 9,4 |
| 6008 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
| 6009 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
| 6010 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,3 |
| 6011 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Romania | 5,4 |
| 6012 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Romania | 4,1 |
| 6013 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Romania | 4,1 |
| 6014 | Cord Blood | Allogeneic - Related | Cd40 Ligand Deficiency | Hematology | 2017 | Standard Therapy | Turkey | 9,7 |
| 6015 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Spain | 7 |
| 6016 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,2 |
| 6017 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,4 |
| 6018 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 10,3 |
| 6019 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,8 |
| 6020 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | UK | 7 |
| 6021 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | UK | 3,4 |
| 6022 | Cord Blood | Allogeneic - Related | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Turkey | 3,9 |
| 6023 | Cord Blood | no data | Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | UK | 3 |
| 6024 | Cord Blood | Allogeneic - Related | Relapse Of Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7,3 |
| 6025 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2017 | Standard Therapy | Turkey | 4,1 |
| 6026 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2017 | Standard Therapy | Turkey | 4,1 |
| 6027 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6028 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 6029 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
| 6030 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6031 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 52 |
| 6032 | Bone Marrow Family | Allogeneic | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 6033 | Bone Marrow Family | Allogeneic | Hurler Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6034 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6035 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6036 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 50 |
| 6037 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 29 |
| 6038 | Bone Marrow Family | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6039 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6040 | Bone Marrow Family | Allogeneic | No Data | no data | 2017 | Standard Therapy | Poland | 39 |
| 6041 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 39 |
| 6042 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6043 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6044 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6045 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6046 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 6 |
| 6047 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
| 6048 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
| 6049 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
| 6050 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
| 6051 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 6052 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 9 |
| 6053 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 21 |
| 6054 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 3 |
| 6055 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 8 |
| 6056 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
| 6057 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 6058 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6059 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6060 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6061 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 18 |
| 6062 | Bone Marrow | Allogeneic | Acute Megakaryocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6063 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6064 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 19 |
| 6065 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 76 |
| 6066 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 22 |
| 6067 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6068 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6069 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6070 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 13 |
| 6071 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6072 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 6073 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6074 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6075 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
| 6076 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6077 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6078 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
| 6079 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 17 |
| 6080 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6081 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6082 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
| 6083 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 9 |
| 6084 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 12 |
| 6085 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6086 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 70 |
| 6087 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia (High Risk) | Hematology | 2017 | Standard Therapy | Germany | 31 |
| 6088 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6089 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 6090 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6091 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
| 6092 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
| 6093 | Bone Marrow | Allogeneic | Hyper-Igm Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6094 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 6095 | Bone Marrow | Allogeneic | Leukemia | Hematology | 2017 | Standard Therapy | Poland | 40 |
| 6096 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6097 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6098 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6099 | Bone Marrow | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 50 |
| 6100 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2017 | Standard Therapy | Poland | 8 |
| 6101 | Bone Marrow | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6102 | Bone Marrow | Allogeneic | Other Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 11 |
| 6103 | Bone Marrow | Allogeneic | Primary Immunodeficiency; Nijmegen Breakage Syndrome | Hematology | 2017 | Standard Therapy | Poland | 6 |
| 6104 | Bone Marrow | Allogeneic | Pure Red Cell Aplasia | Hematology | 2017 | Standard Therapy | Poland | 5 |
| 6105 | Bone Marrow | Allogeneic | Secondary Acute Myelogenous Leukemia After Ewing Sarcoma | Hematology | 2017 | Standard Therapy | Poland | 16 |
| 6106 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 6 |
| 6107 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 6108 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 6109 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6110 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 6111 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 8 |
| 6112 | Bone Marrow | Allogeneic | T-Cell Leukemia/Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 18 |
| 6113 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2017 | Standard Therapy | Poland | 11 |
| 6114 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6115 | Apheresis | Allogeneic | Accrued Hemophagocytic Lymphohistiocytosis | Hematology | 2017 | Standard Therapy | Germany | 43 |
| 6116 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
| 6117 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
| 6118 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 17 |
| 6119 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6120 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
| 6121 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 3 |
| 6122 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 12 |
| 6123 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 19 |
| 6124 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6125 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 33 |
| 6126 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6127 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6128 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 35 |
| 6129 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
| 6130 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 12 |
| 6131 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 6132 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6133 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6134 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 19 |
| 6135 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 11 |
| 6136 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 6137 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 41 |
| 6138 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6139 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
| 6140 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6141 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6142 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 17 |
| 6143 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 36 |
| 6144 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
| 6145 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 21 |
| 6146 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6147 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6148 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 6 |
| 6149 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6150 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
| 6151 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
| 6152 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 26 |
| 6153 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 8 |
| 6154 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 13 |
| 6155 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 26 |
| 6156 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 39 |
| 6157 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6158 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6159 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
| 6160 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6161 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6162 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 6163 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
| 6164 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 20 |
| 6165 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 44 |
| 6166 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 66 |
| 6167 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 75 |
| 6168 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6169 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6170 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6171 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6172 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 45 |
| 6173 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6174 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
| 6175 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6176 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6177 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6178 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 75 |
| 6179 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6180 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6181 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6182 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6183 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6184 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 75 |
| 6185 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6186 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6187 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 70 |
| 6188 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 34 |
| 6189 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 52 |
| 6190 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6191 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6192 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6193 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
| 6194 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6195 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6196 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6197 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6198 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 39 |
| 6199 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6200 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 35 |
| 6201 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 29 |
| 6202 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6203 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6204 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 6205 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6206 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6207 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6208 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6209 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6210 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
| 6211 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 42 |
| 6212 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6213 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6214 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 52 |
| 6215 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 49 |
| 6216 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6217 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6218 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6219 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 35 |
| 6220 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6221 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 31 |
| 6222 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6223 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6224 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 49 |
| 6225 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6226 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 22 |
| 6227 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6228 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6229 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 40 |
| 6230 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6231 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6232 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6233 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
| 6234 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6235 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6236 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6237 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
| 6238 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6239 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 71 |
| 6240 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
| 6241 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6242 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 66 |
| 6243 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6244 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6245 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6246 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6247 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 37 |
| 6248 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
| 6249 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 26 |
| 6250 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
| 6251 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6252 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 71 |
| 6253 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6254 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6255 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 27 |
| 6256 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 72 |
| 6257 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 72 |
| 6258 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 37 |
| 6259 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 71 |
| 6260 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 58 |
| 6261 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 38 |
| 6262 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6263 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 57 |
| 6264 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 56 |
| 6265 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 52 |
| 6266 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 63 |
| 6267 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 44 |
| 6268 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 6269 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 54 |
| 6270 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 25 |
| 6271 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 71 |
| 6272 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 34 |
| 6273 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 49 |
| 6274 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 68 |
| 6275 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 39 |
| 6276 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 30 |
| 6277 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 57 |
| 6278 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6279 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia | Hematology | 2017 | Standard Therapy | Germany | 36 |
| 6280 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
| 6281 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 44 |
| 6282 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 28 |
| 6283 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6284 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
| 6285 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 65 |
| 6286 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 57 |
| 6287 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
| 6288 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2017 | Standard Therapy | Germany | 68 |
| 6289 | Apheresis | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6290 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6291 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 45 |
| 6292 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 6293 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6294 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6295 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6296 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6297 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 31 |
| 6298 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 29 |
| 6299 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 74 |
| 6300 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6301 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6302 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6303 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
| 6304 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6305 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 72 |
| 6306 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6307 | Apheresis | Allogeneic | Chronic Myeloproliferative Neoplasm Blast Crisis | Hematology | 2017 | Standard Therapy | Poland | 29 |
| 6308 | Apheresis | Allogeneic | Common Variable Immunodeficiency, Relapsed Hemophagocytic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 44 |
| 6309 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6310 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 41 |
| 6311 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2017 | Standard Therapy | Germany | 67 |
| 6312 | Apheresis | Autologous | Follicular B-Cell Non-Hodgkin-Lymphoma Grade I-Ii Relapse | Hematology | 2017 | Standard Therapy | Germany | 59 |
| 6313 | Apheresis | Allogeneic | Follicular Ca | Hematology | 2017 | Standard Therapy | Poland | 42 |
| 6314 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 47 |
| 6315 | Apheresis | Allogeneic | Hemophagocytosis | Hematology | 2017 | Standard Therapy | Poland | 52 |
| 6316 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 25 |
| 6317 | Apheresis | Allogeneic | Langerhans Lymphohistiocytosis | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6318 | Apheresis | Autologous | Light-Chain Myeloma | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 6319 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 58 |
| 6320 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 63 |
| 6321 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 6322 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6323 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 59 |
| 6324 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 68 |
| 6325 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
| 6326 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 56 |
| 6327 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 6328 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 53 |
| 6329 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2017 | Standard Therapy | Germany | 38 |
| 6330 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2017 | Standard Therapy | Germany | 60 |
| 6331 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 6332 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 65 |
| 6333 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6334 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 6335 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 60 |
| 6336 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 58 |
| 6337 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 6338 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 63 |
| 6339 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 58 |
| 6340 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 72 |
| 6341 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 63 |
| 6342 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 50 |
| 6343 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 52 |
| 6344 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 72 |
| 6345 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 57 |
| 6346 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 56 |
| 6347 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 59 |
| 6348 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6349 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 72 |
| 6350 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 69 |
| 6351 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 52 |
| 6352 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 67 |
| 6353 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6354 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6355 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 50 |
| 6356 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 67 |
| 6357 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 53 |
| 6358 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 6359 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 44 |
| 6360 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 6361 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 56 |
| 6362 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 60 |
| 6363 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6364 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
| 6365 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 60 |
| 6366 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 3 |
| 6367 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6368 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6369 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 75 |
| 6370 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6371 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 64 |
| 6372 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 46 |
| 6373 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6374 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 71 |
| 6375 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 50 |
| 6376 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6377 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6378 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6379 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6380 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6381 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6382 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6383 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6384 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6385 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6386 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 54 |
| 6387 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 49 |
| 6388 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 39 |
| 6389 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 67 |
| 6390 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6391 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 76 |
| 6392 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 70 |
| 6393 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6394 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6395 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6396 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 66 |
| 6397 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6398 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6399 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6400 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 61 |
| 6401 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 22 |
| 6402 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 40 |
| 6403 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6404 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6405 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 70 |
| 6406 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 51 |
| 6407 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 53 |
| 6408 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 68 |
| 6409 | Apheresis | Allogeneic | Myelodysplastic Syndrome In Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
| 6410 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2017 | Standard Therapy | Germany | 62 |
| 6411 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6412 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6413 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 66 |
| 6414 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6415 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6416 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6417 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
| 6418 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 72 |
| 6419 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Germany | 70 |
| 6420 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 6421 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 44 |
| 6422 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6423 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6424 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 6425 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6426 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Germany | 37 |
| 6427 | Apheresis | Allogeneic | Niemann–Pick Disease | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6428 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 36 |
| 6429 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6430 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6431 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 1 |
| 6432 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6433 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6434 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6435 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 47 |
| 6436 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 57 |
| 6437 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6438 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 58 |
| 6439 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 42 |
| 6440 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 36 |
| 6441 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6442 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 68 |
| 6443 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 52 |
| 6444 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 53 |
| 6445 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
| 6446 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 65 |
| 6447 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 55 |
| 6448 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6449 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 69 |
| 6450 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 72 |
| 6451 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 51 |
| 6452 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 57 |
| 6453 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2017 | Standard Therapy | Germany | 52 |
| 6454 | Apheresis | Allogeneic | Osteopetrosis | Metabolic | 2017 | Standard Therapy | Poland | 3 |
| 6455 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2017 | Standard Therapy | Poland | 59 |
| 6456 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 71 |
| 6457 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 6458 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 51 |
| 6459 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 66 |
| 6460 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
| 6461 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 6462 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 2 |
| 6463 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 29 |
| 6464 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6465 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
| 6466 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
| 6467 | Apheresis | Allogeneic | Richter's Transformation At Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 60 |
| 6468 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
| 6469 | Apheresis | Allogeneic | Secondary Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 61 |
| 6470 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
| 6471 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 27 |
| 6472 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
| 6473 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
| 6474 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
| 6475 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
| 6476 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 25 |
| 6477 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 28 |
| 6478 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 24 |
| 6479 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 19 |
| 6480 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 56 |
| 6481 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 63 |
| 6482 | Apheresis | Allogeneic | Β - Thalassemia Major | Hematology | 2017 | Standard Therapy | Poland | 4 |
| 6483 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 22 |
| 6484 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 32,3 |
| 6485 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 44,7 |
| 6486 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 14 |
| 6487 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 6 |
| 6488 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 60,5 |
| 6489 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 3,11 |
| 6490 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 11,11 |
| 6491 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 6,11 |
| 6492 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 9,7 |
| 6493 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy; Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 8,4 |
| 6494 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2016 | Experimental Therapy | Poland | 86,5 |
| 6495 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 44,5 |
| 6496 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,8 |
| 6497 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 32,2 |
| 6498 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,7 |
| 6499 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,4 |
| 6500 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 33,4 |
| 6501 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 37,4 |
| 6502 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 39,3 |
| 6503 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 63,2 |
| 6504 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,11 |
| 6505 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,9 |
| 6506 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 46,9 |
| 6507 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 58 |
| 6508 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55 |
| 6509 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 58,1 |
| 6510 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,7 |
| 6511 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 52,6 |
| 6512 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,11 |
| 6513 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,9 |
| 6514 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59 |
| 6515 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,9 |
| 6516 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 42,7 |
| 6517 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 45,1 |
| 6518 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,4 |
| 6519 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 36,1 |
| 6520 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,1 |
| 6521 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,2 |
| 6522 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,7 |
| 6523 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,1 |
| 6524 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 46,1 |
| 6525 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 72,4 |
| 6526 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,3 |
| 6527 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,1 |
| 6528 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,8 |
| 6529 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 64,7 |
| 6530 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 64,2 |
| 6531 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 62,8 |
| 6532 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,5 |
| 6533 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 51,3 |
| 6534 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 33,1 |
| 6535 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,4 |
| 6536 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 73,7 |
| 6537 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,6 |
| 6538 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,4 |
| 6539 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 79,2 |
| 6540 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 72,6 |
| 6541 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 48,4 |
| 6542 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,2 |
| 6543 | Cord Tissue | Allogeneic - Unrelated & Related | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 50,9 |
| 6544 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,9 |
| 6545 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 62,6 |
| 6546 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,2 |
| 6547 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,9 |
| 6548 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,4 |
| 6549 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,7 |
| 6550 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 58,1 |
| 6551 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,8 |
| 6552 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 39,6 |
| 6553 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 47,11 |
| 6554 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,3 |
| 6555 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,2 |
| 6556 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 31,9 |
| 6557 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,4 |
| 6558 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 65,9 |
| 6559 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 52,7 |
| 6560 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 71,5 |
| 6561 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 68,5 |
| 6562 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 44,5 |
| 6563 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,7 |
| 6564 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 51,9 |
| 6565 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,3 |
| 6566 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 68,2 |
| 6567 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,4 |
| 6568 | Cord Tissue | Allogeneic - Unrelated & Related | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 41,2 |
| 6569 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 72,1 |
| 6570 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,8 |
| 6571 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 48,1 |
| 6572 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,3 |
| 6573 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,1 |
| 6574 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | no data |
| 6575 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,2 |
| 6576 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,8 |
| 6577 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,5 |
| 6578 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2016 | Experimental Therapy | Poland | 20,3 |
| 6579 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2016 | Experimental Therapy | Poland | 20,11 |
| 6580 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 18,4 |
| 6581 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6 |
| 6582 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 12,11 |
| 6583 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 8,5 |
| 6584 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 7,11 |
| 6585 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 8,5 |
| 6586 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6,9 |
| 6587 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 10,1 |
| 6588 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6,2 |
| 6589 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 11,3 |
| 6590 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6,1 |
| 6591 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 13,2 |
| 6592 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 8,4 |
| 6593 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 5 |
| 6594 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 12,3 |
| 6595 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 24,5 |
| 6596 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 10,3 |
| 6597 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6 |
| 6598 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 20,9 |
| 6599 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 57 |
| 6600 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2016 | Experimental Therapy | Poland | 28,6 |
| 6601 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 7,1 |
| 6602 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 5,1 |
| 6603 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,11 |
| 6604 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,3 |
| 6605 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 12,2 |
| 6606 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
| 6607 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 9,7 |
| 6608 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,3 |
| 6609 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,9 |
| 6610 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 9,11 |
| 6611 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,1 |
| 6612 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 4,2 |
| 6613 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 12,6 |
| 6614 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 3 |
| 6615 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 9,9 |
| 6616 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 3 |
| 6617 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 13,7 |
| 6618 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,2 |
| 6619 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 12,11 |
| 6620 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,8 |
| 6621 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 1,1 |
| 6622 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 7,6 |
| 6623 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 6,8 |
| 6624 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 16,4 |
| 6625 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 13,1 |
| 6626 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 4,1 |
| 6627 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 3,7 |
| 6628 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 4,4 |
| 6629 | Cord Tissue | Allogeneic - Unrelated | Chondronecrosis Femoral Condyle | Orthopedy | 2016 | Experimental Therapy | Poland | 54 |
| 6630 | Cord Tissue | Allogeneic - Unrelated | Choroideremia | Ophthalmology | 2016 | Experimental Therapy | Poland | 50,8 |
| 6631 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 19,2 |
| 6632 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 8 months |
| 6633 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2016 | Experimental Therapy | Poland | 54 |
| 6634 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2016 | Experimental Therapy | Poland | 3,1 |
| 6635 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2016 | Experimental Therapy | Poland | 7,4 |
| 6636 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2016 | Experimental Therapy | Poland | 2,7 |
| 6637 | Cord Tissue | Allogeneic - Unrelated | Diffuse Cartilage Damage Left Medial Compartment Of The Knee | Orthopedy | 2016 | Experimental Therapy | Poland | 50 |
| 6638 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 48,8 |
| 6639 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 14,4 |
| 6640 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 34,7 |
| 6641 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 9,2 |
| 6642 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 4,8 |
| 6643 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 10 |
| 6644 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 19,2 |
| 6645 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
| 6646 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 3 |
| 6647 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 4,3 |
| 6648 | Cord Tissue | Allogeneic - Unrelated | Endometrial Atrophy | Gynecology | 2016 | Experimental Therapy | Poland | 37,3 |
| 6649 | Cord Tissue | Allogeneic - Unrelated | Endometrial Atrophy | Gynecology | 2016 | Experimental Therapy | Poland | 39,1 |
| 6650 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 19,5 |
| 6651 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 14,9 |
| 6652 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 13,11 |
| 6653 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 14,7 |
| 6654 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 14,9 |
| 6655 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 16,2 |
| 6656 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 3,6 |
| 6657 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 35,3 |
| 6658 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 39,1 |
| 6659 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 25,4 |
| 6660 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 59,6 |
| 6661 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 30,3 |
| 6662 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 15 |
| 6663 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 31,11 |
| 6664 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 33,4 |
| 6665 | Cord Tissue | Allogeneic - Unrelated | Fetal Alcohol Spectrum Disorders | Neurology | 2016 | Experimental Therapy | Poland | 5,2 |
| 6666 | Cord Tissue | Allogeneic - Unrelated | Gangliosidosis T. 1 | Neurology | 2016 | Experimental Therapy | Poland | 1,4 |
| 6667 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2016 | Experimental Therapy | Poland | 6,9 |
| 6668 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 65,8 |
| 6669 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 69,6 |
| 6670 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 69,3 |
| 6671 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 49 |
| 6672 | Cord Tissue | Allogeneic - Unrelated | Hereditary Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 69 |
| 6673 | Cord Tissue | Allogeneic - Unrelated | Injuries To The Spinal Nerves | Neurology | 2016 | Experimental Therapy | Poland | 5 months |
| 6674 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 2,9 |
| 6675 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
| 6676 | Cord Tissue | Allogeneic - Unrelated | Malformation Syndrome | Neurology | 2016 | Experimental Therapy | Poland | 3,5 |
| 6677 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 35,5 |
| 6678 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 31,9 |
| 6679 | Cord Tissue | Allogeneic - Unrelated | Myopia; Hyperopia; Astigmatism; Abnormal Refraction And Accommodation; Optic Atrophy | Ophthalmology | 2016 | Experimental Therapy | Poland | 37,1 |
| 6680 | Cord Tissue | Allogeneic - Unrelated | Neurodevelopmental Disorders | Neurology | 2016 | Experimental Therapy | Poland | 4,5 |
| 6681 | Cord Tissue | Allogeneic - Unrelated | No Data | Ophthalmology | 2016 | Experimental Therapy | Poland | 66,1 |
| 6682 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2016 | Experimental Therapy | Poland | 69,9 |
| 6683 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2016 | Experimental Therapy | Poland | 69,1 |
| 6684 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2016 | Experimental Therapy | Poland | 66 |
| 6685 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2016 | Experimental Therapy | Poland | 79,8 |
| 6686 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2016 | Experimental Therapy | Poland | 33,5 |
| 6687 | Cord Tissue | Allogeneic - Unrelated | Patella Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 60 |
| 6688 | Cord Tissue | Allogeneic - Unrelated | Patella Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 60 |
| 6689 | Cord Tissue | Allogeneic - Unrelated | Patella Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 53 |
| 6690 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2016 | Experimental Therapy | Poland | 70,8 |
| 6691 | Cord Tissue | Allogeneic - Unrelated | Premature Ovarian Failure | Gynecology | 2016 | Experimental Therapy | Poland | 23,4 |
| 6692 | Cord Tissue | Allogeneic - Unrelated | Premature Ovarian Failure | Gynecology | 2016 | Experimental Therapy | Poland | 34,9 |
| 6693 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 38 |
| 6694 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 63,1 |
| 6695 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 32,7 |
| 6696 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 23,6 |
| 6697 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 54,6 |
| 6698 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | no data |
| 6699 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 59,4 |
| 6700 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 60,7 |
| 6701 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 44,8 |
| 6702 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 29,11 |
| 6703 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 44,8 |
| 6704 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 55,4 |
| 6705 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 54,8 |
| 6706 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 41,4 |
| 6707 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 49,3 |
| 6708 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 61,11 |
| 6709 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 45,8 |
| 6710 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 38,1 |
| 6711 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 68,5 |
| 6712 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 38,4 |
| 6713 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 28,8 |
| 6714 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 47,9 |
| 6715 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 58,4 |
| 6716 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 18 |
| 6717 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 2,4 |
| 6718 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 4,8 |
| 6719 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 1,5 |
| 6720 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 7,4 |
| 6721 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 1,3 |
| 6722 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
| 6723 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 15,9 |
| 6724 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
| 6725 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 4,9 |
| 6726 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 33,5 |
| 6727 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 22,2 |
| 6728 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 28 |
| 6729 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 33,11 |
| 6730 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 20,7 |
| 6731 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 24,5 |
| 6732 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 25,6 |
| 6733 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 18,8 |
| 6734 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 7,4 |
| 6735 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 48,3 |
| 6736 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 58,1 |
| 6737 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 37,11 |
| 6738 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 29,7 |
| 6739 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 17,9 |
| 6740 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 44,5 |
| 6741 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 34,9 |
| 6742 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 3,3 |
| 6743 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 34,2 |
| 6744 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 17,1 |
| 6745 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 1,1 |
| 6746 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 64 |
| 6747 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 62,5 |
| 6748 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 54,3 |
| 6749 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 41,8 |
| 6750 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2016 | Experimental Therapy | Poland | 53 |
| 6751 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2016 | Experimental Therapy | Poland | 24,5 |
| 6752 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2016 | Experimental Therapy | Poland | 37,7 |
| 6753 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 27,9 |
| 6754 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 27,2 |
| 6755 | Cord Tissue | Allogeneic - Unrelated | Traumatic Brain Injury | Neurology | 2016 | Experimental Therapy | Poland | 54,9 |
| 6756 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Hungary | 7 |
| 6757 | Cord Blood | Allogeneic - Unrelated | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 6 |
| 6758 | Cord Blood | Autologous | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6 |
| 6759 | Cord Blood | Autologous | Brain Damage | Neurology | 2016 | Experimental Therapy | Germany | 1 |
| 6760 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | UK | 6 |
| 6761 | Cord Blood | Allogeneic - Related | Hermansky-Pudlak Syndrome Type 2 | Hematology | 2016 | Standard Therapy | Turkey | 6 |
| 6762 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2016 | Standard Therapy | Germany | 4,3 |
| 6763 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6764 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6765 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6766 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6767 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6768 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 72 |
| 6769 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia, Minimal Residual Disease | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6770 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6771 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6772 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6773 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6774 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6775 | Bone Marrow Family | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 59 |
| 6776 | Bone Marrow Family | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 4 |
| 6777 | Bone Marrow Family | Allogeneic | Plasma Cell Disorder | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6778 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6779 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 6 |
| 6780 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 14 |
| 6781 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
| 6782 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 11 |
| 6783 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6784 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 6785 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 25 |
| 6786 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 1 |
| 6787 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 6788 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 6789 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 6 |
| 6790 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
| 6791 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
| 6792 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
| 6793 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 12 |
| 6794 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6795 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 29 |
| 6796 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6797 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 39 |
| 6798 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6799 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 45 |
| 6800 | Bone Marrow | Allogeneic | Anemia | Hematology | 2016 | Standard Therapy | Poland | 16 |
| 6801 | Bone Marrow | Allogeneic | Anemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 6802 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 6803 | Bone Marrow | Allogeneic | Bilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 27 |
| 6804 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2016 | Standard Therapy | Poland | 2 |
| 6805 | Bone Marrow | Allogeneic | Digeorge Syndrome | Hematology | 2016 | Standard Therapy | Poland | 24 |
| 6806 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
| 6807 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
| 6808 | Bone Marrow | Allogeneic | High-Risk Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6809 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 17 |
| 6810 | Bone Marrow | Allogeneic | Hurler Syndrome | Metabolic | 2016 | Standard Therapy | Poland | 2 |
| 6811 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 3 |
| 6812 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 1 |
| 6813 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6814 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 6815 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Poland | 22 |
| 6816 | Bone Marrow | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 3 |
| 6817 | Bone Marrow | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 7 |
| 6818 | Bone Marrow | Allogeneic | No Data | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6819 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6820 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2016 | Standard Therapy | Poland | 6 |
| 6821 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2016 | Standard Therapy | Poland | 1 |
| 6822 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6823 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6824 | Bone Marrow | Allogeneic | Severe Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2016 | Standard Therapy | Poland | 17 |
| 6825 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 2 |
| 6826 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 4 |
| 6827 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 7 months |
| 6828 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 12 |
| 6829 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 4 |
| 6830 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2016 | Standard Therapy | Germany | 18 |
| 6831 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6832 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 43 |
| 6833 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6834 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 24 |
| 6835 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 13 |
| 6836 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 6837 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 6838 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 23 |
| 6839 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 27 |
| 6840 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
| 6841 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6842 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6843 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 28 |
| 6844 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
| 6845 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 39 |
| 6846 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6847 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 6848 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6849 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6850 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6851 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 21 |
| 6852 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
| 6853 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6854 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 29 |
| 6855 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 1 |
| 6856 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 42 |
| 6857 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2016 | Standard Therapy | Germany | 27 |
| 6858 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 6859 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6860 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
| 6861 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6862 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6863 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
| 6864 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6865 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6866 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6867 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 6868 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
| 6869 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6870 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 29 |
| 6871 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6872 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 49 |
| 6873 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
| 6874 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 42 |
| 6875 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 13 |
| 6876 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 8 |
| 6877 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6878 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
| 6879 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6880 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6881 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 43 |
| 6882 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6883 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6884 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 6885 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6886 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 57 |
| 6887 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6888 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 6889 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
| 6890 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 72 |
| 6891 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6892 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6893 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6894 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 69 |
| 6895 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6896 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
| 6897 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6898 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6899 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6900 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6901 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 48 |
| 6902 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6903 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6904 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 months |
| 6905 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 36 |
| 6906 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6907 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 68 |
| 6908 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6909 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 60 |
| 6910 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6911 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6912 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6913 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6914 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
| 6915 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6916 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6917 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
| 6918 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6919 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 68 |
| 6920 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6921 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 24 |
| 6922 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 44 |
| 6923 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
| 6924 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
| 6925 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 6926 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6927 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6928 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6929 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 19 |
| 6930 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6931 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 29 |
| 6932 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 39 |
| 6933 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 6934 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 69 |
| 6935 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 38 |
| 6936 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 66 |
| 6937 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 50 |
| 6938 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 74 |
| 6939 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 18 |
| 6940 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 54 |
| 6941 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6942 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6943 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 54 |
| 6944 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 41 |
| 6945 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 53 |
| 6946 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6947 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 71 |
| 6948 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 6949 | Apheresis | Allogeneic | Acute Myeloid Leukemia M2/M4 | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6950 | Apheresis | Allogeneic | Adrenoleukodystrophy | Metabolic | 2016 | Standard Therapy | Poland | 1 |
| 6951 | Apheresis | Autologous | Amyloid Light-Chain Amyloidosis | Hematology | 2016 | Standard Therapy | Germany | 45 |
| 6952 | Apheresis | Autologous | Amyloidosis | Hematology | 2016 | Standard Therapy | Germany | 71 |
| 6953 | Apheresis | Autologous | Anaplastic Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6954 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 23 |
| 6955 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 44 |
| 6956 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 6957 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6958 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 42 |
| 6959 | Apheresis | Autologous | Burkitt Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 40 |
| 6960 | Apheresis | Allogeneic | C-Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 60 |
| 6961 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 6962 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6963 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6964 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6965 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6966 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
| 6967 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
| 6968 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6969 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 39 |
| 6970 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 51 |
| 6971 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 64 |
| 6972 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2016 | Standard Therapy | Germany | 69 |
| 6973 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
| 6974 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 38 |
| 6975 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6976 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6977 | Apheresis | Allogeneic | High-Risk Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 6978 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 6979 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6980 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6981 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2016 | Standard Therapy | Germany | 44 |
| 6982 | Apheresis | Allogeneic | Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
| 6983 | Apheresis | Allogeneic | Lymphoblastic Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6984 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 6985 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6986 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 53 |
| 6987 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 60 |
| 6988 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2016 | Standard Therapy | Germany | 32 |
| 6989 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
| 6990 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
| 6991 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 44 |
| 6992 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6993 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 70 |
| 6994 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 6995 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 6996 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 6997 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 6998 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 73 |
| 6999 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 65 |
| 7000 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 7001 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 7002 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
| 7003 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 66 |
| 7004 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 7005 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 7006 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 7007 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 7008 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 7009 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 7010 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 7011 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 7012 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 64 |
| 7013 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 64 |
| 7014 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 52 |
| 7015 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 7016 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 7017 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 49 |
| 7018 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 7019 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 47 |
| 7020 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 53 |
| 7021 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 7022 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 49 |
| 7023 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 69 |
| 7024 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 7025 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 54 |
| 7026 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 65 |
| 7027 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 7028 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 60 |
| 7029 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 7030 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 7031 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 73 |
| 7032 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 7033 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 7034 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 7035 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 7036 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 68 |
| 7037 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 7038 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 7039 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 7040 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 7041 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 60 |
| 7042 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 7043 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 7044 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 7045 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 7046 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 7047 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 7048 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 7049 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 7050 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 69 |
| 7051 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 7052 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Germany | 67 |
| 7053 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 7054 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Rcmd | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 7055 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 7056 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 72 |
| 7057 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 7058 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 7059 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 7060 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 7061 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 7062 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 7063 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Germany | 63 |
| 7064 | Apheresis | Autologous | Neuroblastoma | Hematology | 2016 | Standard Therapy | Germany | 5 |
| 7065 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 45 |
| 7066 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 70 |
| 7067 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 43 |
| 7068 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 69 |
| 7069 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 28 |
| 7070 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 1 |
| 7071 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 30 |
| 7072 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 71 |
| 7073 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 58 |
| 7074 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 17 |
| 7075 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 59 |
| 7076 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 58 |
| 7077 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 55 |
| 7078 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 44 |
| 7079 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 7080 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 7081 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 7082 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 39 |
| 7083 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 7084 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 73 |
| 7085 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 27 |
| 7086 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 65 |
| 7087 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 61 |
| 7088 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 7089 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 7090 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 68 |
| 7091 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 7092 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 7093 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 51 |
| 7094 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 62 |
| 7095 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 5 |
| 7096 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 50 |
| 7097 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 7098 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 7099 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Germany | 56 |
| 7100 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Germany | 58 |
| 7101 | Apheresis | Allogeneic | Refractory Anemia With Excess Blasts | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 7102 | Apheresis | Allogeneic | Severe Aplastic Anemia / Amyloidosis | Hematology | 2016 | Standard Therapy | Poland | 45 |
| 7103 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Germany | 28 |
| 7104 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 7105 | Apheresis | Autologous | Small Cell Ovarian Carcinoma | Hematology | 2016 | Standard Therapy | Germany | 18 |
| 7106 | Apheresis | Allogeneic | T Cell Lymphoma/ Nos - Not Otherwise Specified | Hematology | 2016 | Standard Therapy | Poland | 55 |
| 7107 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 19 |
| 7108 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 21 |
| 7109 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
| 7110 | Apheresis | Allogeneic | T-Cell Leukemia/Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 7111 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 48 |
| 7112 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 24 |
| 7113 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 55 |
| 7114 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 33 |
| 7115 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 7116 | Apheresis | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2016 | Standard Therapy | Poland | 1 |
| 7117 | Apheresis | Allogeneic | X-Linked Lymphoproliferative Disease | Hematology | 2016 | Standard Therapy | Poland | 12 |
| 7118 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 1,4 |
| 7119 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 11 months |
| 7120 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 51,5 |
| 7121 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 6,6 |
| 7122 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 13,4 |
| 7123 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy; Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 23 |
| 7124 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,6 |
| 7125 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61 |
| 7126 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 56 |
| 7127 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 51 |
| 7128 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 65 |
| 7129 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 60 |
| 7130 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 52 |
| 7131 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 59,4 |
| 7132 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,5 |
| 7133 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 58 |
| 7134 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,6 |
| 7135 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 62 |
| 7136 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 26,5 |
| 7137 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 27 |
| 7138 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 63,11 |
| 7139 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 67,6 |
| 7140 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 37,6 |
| 7141 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 58,1 |
| 7142 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 46,2 |
| 7143 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 48,7 |
| 7144 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,3 |
| 7145 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 54 |
| 7146 | Cord Tissue | Allogeneic - Unrelated | Anterior Ischemic Optic Neuropathy | Ophthalmology | 2015 | Experimental Therapy | Poland | 54,1 |
| 7147 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 5,4 |
| 7148 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 3 |
| 7149 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 12,5 |
| 7150 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 6,1 |
| 7151 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 4,6 |
| 7152 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 5,6 |
| 7153 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 8,7 |
| 7154 | Cord Tissue | Allogeneic - Unrelated | Bilateral Blindness | Ophthalmology | 2015 | Experimental Therapy | Poland | 36,1 |
| 7155 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 18,7 |
| 7156 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 26,1 |
| 7157 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 3,8 |
| 7158 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 15,8 |
| 7159 | Cord Tissue | Allogeneic - Unrelated & Related | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 7,1 |
| 7160 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 13,1 |
| 7161 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 8,11 |
| 7162 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 2,7 |
| 7163 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 12,1 |
| 7164 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 4,1 |
| 7165 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 22 |
| 7166 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 9,9 |
| 7167 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 1,6 |
| 7168 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 14,1 |
| 7169 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 16,9 |
| 7170 | Cord Tissue | Allogeneic - Unrelated | Ceroid Lipofuscinosis | Neurology | 2015 | Experimental Therapy | Poland | 5,1 |
| 7171 | Cord Tissue | Allogeneic - Unrelated | Ceroid Lipofuscinosis | Neurology | 2015 | Experimental Therapy | Poland | 7,1 |
| 7172 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 10 |
| 7173 | Cord Tissue | Allogeneic - Unrelated | Decerebration Rigidity | Neurology | 2015 | Experimental Therapy | Poland | 9,6 |
| 7174 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2015 | Experimental Therapy | Poland | 3,6 |
| 7175 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development, Deafness | Neurology | 2015 | Experimental Therapy | Poland | 3,3 |
| 7176 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 14,5 |
| 7177 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 8 months |
| 7178 | Cord Tissue | Allogeneic - Unrelated & Related | Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 11,2 |
| 7179 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2015 | Experimental Therapy | Poland | 30,1 |
| 7180 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2015 | Experimental Therapy | Poland | 66 |
| 7181 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2015 | Experimental Therapy | Poland | 65 |
| 7182 | Cord Tissue | Allogeneic - Unrelated | Iatrogenic Spinal Cord Injury | Neurology | 2015 | Experimental Therapy | Poland | 17,2 |
| 7183 | Cord Tissue | Allogeneic - Unrelated | Intracranial Injury | Neurology | 2015 | Experimental Therapy | Poland | 24,3 |
| 7184 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2015 | Experimental Therapy | Poland | 18,8 |
| 7185 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2015 | Experimental Therapy | Poland | 15,8 |
| 7186 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2015 | Experimental Therapy | Poland | 45,1 |
| 7187 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2015 | Experimental Therapy | Poland | 74,2 |
| 7188 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2015 | Experimental Therapy | Poland | 34,5 |
| 7189 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2015 | Experimental Therapy | Poland | 23,2 |
| 7190 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2015 | Experimental Therapy | Poland | 33,3 |
| 7191 | Cord Tissue | Allogeneic - Unrelated | Severe Developmental Delay | Neurology | 2015 | Experimental Therapy | Poland | 1,1 |
| 7192 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2015 | Experimental Therapy | Poland | 2 |
| 7193 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 31,2 |
| 7194 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 18,8 |
| 7195 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 40 |
| 7196 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 26,1 |
| 7197 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 37,1 |
| 7198 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 32,1 |
| 7199 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 21,4 |
| 7200 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 24,7 |
| 7201 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 34,4 |
| 7202 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2015 | Experimental Therapy | Poland | 11 months |
| 7203 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2015 | Experimental Therapy | Poland | 26,2 |
| 7204 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 35,6 |
| 7205 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 44,6 |
| 7206 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 24,3 |
| 7207 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2015 | Experimental Therapy | Poland | 62,8 |
| 7208 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2015 | Experimental Therapy | Poland | 54,9 |
| 7209 | Cord Tissue | Allogeneic - Unrelated | Traumatic Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 20,11 |
| 7210 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2015 | Standard Therapy | Poland | 4 |
| 7211 | Cord Blood | Autologous | Brain Damage | Neurology | 2015 | Experimental Therapy | Germany | 5 |
| 7212 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2015 | Experimental Therapy | UK | 6 months |
| 7213 | Cord Blood | Autologous | Neuroblastoma | Hematology | 2015 | Standard Therapy | Germany | 5 |
| 7214 | Cord Blood | Allogeneic - Related | Scid (Severe Combined Immunodeficiency) | Hematology | 2015 | Standard Therapy | UK | 3 months |
| 7215 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2015 | Standard Therapy | UK | 2,6 |
| 7216 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2015 | Standard Therapy | UK | 12 |
| 7217 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2015 | Standard Therapy | Turkey | 3 |
| 7218 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2015 | Standard Therapy | Turkey | 2 |
| 7219 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 74 |
| 7220 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 7221 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 23 |
| 7222 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 7223 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 43 |
| 7224 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 7225 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 7226 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7227 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 33 |
| 7228 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 42 |
| 7229 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 7230 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 37 |
| 7231 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 7232 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 7233 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 7234 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 45 |
| 7235 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 7236 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 59 |
| 7237 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 58 |
| 7238 | Apheresis | Autologous | Anaplastic Large Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 7239 | Apheresis | Autologous | Anaplastic T-Cell Lymphoma - Relapse | Hematology | 2015 | Standard Therapy | Germany | 26 |
| 7240 | Apheresis | Allogeneic | Aplastic Anemia - Relapse | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 7241 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 59 |
| 7242 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 7243 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 23 |
| 7244 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 7245 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 51 |
| 7246 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2015 | Standard Therapy | Germany | 50 |
| 7247 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 31 |
| 7248 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 7249 | Apheresis | Autologous | Ewing Sarcoma | Hematology | 2015 | Standard Therapy | Germany | 24 |
| 7250 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2015 | Standard Therapy | Germany | 17 |
| 7251 | Apheresis | Autologous | Gray Zone Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 26 |
| 7252 | Apheresis | Autologous | Hodgkin Relapse | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 7253 | Apheresis | Autologous | Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 7254 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 7255 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 7256 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 7257 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 7258 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 58 |
| 7259 | Apheresis | Autologous | Mantle Cell Lymphoma-Relapse | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 7260 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2015 | Standard Therapy | Germany | 25 |
| 7261 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2015 | Standard Therapy | Germany | 22 |
| 7262 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 58 |
| 7263 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 7264 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 7265 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 7266 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 69 |
| 7267 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 7268 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 75 |
| 7269 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 7270 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 7271 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 7272 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 7273 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 65 |
| 7274 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 37 |
| 7275 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 7276 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 7277 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 68 |
| 7278 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 50 |
| 7279 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7280 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 69 |
| 7281 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 7282 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 7283 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 43 |
| 7284 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 7285 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 7286 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 66 |
| 7287 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7288 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 7289 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 71 |
| 7290 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 7291 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
| 7292 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 74 |
| 7293 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 50 |
| 7294 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 51 |
| 7295 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 7296 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 53 |
| 7297 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
| 7298 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 7299 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 63 |
| 7300 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 7301 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 65 |
| 7302 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 71 |
| 7303 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7304 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7305 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7306 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 7307 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
| 7308 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 49 |
| 7309 | Apheresis | Allogeneic | Multiple Myeloma, Second Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
| 7310 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 57 |
| 7311 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 60 |
| 7312 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 29 |
| 7313 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 73 |
| 7314 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
| 7315 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 22 |
| 7316 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7317 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 54 |
| 7318 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
| 7319 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 41 |
| 7320 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 7321 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 70 |
| 7322 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 44 |
| 7323 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2014 | Experimental Therapy | Poland | 6 |
| 7324 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 60,1 |
| 7325 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 24,1 |
| 7326 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 12,6 |
| 7327 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 8,3 |
| 7328 | Cord Tissue | Allogeneic - Unrelated | Birth Asphyxia; Retinopathy | Neurology | 2014 | Experimental Therapy | Poland | 11 months |
| 7329 | Cord Tissue | Allogeneic - Unrelated | Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth | Neurology | 2014 | Experimental Therapy | Poland | 2,1 |
| 7330 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 4,1 |
| 7331 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 15,1 |
| 7332 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2014 | Experimental Therapy | Poland | 6 |
| 7333 | Cord Tissue | Allogeneic - Unrelated | Neuropathy | Neurology | 2014 | Experimental Therapy | Poland | 23,6 |
| 7334 | Cord Blood | Allogeneic - Unrelated | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Spain | 15 |
| 7335 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Turkey | 8,8 |
| 7336 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 45 |
| 7337 | Cord Blood | Autologous | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Portugal | 6 |
| 7338 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2014 | Standard Therapy | Germany | 6 |
| 7339 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Portugal | 4 |
| 7340 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | UK | 1 |
| 7341 | Cord Blood | Autologous | Hsv Encephalitis And Nmda Receptor Antibody Encephalitis | Neurology | 2014 | Experimental Therapy | UK | 2 |
| 7342 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2014 | Experimental Therapy | UK | 3 months |
| 7343 | Cord Blood | Allogeneic - Related | Leukemia | Hematology | 2014 | Standard Therapy | UK | 4 |
| 7344 | Cord Blood | Autologous | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 11 |
| 7345 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 35 |
| 7346 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 73 |
| 7347 | Bone Marrow | Allogeneic | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 7348 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7349 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 7350 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 7351 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 7352 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 7353 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 7354 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 29 |
| 7355 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 76 |
| 7356 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 48 |
| 7357 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 7358 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2014 | Standard Therapy | Germany | 45 |
| 7359 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 27 |
| 7360 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 7361 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
| 7362 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2014 | Standard Therapy | Germany | 67 |
| 7363 | Apheresis | Autologous | Bing–Neel Syndrome; Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 7364 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
| 7365 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2014 | Standard Therapy | Germany | 57 |
| 7366 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 7367 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 7368 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 50 |
| 7369 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 7370 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2014 | Standard Therapy | Germany | 24 |
| 7371 | Apheresis | Autologous | Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 7372 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 7373 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
| 7374 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 58 |
| 7375 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
| 7376 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 7377 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 7378 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 68 |
| 7379 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7380 | Apheresis | Autologous | Marginal Zone Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 7381 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2014 | Standard Therapy | Germany | 31 |
| 7382 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
| 7383 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 37 |
| 7384 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 19 |
| 7385 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
| 7386 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
| 7387 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7388 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
| 7389 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 66 |
| 7390 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7391 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 53 |
| 7392 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 7393 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7394 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 30 |
| 7395 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 7396 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
| 7397 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 77 |
| 7398 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 52 |
| 7399 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7400 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 7401 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 7402 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
| 7403 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 68 |
| 7404 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 49 |
| 7405 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 55 |
| 7406 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 57 |
| 7407 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 7408 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7409 | Apheresis | Autologous | Neuroblastoma | Hematology | 2014 | Standard Therapy | Germany | 7 |
| 7410 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7411 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 43 |
| 7412 | Apheresis | Autologous | Post-Transplant Lymphoproliferative Disorder | Hematology | 2014 | Standard Therapy | Germany | 60 |
| 7413 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 69 |
| 7414 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 64 |
| 7415 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
| 7416 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
| 7417 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 7418 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 75 |
| 7419 | Apheresis | Autologous | Secondary Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
| 7420 | Apheresis | Autologous | T-Cell Lymphoblastic Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 54 |
| 7421 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
| 7422 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 48 |
| 7423 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 43 |
| 7424 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
| 7425 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 18,9 |
| 7426 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 2,11 |
| 7427 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 3,5 |
| 7428 | Cord Tissue | Allogeneic - Unrelated | Acute Myeloid Leukemia | Hematology | 2013 | Experimental Therapy | Poland | 3,5 |
| 7429 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 18,8 |
| 7430 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 17,5 |
| 7431 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 8 |
| 7432 | Cord Blood | Allogeneic - Related | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Poland | 3 |
| 7433 | Cord Blood | Allogeneic - Related | Aplastic Anemia | Hematology | 2013 | Standard Therapy | Poland | 3 |
| 7434 | Cord Blood | Allogeneic - Related | Leukemia | Hematology | 2013 | Standard Therapy | Turkey | 7 |
| 7435 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2013 | Standard Therapy | UK | 5 |
| 7436 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | 7,12 |
| 7437 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | 3 |
| 7438 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | ? |
| 7439 | Cord Blood | Allogeneic - Related | Wiskott-Aldrich Syndrome | Hematology | 2013 | Standard Therapy | Germany | 3 |
| 7440 | Cord Blood | Allogeneic - Related | X-Linked Lymphoproliferative Syndrome | Hematology | 2013 | Standard Therapy | Poland | 10 months |
| 7441 | Bone Marrow Family | Allogeneic | Follicular Lymphoma + Non-Hodgkin-Hodgkin | Hematology | 2013 | Standard Therapy | Germany | 38 |
| 7442 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 58 |
| 7443 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 73 |
| 7444 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2013 | Standard Therapy | Germany | 71 |
| 7445 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 44 |
| 7446 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 17 |
| 7447 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 7448 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 7449 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 21 |
| 7450 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 18 |
| 7451 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 7452 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 7453 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7454 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia - Relapse | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 7455 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia - Relapse | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 7456 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 7457 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7458 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2013 | Standard Therapy | Germany | 52 |
| 7459 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2013 | Standard Therapy | Germany | 32 |
| 7460 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 7461 | Apheresis | Autologous | Burkitt Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 49 |
| 7462 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 48 |
| 7463 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 48 |
| 7464 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 64 |
| 7465 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 7466 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 7467 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7468 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 7469 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 39 |
| 7470 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 43 |
| 7471 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 32 |
| 7472 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 47 |
| 7473 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2013 | Standard Therapy | Germany | 50 |
| 7474 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7475 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 70 |
| 7476 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 52 |
| 7477 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 48 |
| 7478 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 7479 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7480 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 73 |
| 7481 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 55 |
| 7482 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 53 |
| 7483 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 56 |
| 7484 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 7485 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 54 |
| 7486 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 7487 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 64 |
| 7488 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 66 |
| 7489 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 7490 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 7491 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 7492 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 7493 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 45 |
| 7494 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 50 |
| 7495 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 78 |
| 7496 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 46 |
| 7497 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 53 |
| 7498 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
| 7499 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 7500 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 40 |
| 7501 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 58 |
| 7502 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7503 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7504 | Apheresis | Autologous | Neuroblastoma | Hematology | 2013 | Standard Therapy | Germany | 3 |
| 7505 | Apheresis | Autologous | Neuroblastoma | Hematology | 2013 | Standard Therapy | Germany | 1 |
| 7506 | Apheresis | Allogeneic | No Data | Hematology | 2013 | Standard Therapy | Germany | 51 |
| 7507 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 7508 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 7509 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 7510 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2013 | Standard Therapy | Germany | 68 |
| 7511 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2013 | Standard Therapy | Germany | 73 |
| 7512 | Apheresis | Autologous | Plasmacytoma | Hematology | 2013 | Standard Therapy | Germany | 62 |
| 7513 | Apheresis | Allogeneic | Primary Central Nervous System Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 52 |
| 7514 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2013 | Standard Therapy | Germany | 43 |
| 7515 | Apheresis | Allogeneic | Primary Myelofibrosis, Second Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 60 |
| 7516 | Apheresis | Allogeneic | Primary Osteomyelofibrosis | Hematology | 2013 | Standard Therapy | Germany | 59 |
| 7517 | Apheresis | Allogeneic | T-Cell Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 61 |
| 7518 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 45 |
| 7519 | Apheresis | Autologous | Teratocarcinoma | Hematology | 2013 | Standard Therapy | Germany | 49 |
| 7520 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2013 | Standard Therapy | Germany | 27 |
| 7521 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 19,7 |
| 7522 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 7,1 |
| 7523 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 4,3 |
| 7524 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 2 |
| 7525 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2012 | Standard Therapy | Germany | 14 |
| 7526 | Cord Blood | Autologous | Brain Damage | Neurology | 2012 | Experimental Therapy | Germany | 3 |
| 7527 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2012 | Experimental Therapy | Portugal | 3 |
| 7528 | Cord Blood | Allogeneic - Related | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Hungary | 3 |
| 7529 | Cord Blood | Allogeneic - Related | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Turkey | 4,1 |
| 7530 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2012 | Standard Therapy | Turkey | 6,7 |
| 7531 | Cord Blood | Allogeneic - Related | Thalassemia Major, Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Turkey | 3,6 |
| 7532 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2012 | Experimental Therapy | Germany | 5 |
| 7533 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 64 |
| 7534 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 75 |
| 7535 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 7536 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 56 |
| 7537 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome Refractory Anemia With Blast Excess | Hematology | 2012 | Standard Therapy | Germany | 70 |
| 7538 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 18 |
| 7539 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 42 |
| 7540 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 43 |
| 7541 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 60 |
| 7542 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 39 |
| 7543 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 7544 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 7545 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 17 |
| 7546 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2012 | Standard Therapy | Germany | 48 |
| 7547 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2012 | Standard Therapy | Germany | 46 |
| 7548 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2012 | Standard Therapy | Germany | 68 |
| 7549 | Apheresis | Allogeneic | Acute Myeloid Leukemia (High Risk) | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 7550 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 47 |
| 7551 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 43 |
| 7552 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2012 | Standard Therapy | Germany | 70 |
| 7553 | Apheresis | Autologous | Central Nervous System Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 7554 | Apheresis | Autologous | Cerebral Diffuse Large B-Cell Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 7555 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 7556 | Apheresis | Autologous | Extragonadal Germ Cell Tumor | Hematology | 2012 | Standard Therapy | Germany | 59 |
| 7557 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 7558 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 7559 | Apheresis | Autologous | Follicular Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 59 |
| 7560 | Apheresis | Autologous | Lymphoblastic B-Cell Non-Hodgkin-Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 52 |
| 7561 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 61 |
| 7562 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 52 |
| 7563 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 7564 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 7565 | Apheresis | Autologous | Medulloblastoma | Hematology | 2012 | Standard Therapy | Germany | 42 |
| 7566 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2012 | Standard Therapy | Germany | 27 |
| 7567 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 51 |
| 7568 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 60 |
| 7569 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 52 |
| 7570 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 71 |
| 7571 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 61 |
| 7572 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 53 |
| 7573 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 55 |
| 7574 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 70 |
| 7575 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 46 |
| 7576 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 64 |
| 7577 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 56 |
| 7578 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 68 |
| 7579 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 48 |
| 7580 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 59 |
| 7581 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 7582 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 72 |
| 7583 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 50 |
| 7584 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 60 |
| 7585 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 65 |
| 7586 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 67 |
| 7587 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Germany | 49 |
| 7588 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Germany | 69 |
| 7589 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 7590 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 7591 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 62 |
| 7592 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 57 |
| 7593 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 44 |
| 7594 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 43 |
| 7595 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2012 | Standard Therapy | Germany | 61 |
| 7596 | Apheresis | Autologous | Plasmablastic Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
| 7597 | Apheresis | Autologous | Plasmacytoma | Hematology | 2012 | Standard Therapy | Germany | 69 |
| 7598 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2012 | Standard Therapy | Germany | 36 |
| 7599 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2011 | Experimental Therapy | Poland | 17,2 |
| 7600 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Poland | 5 |
| 7601 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | UK | 8 |
| 7602 | Cord Blood | Allogeneic - Related | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Hungary | 2 |
| 7603 | Cord Blood | Autologous | Brain Damage | Neurology | 2011 | Experimental Therapy | Germany | 3 |
| 7604 | Cord Blood | Autologous | Brain Damage | Neurology | 2011 | Experimental Therapy | Germany | 7 |
| 7605 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2011 | Experimental Therapy | Portugal | 6 |
| 7606 | Cord Blood | Allogeneic - Related | Chronic Granulomatous Disease | Hematology | 2011 | Standard Therapy | Poland | 7,5 |
| 7607 | Cord Blood | Allogeneic - Related | Fanconi Anemia | Hematology | 2011 | Standard Therapy | Poland | 12 |
| 7608 | Cord Blood | Allogeneic - Related | Histiocytosis | Hematology | 2011 | Standard Therapy | Poland | 2,5 |
| 7609 | Cord Blood | Allogeneic | Scid (Severe Combined Immunodeficiency) | Hematology | 2011 | Standard Therapy | Germany | 1 |
| 7610 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2011 | Standard Therapy | Turkey | 15 |
| 7611 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2011 | Standard Therapy | Turkey | 15 |
| 7612 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2011 | Experimental Therapy | Germany | 2 |
| 7613 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 65 |
| 7614 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 50 |
| 7615 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 64 |
| 7616 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 45 |
| 7617 | Bone Marrow | Autologous | Coronary Artery Disease | Hematology | 2011 | Standard Therapy | Germany | 68 |
| 7618 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 70 |
| 7619 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 55 |
| 7620 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 64 |
| 7621 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 71 |
| 7622 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 62 |
| 7623 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2011 | Standard Therapy | Germany | 62 |
| 7624 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2011 | Standard Therapy | Germany | 69 |
| 7625 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2011 | Standard Therapy | Germany | 40 |
| 7626 | Bone Marrow | Autologous | Peripheral Artery Disease | Hematology | 2011 | Standard Therapy | Germany | 74 |
| 7627 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2011 | Standard Therapy | Germany | 31 |
| 7628 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Germany | 41 |
| 7629 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Germany | 42 |
| 7630 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Germany | 31 |
| 7631 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 64 |
| 7632 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 42 |
| 7633 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 73 |
| 7634 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 54 |
| 7635 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 70 |
| 7636 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 65 |
| 7637 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 69 |
| 7638 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 25 |
| 7639 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 48 |
| 7640 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 59 |
| 7641 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2011 | Standard Therapy | Germany | 53 |
| 7642 | Apheresis | Autologous | Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 60 |
| 7643 | Apheresis | Autologous | Angioimmunoblastic T-Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 63 |
| 7644 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2011 | Standard Therapy | Germany | 62 |
| 7645 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 41 |
| 7646 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 61 |
| 7647 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 51 |
| 7648 | Apheresis | Autologous | Central Nervous System Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 41 |
| 7649 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2011 | Standard Therapy | Germany | 62 |
| 7650 | Apheresis | Autologous | Follicular Lymphoma-Relapse | Hematology | 2011 | Standard Therapy | Germany | 68 |
| 7651 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2011 | Standard Therapy | Germany | 28 |
| 7652 | Apheresis | Autologous | Lymphoblastic Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 49 |
| 7653 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 62 |
| 7654 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 51 |
| 7655 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 67 |
| 7656 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2011 | Standard Therapy | Germany | 70 |
| 7657 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2011 | Standard Therapy | Germany | 24 |
| 7658 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 58 |
| 7659 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 70 |
| 7660 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 59 |
| 7661 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 44 |
| 7662 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 52 |
| 7663 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 70 |
| 7664 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 55 |
| 7665 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 69 |
| 7666 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 58 |
| 7667 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 58 |
| 7668 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 60 |
| 7669 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 56 |
| 7670 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 66 |
| 7671 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 57 |
| 7672 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 47 |
| 7673 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 66 |
| 7674 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 60 |
| 7675 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 61 |
| 7676 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 69 |
| 7677 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 54 |
| 7678 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2011 | Standard Therapy | Germany | 68 |
| 7679 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2011 | Standard Therapy | Germany | 40 |
| 7680 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 47 |
| 7681 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2011 | Standard Therapy | Germany | 61 |
| 7682 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2011 | Standard Therapy | Germany | 43 |
| 7683 | Apheresis | Autologous | Plasmacytoma | Hematology | 2011 | Standard Therapy | Germany | 68 |
| 7684 | Apheresis | Autologous | Plasmacytoma | Hematology | 2011 | Standard Therapy | Germany | 51 |
| 7685 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 43 |
| 7686 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2011 | Standard Therapy | Germany | 36 |
| 7687 | Apheresis | Allogeneic | Refractory Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 27 |
| 7688 | Apheresis | Autologous | Richter's Transformation | Hematology | 2011 | Standard Therapy | Germany | 71 |
| 7689 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 50 |
| 7690 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 48 |
| 7691 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2011 | Standard Therapy | Germany | 56 |
| 7692 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2011 | Standard Therapy | Germany | 43 |
| 7693 | Cord Blood | Autologous | Brain Damage | Neurology | 2010 | Experimental Therapy | Germany | 5 |
| 7694 | Cord Blood | Autologous | Brain Damage | Neurology | 2010 | Experimental Therapy | Germany | 4 |
| 7695 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | Portugal | 1 |
| 7696 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | Portugal | 1 |
| 7697 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | Portugal | 6 |
| 7698 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | UK | 3 |
| 7699 | Cord Blood | Allogeneic - Related | Pre-B Acute Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Hungary | 1,5 |
| 7700 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2010 | Experimental Therapy | Germany | 3 |
| 7701 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2010 | Experimental Therapy | Germany | 2 |
| 7702 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 57 |
| 7703 | Bone Marrow | Autologous | Chronic Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 71 |
| 7704 | Bone Marrow | Autologous | Coronary Artery Disease | Hematology | 2010 | Standard Therapy | Germany | 75 |
| 7705 | Bone Marrow | Autologous | Coronary Artery Disease; Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 52 |
| 7706 | Bone Marrow | Autologous | Dilated Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 67 |
| 7707 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 70 |
| 7708 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 49 |
| 7709 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 48 |
| 7710 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 50 |
| 7711 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 54 |
| 7712 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 73 |
| 7713 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 47 |
| 7714 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2010 | Standard Therapy | Germany | 51 |
| 7715 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2010 | Standard Therapy | Germany | 54 |
| 7716 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2010 | Standard Therapy | Germany | 51 |
| 7717 | Bone Marrow | Autologous | Peripheral Artery Disease | Hematology | 2010 | Standard Therapy | Germany | 56 |
| 7718 | Bone Marrow | Autologous | Peripheral Artery Disease With Ulcer | Hematology | 2010 | Standard Therapy | Germany | 79 |
| 7719 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 26 |
| 7720 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 64 |
| 7721 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 47 |
| 7722 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 44 |
| 7723 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 48 |
| 7724 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 59 |
| 7725 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 50 |
| 7726 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 66 |
| 7727 | Apheresis | Allogeneic | Atypical Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 25 |
| 7728 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 56 |
| 7729 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 54 |
| 7730 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2010 | Standard Therapy | Germany | 52 |
| 7731 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2010 | Standard Therapy | Germany | 45 |
| 7732 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 57 |
| 7733 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2010 | Standard Therapy | Germany | 43 |
| 7734 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 57 |
| 7735 | Apheresis | Autologous | Extramedullary Plasmacytoma | Hematology | 2010 | Standard Therapy | Germany | 48 |
| 7736 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 61 |
| 7737 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 72 |
| 7738 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 53 |
| 7739 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2010 | Standard Therapy | Germany | 29 |
| 7740 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2010 | Standard Therapy | Germany | 21 |
| 7741 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2010 | Standard Therapy | Germany | 23 |
| 7742 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 43 |
| 7743 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 57 |
| 7744 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 62 |
| 7745 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 45 |
| 7746 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 47 |
| 7747 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 52 |
| 7748 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 52 |
| 7749 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 67 |
| 7750 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 55 |
| 7751 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 57 |
| 7752 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 51 |
| 7753 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 53 |
| 7754 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 69 |
| 7755 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 58 |
| 7756 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 70 |
| 7757 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 64 |
| 7758 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 69 |
| 7759 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 68 |
| 7760 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 63 |
| 7761 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 61 |
| 7762 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 56 |
| 7763 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 68 |
| 7764 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 52 |
| 7765 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 60 |
| 7766 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 64 |
| 7767 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 70 |
| 7768 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 57 |
| 7769 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 60 |
| 7770 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 33 |
| 7771 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Acute Myelogenous Leukemia | Hematology | 2010 | Standard Therapy | Germany | 54 |
| 7772 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2010 | Standard Therapy | Germany | 48 |
| 7773 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2010 | Standard Therapy | Germany | 44 |
| 7774 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 66 |
| 7775 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2010 | Standard Therapy | Germany | 60 |
| 7776 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2010 | Standard Therapy | Germany | 59 |
| 7777 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 48 |
| 7778 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 61 |
| 7779 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 41 |
| 7780 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2010 | Standard Therapy | Germany | 43 |
| 7781 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 49 |
| 7782 | Apheresis | Autologous | Testicular Carcinoma | Hematology | 2010 | Standard Therapy | Germany | 39 |
| 7783 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 10 |
| 7784 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2009 | Standard Therapy | Germany | 10 |
| 7785 | Cord Blood | Autologous | Brain Damage | Neurology | 2009 | Experimental Therapy | Germany | 2 |
| 7786 | Cord Blood | Autologous | Brain Damage | Neurology | 2009 | Experimental Therapy | Germany | 4 months |
| 7787 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2009 | Experimental Therapy | Portugal | 2 |
| 7788 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2009 | Experimental Therapy | Portugal | 2 |
| 7789 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2009 | Experimental Therapy | UK | 3 |
| 7790 | Cord Blood | Allogeneic - Related | Myelodysplastic Syndrome | Hematology | 2009 | Standard Therapy | Poland | 5 |
| 7791 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2009 | Standard Therapy | Turkey | 12 |
| 7792 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2009 | Experimental Therapy | Germany | 3 |
| 7793 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2009 | Experimental Therapy | Germany | 3 |
| 7794 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2009 | Experimental Therapy | Germany | 3 |
| 7795 | Bone Marrow | Autologous | Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 67 |
| 7796 | Bone Marrow | Autologous | Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 50 |
| 7797 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 49 |
| 7798 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 64 |
| 7799 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 55 |
| 7800 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 56 |
| 7801 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 46 |
| 7802 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 46 |
| 7803 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 63 |
| 7804 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7805 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 47 |
| 7806 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7807 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 61 |
| 7808 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 44 |
| 7809 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 32 |
| 7810 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7811 | Bone Marrow | Autologous | Non St-Elevated Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 56 |
| 7812 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 24 |
| 7813 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 43 |
| 7814 | Apheresis | Autologous | Acute Lymphoblastic Leukemia; Lymphoma - Relapse | Hematology | 2009 | Standard Therapy | Germany | 47 |
| 7815 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 42 |
| 7816 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 49 |
| 7817 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 56 |
| 7818 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7819 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 56 |
| 7820 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 61 |
| 7821 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7822 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 60 |
| 7823 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2009 | Standard Therapy | Germany | 43 |
| 7824 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2009 | Standard Therapy | Germany | 61 |
| 7825 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 47 |
| 7826 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2009 | Standard Therapy | Germany | 49 |
| 7827 | Apheresis | Autologous | Hodgkin Relapse | Hematology | 2009 | Standard Therapy | Germany | 46 |
| 7828 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 69 |
| 7829 | Apheresis | Autologous | Mantle Cell Non-Hodgkin-Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 56 |
| 7830 | Apheresis | Autologous | Mucosa Associated Lymphoid Tissue/ Diffuse Large Cell Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 55 |
| 7831 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 68 |
| 7832 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 55 |
| 7833 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 51 |
| 7834 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 58 |
| 7835 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 63 |
| 7836 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 63 |
| 7837 | Apheresis | Allogeneic | Multiple Myeloma; Myelodysplastic Syndrome | Hematology | 2009 | Standard Therapy | Germany | 44 |
| 7838 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 70 |
| 7839 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7840 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 67 |
| 7841 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 68 |
| 7842 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2009 | Standard Therapy | Germany | 46 |
| 7843 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2009 | Standard Therapy | Germany | 74 |
| 7844 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2009 | Standard Therapy | Germany | 39 |
| 7845 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 63 |
| 7846 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 50 |
| 7847 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 60 |
| 7848 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 49 |
| 7849 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 68 |
| 7850 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 57 |
| 7851 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 53 |
| 7852 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 64 |
| 7853 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2009 | Standard Therapy | Germany | 55 |
| 7854 | Apheresis | Allogeneic | Severe Aplastic Anemia And Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2009 | Standard Therapy | Germany | 47 |
| 7855 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2008 | Standard Therapy | Poland | 5 |
| 7856 | Cord Blood | Autologous | Brain Damage | Neurology | 2008 | Experimental Therapy | Germany | 1 |
| 7857 | Cord Blood | Autologous | Cerebral Ischemia | Neurology | 2008 | Experimental Therapy | Poland | 1,5 |
| 7858 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2008 | Standard Therapy | Turkey | 7 |
| 7859 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 17 |
| 7860 | Bone Marrow Family | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2008 | Standard Therapy | Germany | 53 |
| 7861 | Bone Marrow | Autologous | Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 46 |
| 7862 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 60 |
| 7863 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 44 |
| 7864 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 67 |
| 7865 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 58 |
| 7866 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 56 |
| 7867 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 72 |
| 7868 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 69 |
| 7869 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 53 |
| 7870 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 70 |
| 7871 | Bone Marrow | Autologous | Peripheral Artery Disease | Hematology | 2008 | Standard Therapy | Germany | 76 |
| 7872 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 56 |
| 7873 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 58 |
| 7874 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 70 |
| 7875 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 56 |
| 7876 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 65 |
| 7877 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 38 |
| 7878 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2008 | Standard Therapy | Germany | 49 |
| 7879 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 51 |
| 7880 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 49 |
| 7881 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 44 |
| 7882 | Apheresis | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 73 |
| 7883 | Apheresis | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 46 |
| 7884 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 64 |
| 7885 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2008 | Standard Therapy | Germany | 25 |
| 7886 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 52 |
| 7887 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 45 |
| 7888 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 61 |
| 7889 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 58 |
| 7890 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 67 |
| 7891 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 57 |
| 7892 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2008 | Standard Therapy | Germany | 58 |
| 7893 | Apheresis | Autologous | Myosarcoma | Hematology | 2008 | Standard Therapy | Germany | 56 |
| 7894 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 55 |
| 7895 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2008 | Standard Therapy | Germany | 65 |
| 7896 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2008 | Standard Therapy | Germany | 62 |
| 7897 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 68 |
| 7898 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 52 |
| 7899 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 53 |
| 7900 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 67 |
| 7901 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 69 |
| 7902 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 56 |
| 7903 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 59 |
| 7904 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 52 |
| 7905 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 60 |
| 7906 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 67 |
| 7907 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 68 |
| 7908 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 57 |
| 7909 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 62 |
| 7910 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 63 |
| 7911 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 66 |
| 7912 | Apheresis | Allogeneic | Refractory Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 71 |
| 7913 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 53 |
| 7914 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 55 |
| 7915 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 65 |
| 7916 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2008 | Standard Therapy | Germany | 29 |
| 7917 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 38 |
| 7918 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 28 |
| 7919 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2008 | Standard Therapy | Germany | 21 |
| 7920 | Cord Blood | Allogeneic - Related | Neuroblastoma | Hematology | 2007 | Standard Therapy | Poland | 8 |
| 7921 | Cord Blood | Allogeneic - Related | Scid (Severe Combined Immunodeficiency) | Hematology | 2007 | Standard Therapy | Portugal | 1 |
| 7922 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2007 | Standard Therapy | UK | 7 |
| 7923 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2007 | Standard Therapy | Germany | 68 |
| 7924 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2007 | Standard Therapy | Germany | 38 |
| 7925 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2007 | Standard Therapy | Germany | 49 |
| 7926 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2007 | Standard Therapy | Germany | 57 |
| 7927 | Apheresis | Autologous | Myocardial Infarction | Hematology | 2007 | Standard Therapy | Germany | 61 |
| 7928 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2007 | Standard Therapy | Germany | 57 |
| 7929 | Cord Blood | Allogeneic - Related | Aplastic Anemia | Hematology | 2005 | Standard Therapy | Germany | 5 |
| 7930 | Cord Blood | Autologous | Brain Damage | Neurology | 2005 | Experimental Therapy | Germany | 1 |
| 7931 | Cord Blood | Allogeneic - Related | Leukemia | Hematology | 2005 | Standard Therapy | UK | no data |
| 7932 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2005 | Standard Therapy | UK | 4 |
| 7933 | Cord Blood | Autologous | Acute Lymphoblastic Leukemia | Hematology | 2004 | Standard Therapy | Germany | 3 |